



A Needs-Based Approach 
Edited by 
Yves Bergevin 
INTERNATIONAL DEVELOPMENT RESEARCH CENTRE 
Ottawa Cairo Dakar Johannesburg Montevideo Nairobi New Delhi Singapore 
Published by the International Development Research Centre 
PO Box 8500, Ottawa, ON, Canada K1 G 3H9 
November 1995 
Bergervin, Y. 
IDRC, Ottawa, ON CA 
Canadian Coordinating Office for Health Technology Assessment, Ottawa, ON CA 
Canadian Society for lnternational Health, Ottawa, ON CA 
Canadian University Consortium for Health in Development, Ottawa, ON CA 
University of Ottawa, Ottawa, ON CA. Clinical Epidemiology Unit 
PATH Canada, Ottawa, ON CA 
Health technology assessment : a needs-based approach. Ottawa, ON, IDRC, 1995.1 56 p. : ill. 
/Health services /, /technology assessment/, /needs assessment/, /developing countries/ - /health 
conditions/, /disease controll, /conference reports/, /case studies/ . 
UDC: 613:620 ISBN: 0489367523 
A microfiche edition is available. 
Material contained in this report is produced as submitted and has not been subjected to peer review or 
editing by IDRC Public Information Program staff. Unless otherwise stated, copyright for material in this 
report is held.by the authors. Mention of a proprietary name does not constitute endorsement of the 
product and is given only for information. 
International Development Research Centre 
250 Albert Street, PO Box 8500, Ottawa, ON, Canada, K lG  3H9 
Tel 613-236-6163; Fax 613-567-7748 
C A N A D A  
The International Development Research Centre O R C )  is funded by the Parliament 
of Canada but reports to an International Board of Governors. DRC7s  mandate is to 
support research for development through building indigenous capacity for such research in developing 
countries. D R C  therefore works predominantly through direct financial and tecbca l  support to 
developing country researchers in universities, government, business and nonprofit organizations. 
IDRC-supported projects are designed to alleviate poverty, maximize use of local resources, and 
strengthen human and institutional capacity. Through funding of scientific research in Africa, Asia, 
Latin America, the Caribbean, and Canada, D R C  helps communities in the developing world find 
solutions to social, economic, and environmental problems. 
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The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 
was created by the Ministers of Health (Federal, Provincial, and Temtorial) in 
December 1989, and has been in operation since August 1990. CCOHTA is a nonprofit corporation, 
wholly funded by the federal, provincial, and temtorial governments. 
CCOHTA7s mission is to encourage the appropriate use of health technology by influencing decision 
makers through the collection, analysis, creation, and dissemination of information concerning the 
effectiveness and cost of technology and its impact on health." 
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The Canadian Society for International Health (CSIH) is committed to the 
promotion of international health and development. Through the mobilization of 
Canadian resources, CSIH advocates and facilitates research, education, and service activities in 
international health. The Society seeks further progressive health and programming in all fields where 
global and domestic health concerns meet. Building on the past work of Society members and 
colleagues, CSM actively contributes to the evolving global understanding of health and development. 
CSM7s goals are 
To facilitate and strengthen communication and networking regarding international health and 
development issues, activities, and opportunities among health-related personnel and the public; 
To promote increased education (knowledge, awareness, and skills) of Canadians and overseas 
partners related to international health; 
To advocate recognition of the importance of health in development activities among Canadian 
policy makers, the public, and health-related professions; and 
To facilitate exploration of new ideas in education, research, and services in international health 
and development with Canadian policy makers, the public, and health-related personnel. 
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The Canadian University Consortium for Health in Development (CUCHID) aims to 
strengthen academic capacity for contributing to the solution of important global 
problems related to health in development, and to bring together Canadian and partner university 
resources in this process. 
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The main interest of the Clinical Epidemiology Unit of the University of Ottawa 
group is to study the determinants and consequences of clinical decisions and healthcare delivery. The 
members of the Clinical Epidemiology Unit focus on various areas of investigation, including the 
design and execution of clinical trials, studies of quality of life, technology assessment, health 
economics, and health policy. Resources for the Unit include state of the art computer facilities. The 
Clinical Epidemiology Unit is the latest addition to the Loeb Medical Research Institute. Its academic 
faculty currently include clinicians with training in epidemiology, biostatisticians, health economists, 
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pathCanada PATH Canada: Program for Appropriate Technology in Health Canada 
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Tel 613-233-0623; Fax 613-230-8401 
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PATH'S mission is to improve health, especially the health of women and children 
in developing countries. To accomplish this mission, PATH focuses on the appropriateness, 
effectiveness, safety, and availability of technologies for health and family planning. 
PATH defines technology to include equipment, drugs, devices, vaccines, and procedures used to 
prevent, diagnose, and treat illness and to meet health needs. Technology also includes the systems 
through which health care is delivered and the information that must necessarily accompany each 
technology. 
To accomplish its Mission, PATH 
Assesses technology-related health needs; 
Identifies, develops, adapts, and assesses health and family planning technologies that address 
these needs; 
Tests, produces, advances, and introduces affordable technologies in partnership with local private 
and public sector agencies; 
Assures that these technologies are widely available for the benefit of the public sector through 
intellectual property protection; 
Develops culturally appropriate communication strategies, capabilities, and programs that 
strengthen the technology introduction process; 
Develops and disseminates objective information on primary health care technologies and 
reproductive and child health; 
Strengthens local capabilities for technology assessment, development, production, and 
introduction; and 
Collaborates with national and international agencies and institutions that share a common 
purpose. 
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This conference was the result of a collaboration between the Canadian Coordinating W ~ c e  for Health 
Technology Assessment (CCOHTA), the Canadian Society for International Health (CSJH), the 
Canadian University Consortium for Health in Development (CUCHID), the Clinical Epidemiology 
Unit of the University of Ottawa, the Program for Appropriate Technology in Health Canada (PATH 
Canada), and the International Development Research Centre (IDRC). 
Conference purpose and goals 
Intended primarily for the key stakeholders of needs-based health technology assessment, including 
consumer groups and community representatives, policy makers, researchers, industry and professional 
organizations, etc., the Conference was designed to 
Provide a global and multidisciplinary forum for the debate on promoting needs-based 
technology assessment within a needs-based agenda 
Conference goals were to 
Strengthen international networks of stakeholders who will have a positive impact on health 
decisions regarding needs-based technology assessment and to develop a mechanism for the 
exchange of information amongst those working in technology assessment; and 
Facilitate discussions of the recommendations of the 1993 World Development Report pertaining 
to Health Technology Assessment. 
The goals were to be achieved by 
Identifying common issues around needs-based health technology assessment; 
Sharing international experience in needs-based health technology assessment; 
Developing strategies for improving international linkages and collaboration among key 
stakeholders and for implementing needs-based technology assessment in the Essential National 
Health Research (ENHR) framework; 
Facilitating the development of national research agendas in support of needs-based technology 
assessment as a component of the ENHR strategy; and 
Identifying potential areas of future collaboration and linkages. 
Conference Participants 
There were over 100 participants from 14 countries (see Appendix - Participants). Developing 
countries from Asia, Africa, and Latin America were represented. Participants included senior officers 
of international organizations, faculty members and graduate students from many universities, health 
managers, and health-care providers. 
Organization of the Proceedings 
The Proceedings are organized in three sections: 
Part I - Overview of Needs-Based Technology Assessment presents three key papers which set 
the Conference on a solid theoretical foundation 
Part II - The Case Studies includes six cases from different countries; each case study covers 
specific aspects of technology assessment 
Part III - Oppodunities and Challenges for Collaboration presents a needs-based technology 
assessment tool kit (presentation of the concept and key ideas emergng from group discussions). 
The attention is then focused on working in different policy environments. This section then 
concludes with synthesis and recommendations for action. 
This Conference would not have been possible if it were not for the hard work of members of the 
Organizing Committee and the support of the organizations they represented: Devidas Menon and Edie 
Clark for the Canadian Coordinating Office for Health Technology Assessment, Chuck Shields for the 
Canadian Society for International Health, Vic Neufeld for the Canadian University Consortium for 
Health in Development, Andreas Laupacis for the Clinical Epidemiology Unit of the University of 
Ottawa, Allan Ronald for PATH Canada (Program for Appropriate Technology in Health Canada), and 
Janet Hatcher Roberts for the International Development Research Centre. Finally, a special thank you 
to Peter Tugwell, Conference Chair, University of Ottawa, whose contagious smile, vision, patience, 
and hard work kept everyone working together to ensure the success of the Conference. 
Thank you to Flora MacDonald, Chairperson of the Board of IDRC, and to Keith Bezanson, the 
President of IDRC, for joining the Conference on the opening evening, for their warm welcome, and 
for offering IDRC7s hospitality for this event. 
Thank you to Chitr Sittiu-Amorn of the College of Public Health, Chulalongkorn University, Bangkok, 
for such a clear and thought-provoking opening keynote address and his Synthesis and 
Recommendations for Action at the end of the Conference. Thank you also to Helen Saxenian of the 
World Bank and to Peter Tugwell for their superb presentations. These three initial presentations set 
the Conference on a solid theoretical foundation. 
Going from theory to practice would not have been possible without the help of the case presenters: 
thank you to Yunkap Kwankum of the University of Yaounde; to Janet Hatcher Roberts of IDRC who 
graciously agreed to replace Ana Rita Gonzalez, of PAHO, who unfortunately could not attend; to 
Tessa Tan Torres of the University of the Philippines; to John Darmawan of the Seroja Arthritis 
Center, Semarang, Indonesia; to Marcos Bozi Ferraz, Escola Paulista de Medicina, Sao Paulo; to 
Ronald W~lson of the Aga Khan Foundation; and to Donald W. Juzwishin of the Greater Victoria 
Hospital Society, Victoria, BC, Canada. 
Thank you to the plenary Chairs: Jorge Peiia-Mohr, Allan Ronald, Jane Sisk, Vic Neufeld, and 
Davidson R. Gwatkin; and to the Cochairs: Don de Savigny, Pran Manga, Andreas Laupacis, Renaldo 
N. Battista, Arminee Kazanjian, and Santiago Lastiri. 
A special thank you to the rapporteurs for tackling the difficult task of capturing the essence of the 
discussions: to Jeea Saraswati, Kerry Rhoades, Kameshwar Prasad, Julie Delahanty, Matthew Hodge, 
and Christine Whalen. 
A special thank you to Elizabeth McGregor, of the Office of the President of IDRC, for sharing with 
us her experience on the use and development of tool kits. 
Thank you to Davidson R. Gwatkin of the International Health Policy Program, the World Bank, for 
his insightful advice on working in different, and at times difficult, policy environments. 
To Judith Maxwell of the Queen's-University of Ottawa Economic Projects, a special thank you for 
the relevance of her closing remarks. 
Thank you to all participants who, through their thoughtful contributions and team work, made this 
Conference a success. 
To Linda Russell, the conference coordinator who was responsible for the entire event running as 
smoothly as it did. To the staff who contributed to the coordination of the conference at IDRC, 
CCOHTA, and the University of Ottawa: Lyse Lavictoire, Susan Warren, Angie Anton, Hutoxi Noble, 
Vepe Percival, and Philipp Baker. 
Last, but not least, this Conference was made possible through generous contributions from the 
Canadian International Development Agency, the Canadian Society for International Health / Pan 
American Health Organization, the International Development Research Centre, the Rockefeller 
Foundation, and the Aga Khan Foundation. 
The Conference was designed: 
First, to provide a global and multidisciplinary forum for the debate on promoting needs-based 
technology assessment within a needs-based agenda; 
Second, to strengthen international networks of stakeholders who will have a positive impact on 
health decisions regarding needs-based technology assessment and develop a mechanism for the 
exchange of information amongst those working in technology assessment; and 
Third, to facilitate discussions of the recommendations of the 1993 World Development Report 
pertaining to Health Technology Assessment. 
There were over 100 participants from 14 countries. 
Part I of the Proceedings, Overview of Needs-Based Technology Assessment, presents three key 
papers which set the Conference on a solid theoretical foundation. Part 11, The Case Studies, includes 
six cases from different countries; each case study covers specific aspects of Technology Assessment. 
Part IU, Opportunities and Challenges for Collaboration, presents a needs-based technology 
assessment tool kit (presentation of the concept and key ideas emerging from group discussions), 
issues related to working in different policy environments, and the synthesis and recommendations for 
actions. 
Much as the concept of "essential drugs" has proven veIy useful, the concept of "essential methods" 
for community-based health development would promote orderly, globally consistent and standardized 
approaches to sound policy decision-malung. These essential methods could be regrouped in a "tool 
kit," a user-friendly, portable, interactive, flexible, electronic "tool box" containing a selection of 
"best-practices" and tested tools to assist health policymakers and providers in the planning and 
provision of health care to communities, districts and countries. These essential methods should 
include: 1) Assessment of "Burden of Disease" and "Needs"; 2) Priority setting for services, education 
and research (burden of illness, both current situation and future trends; community concern, political 
circumstances, the social environment and the economic context; health development strategies; cost- 
effectiveness of interventions); 3) Measuring Cost-Effectiveness; 4) Tools for "Equity" and 
"Distribution"; 5) Management Tools; 6) Policy Formulation Tools and; 7) Practice Guidelines 
Incorporating "Evidence-Based Technology Assessment." Furthermore, participants envisaged a 
network where users could seek advice and expert opinion by activating various nodes on the network. 
Conference participants recognized the invaluable contribution of the World Development Report 1993 
"Investing in Health" particularly in its approach to the assessment of "burden of &seasem through the 
use of disability adjusted life years (DALYs). Caution was expressed, however, in employing these 
methods indiscriminantly in the context of developing countries. These methods are relatively 
cumbersome. They require quantitative information and usually focus on "disease entities" rather than 
on "health determinants." The absence of good data, or the biases in existing data (e.g., referral bias 
from health facility-based providers) for important conditions such as violence against women, trauma 
from road accidents or physical violence); and the near impossibility to quantify the effects of health 
determinants such as education, sanitation and water, housing, nutrition, status of women and fertility 
could potentially lead to important miscalculations of the "ranking" of burden of disease or 
contributing factors. Furthermore, it was noted that the focus on disease entities could lead to a 
skewing of policy towards health service interventions where alternative health development strategies 
might have been more cost-effective. Tools addressing alternative "health development" strategses 
could be far more cost-effective and should be placed into the kit in a balanced and complimentary 
fashion. 
Such an approach is likely to lead to more cost-effective health development addressing priority 
community needs and employing the most appropriate technologies. 
Dr Keith Bezanson 
President of IDRC 
On behalf of IDRC, I would like to extend a warm welcome to all 
the conference participants. 
We, in IDRC, are very pleased to be associated with this 
conference; it is both important and timely. The World 
Development Report (World Bank. WorId Development Report 1993 
- Investing in Health. Oxford, 1993) made very clear, perhaps 
more clear than at any other time in recent years, that the link 
between the burden and the cost of disease on the one side and the 
availability of investment and action on the other, is extremely 
imbalanced: the burden of disease lies in countries largely in the 
South and the investment in technologies and the investment in 
health systems is largely in the North. One of the unequivocal 
challenges set out in the World Development Report is to deal with 
this situation in a constructive, systematic, balanced and responsible 
way. 
We were delighted to be part of the sponsorship of the first reflection following the publication of the 
World Development Report, the Conference on the Future Partnership for the Acceleration of Health 
Development, which took place here in Ottawa on 18-20 October, only 1 month ago. 
This Conference, Needs-Based Technology Assessment: Exploring Global Interfaces, is another very 
important follow-up to the World Development Report. 
I wish you fruitlid deliberations, which I am sure will contribute to our understanding of the role of 
technology in responding to priority health needs, both in the South and in the North. 
The Honourable Flora MacDonald 
Chairperson of the International Development Research Centre 
It is my pleasure on behalf of the Board of Governors of IDRC to 
welcome you to what I know will be a very unique and very 
important event. A few weeks ago, IDRC had the privilege of 
hosting the Conference which brought together key international 
donors to debate the recommendations of the World Development 
Report on health (World Bank. World Development Report 1993. 
Investing in Health. Oxford, 1993) and I understand that some of 
the highlights of that Report will be presented later during these 
Conference sessions. 
The World Development Report pointed out that the successes in 
terms of the improved health status have come about in part because 
of growing incomes and better education around the globe, and in 
part because of efforts by Government to expand health services 
enriched by technological progress. However, what is clear, very 
clear, is that we need to examine some of these health technologies that have supported this progress 
in terms of their cost to the system, the availability of and access to less costly alternatives, their 
relative effectiveness and their appropriateness to the health needs of particular populations. 
Considering alternatives may mean that we rethink approaches to prevention, thus diminishing the 
demand for certain health technologies, or that we try to understand better the full impact of 
development, evaluation and diffusion of technology. The role that research can play in such 
considerations, in particular that which is responsive to the health needs of populations or as the 
Conference pamphlet says, a needs-based approach, should have increasing priority. This Conference 
will provide the environment to share the lessons about some of these issues not only within the health 
sector but among sectors which deal with technology and sustainable development. As some of you 
already know, the UN Commission on Sustainable Development (The World Commission on 
Environment and Development. Our Common Future. Oxford, 1987) has identified the necessity of 
examining technologies in the context of human health. So, obviously the time is right to share. I am 
pleased do see such a good representation here among you from some of the IDRC supported projects. 
I know that their contribution will be very worthwhile. 
Given the agenda that has been developed for this Conference, I am sure that your discussions will be 
both lively and fruitful and that this will be a benefit to all of us. So, I wish you well. Thank you. 
Dr Devidas Menon 
Canadian Coordinating Office for Health Technology Assessment 
The need for health technology assessment has been talked about in Canada for many years now. It 
has become more pressing in recent years. The creation of the Canadian Coordinating Office for 
Health Technology Assessment (CCOHTA) was a response to this need. The situation in Canada 
which necessitated the establishment of CCOHTA was characterized by a set of factors. 
First, recognition for the vital importance of health technology and the major role it plays in the 
evaluation of our health care system and its cost. 
Second, fast-paced developments in medical research resulting in a constantly increasing quantity 
of innovations which, in turn, cause heavy pressures on available resources. 
Third, the lack of rationality in the way in which health technology is introduced, disseminated 
and utilized in Canada and the fundamental problems posed by the existing uncertainty as to its 
benefits, risks and costs as well as its economical, ethical and social impacts. 
Fourth, technology assessment is a key element in health policy formulation. In Canada, the 
provision of health services, and therefore technology management, is primarily a provincial 
responsibility. It can be linked with a complementary intervention by the Federal Government. 
And, finally, the necessity to experiment with new mechanisms to improve the functioning of our 
health care system and to improve the utility of intergovernmental cooperation. 
As a result, in December of 1989, the 13 governments in Canada agreed to jointly establish and fund 
CCOHTA. CCOHTA became operational in August of 1990. Our principle purpose is to facilitate 
information exchange, resulting in pooling and coordination of the assessment of technologes. 
Health technology assessment clearly is a global activity. Many jurisdictions face similar technology 
issues and it is imperative that we create networks and linkages. CCOI-ITA itself has a mandated 
international role, specifically to establish links with agencies involved in technology research, 
development and assessment. Our participation in the international arena has slowly but surely 
increased over the three years that we have been in existence. We continue to be approached regularly 
by groups and individuals for various countries, to name a few, Israel, Hungary, Cuba, South Africa, 
and Mexico, seeking advice on and support for developing technology assessment programs. It appears 
the Canadian model we have developed is an attractive one to many countries. 
Two months ago, a new network which is now come to be called the International Network of 
Agencies for Health Technology Assessment was created by a group of twelve organizations in nine 
countries. I am proud to say that CCOHTA was selected unanimously to be the organization to serve 
as the International Network Secretariat. Clearly, our international role will increase. So, it is no 
surprise that we have an interest in a Conference such as this on exploring global interfaces in Needs- 
Based Technology Assessment. 
I would be particularly interested in hearing during the course of this meeting what participants here 
perceive Needs-Based Technology Assessment to mean. To people like me who are responsible for 
running a technology assessment organization, there must not be any technology assessment 
undertaken unless the need for it has been identified. The need is always for information but of 
specific types. The information is needed for decision-malung or policy-making. It could be to decide 
on an acquisition of a new technology by a hospital, to decide on a national screening program, to 
decide on the appropriate medical intervention in a given situation, to develop a clinical practice 
guideline, to decide whether a particular treatment should be paid for by an insurance plan, and the 
list goes on. These are some examples, but they point out that questions on health technologies are 
asked by people in every sector of health care, including consumers. The assessments that are done 
therefore depend upon the perspective of who it is that is doing the assessment. The need in other 
words is perspective-dependent which brings me back to Needs-Based Technology Assessment. My 
request to you, as participants in this Conference, is to give some thought to what exactly you mean 
by this and in this, to recognize that there are many diverse groups that require technology assessment 
information and that need may differ. It would be very useful to have at the end of the 2 days, an 
explicit statement about this that recognizes the different lunds of needs that exist. 


HEALTH TRANSITION AND 
N EEDS-BASED TECHNOLOGY ASSESSMENT 
Chitr Sitthi-Amorn' 
Although health has long been considered a nonproductive sector of the society and many think health 
will improve if the economy improves, there are additional benefits that health can add to 
development independent of economic improvement. Unfortunately, in most instances, health is a 
market failure, i.e., one cannot privatize health and expect the market to provide good, fair, and 
equitable services. 
Why does health matter? It matters because people care about their health and spend money on it. In 
addition, good health improves economic performance and productivity. Healthy children do better in 
education, which is linked with productivity and economy. Finally, if people are healthy, less will be 
spent on health. 
Elements of Health Situations and Their Solutions 
Components of health development consist of 
i) Analysis of the changing contexts of health needs; 
ii) The response to the needs via policy, program planning, improved performance of health services, 
capacity strengthening, and information and research for decision; 
iii) The promotion of appropriate consumer's demand and responsibility through monitoring variation 
of use, demand, and practice with implication for equity to access and coverage; and 
iv) The assessment of outcomes. 
Policy makers and providers of health services must be accountable to the public. The people have 
their right to be healthy but they must also be responsible for their behaviour. Therefore, all 
stakeholders in health must be involved in need- and knowledge-based health systems, providing and 
generating information for decisions and actions. This is the case both for developed and developing 
countries. 
Chitr Sitthi-Amom, MD, MSc, PhD, is a Professor of Clinical Epidemiology at the Faculty of Medicine at 
Chulalongkom University, Bangkok, Thailand, and Dean of the College of Public Health. He is a member of the 
International Clinical Epidemiology Network (MCLEN) and a current Council member of the International 
Epidemiological Association. Among his numerous international activities, and of particular interest to this 
conference, Dr Sitthl-Amorn has contributed to the Commission on Health Research for Development which 
published Health Research: Essential Link to Equity in Development. He is also a member of the Planning and 
Advisory Committee, University Partnership Project in Essential Health Research. Recent publications include 
"Setting Research Priorities at the Country Level" (Bridge, 12, 1-2, 1993) and "Biases in Medical Research" 
(The hncet ,  in press). 
Health Needs 
Indicators of Health Needs 
Mortality has long been used as the main indicator of health. Mortality is expressed in many forms 
such as life expectancy, infant mortality, and mortality from specific diseases or in specific subgroups 
of the population. The potential years of life lost (PYLL) method has been used as a common 
indicator of mortality for comparison across diseases and population subgroups (NEB 1987; Anon. 
1989). 
Due to a reduction in mortality and increase in morbidity, mortality-related indicators are not sensitive 
enough reflect the true burden of illness. This led to the development of many indicators representing 
both mortality and morbidity, such as the healthy days of life lost (HDLL) (HAPT 1981), the quality 
adjusted life years gained (QALYs) (Torrance 1986), and the disability adjusted life years (DALYs) 
(World Bank 1993). DALYs is the most recent indicator used in the 1993 World Development Report. 
These indicators were based on certain assumptions. While they are useful for international 
comparison, the assumptions might not work consistently from culture to culture, particularly those 
dealing with giving values to life and discounting. 
InsuBcient effort has been geared towards inclusion of people's perception in the measurement of 
needs. 
Lack of data for use to estimate health needs is a deficiency particularly in developing countries. 
Many times, utilization data were used as estimates of need. This is not a good estimate because 
people who use the services may not need them and vice-versa (Wadswarth et al. 1971; Sitti-Amom et 
al. 1989). Supply-induced demand for services is a common occurrence. Utilization does not tell us 
what volume of service is optimal, particularly if non-cost effective services are given. It is important 
to know what volume of health services should be consumed, to what extent the volume actually 
consumed reflected what should be consumed and to what extent the service actually consumed do not 
coincide with what should be consumed. Without appropriate data, decision makers might focus on 
provisions without meeting needs. A need-based system is difficult but it is essential to establish one 
so that people will be more responsible for what they do. 
Better health is not only freedom from illness (D7Souza 1978; Cambell et al. 1979). It requires health 
promotion and disease prevention which involve intersectoral issues with implications for physical, 
mental, social, and spiritual well-being. How to incorporate mental, social, and spiritual elements into 
the measurement of health is a challenge. 
The Current Health Situation 
A High Avoidable Burden of Illness 
Currently, too many deaths and much suffering result from the avoidable burden of illnesses. In 1990, 
there was a loss of 1.36 billion DALYs worldwide. Of this loss, two-thirds (893 million DALYs) were 
from premature death and one-third (468 million DALYs) were from disability. Communicable 
diseases accounted for 46% (624 million DALYs), noncommunicable diseases for 42% (575 million 
DALYs), while injuries for 12% (162 million DALYs) (World Bank 1993). 
Health Status Inequity: There has been a clear inequity with respect to health status. Avoidable deaths 
and sufferings affect the world population differently. The DALYs from communicable disease 
accounted for less than 10% among the industrialized countries and more than 71% in sub-Saharan 
Africa. 
Variations were also observed between the rich and the poor. In Thailand in 1987, the infant mortality 
differed two-fold between regions. In the Northeast, a great deal of infant mortality is not reported. 
The difference might be greater than what is shown in the public data (PSR 1988; HSD 1988; Hsiao 
1993; Pavabuta 1993). 
Inequity of Finance: Even though there are six major health insurance schemes, Thailand has not 
insured 49% of its people. There is no organized financing for half of the people. In addition, the 
spending by the scheme is uneven. For the civil service, a person got 916 baht in 1992, compared to 
only 65 baht for the Health Card Program. The benefit coverage varies greatly. Therefore, the poor or 
the near poor do not have any organized financing arrangements. Even for those who have coverage, 
it is often inadequate (Hsiao 1993; Mills 1991; Mongkolsmai et al. 1993; Mongkolsmai 1993; 
Kranandana 1993; Ni ttayaramphong et al. 1993; Pannarunothai and Tangcharoensathien 1993; Rojvanit 
1993; Tangcharoensathien et al. 1993; Wilbulpolprasert 1991). 
Inequity of Service Delivery: Despite the poor health status of the underprivileged, there has been an 
uneven distribution of resources. In Bangkok, there is one physician for 958 people. There is a 10-fold 
difference in the Northeast, where there is one physician per 10,900 people. Similar situations exist for 
hospital beds. There is a three-fold difference is hospital bedslperson in Bangkok compared to the 
Northeast (RHD 1991; Hsiao 1993). 
We need to use the variations of health needs as a basis to reduce inequity through decisions on 
regulation, efficient finance, and service delivery. 
Trends and Transitions 
The current health needs is useful for dealing with problems of the present and the past. We need 
information on trends of health and diseases to design actions to cope with problems of the present 
and future. 
Demographic Trends 
The pattern of population structures has changed worldwide. The population pyramid has a narrower 
base. The elderly are becoming more significant. Fertility and mortality declines go hand in hand 
(Prachuabmoh Ruff010 1993). 
Epidemiologic Trends 
Epidemiological changes are fundamental to health reform. The trend includes a substantial increase in 
life expectancy worldwide, and a more rapid decline in mortality from communicable diseases 
compared to the noncommunicable diseases. Mortality among the young has fallen much faster than 
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among the old. In the last 40 years, mortality has fallen more than in all of human hstory. From 
195&1990, in less developed countries, the life expectancy has increased from 40 to 63 years. The 
risk of dying by age 5 has fallen from 29% to 11%. The greatest effect has been in communicable 
diseases and in the diseases of the very young. We eradicated smallpox, eliminated polio in the 
Americas, and we are working to eliminate polio in Asia. We also made progress in the health of 
adults. 
The rate of change differed in different regons. Mortality before the age of 5 is still a problem in sub- 
Saharan Africa and the Middle East Crescent. In South-East Asia, the probability of dying by age 5 
reduced by 50%. The median age of death also shows a comparable trend. 
The epidemiological transition is complex: 
i) overlap between pre- and post-transition situations; 
ii) resurgence of diseases that have already been controlled; 
iii) a resistance to control such as with malaria; and 
iv) the increasing disparity between population subgroups: rural (communicable disease and 
malnutrition) versus urban (noncommunicable disease and injury). 
Morbidity has contributed a greater share to the burden of illness: problems of infancy and childhood 
involve the diarrhoea-pneumonia-malnutrition triad, the so-called diseases of poverty. There is a need 
for diligent control. 
First, there is a need for the promotion of sanitation and hygiene. We still have a major problem 
with intestinal parasites that can produce diarrhoea and malnutrition. Ascaris and hookworm 
infestations are still important for Thailand and other developing countries. 
Second, food and nutrition programs are needed in rural areas and for the poor in Bangkok. 
Third, there are still occurrences of many vaccine-preventable diseases such as measles and 
hepatitis; the prevention of these conditions require a relatively high investment. 
Finally, vector-control programs need diligent attention. Malaria, dengue haemorrhagic fever, and 
Japanese encephalitis are still prevalent. Vaccines are being developed for these vector-borne 
diseases but, until we have good vaccines, control of vectors should be our prime focus. The 
outcomes of all of these diseases lead to long-term disabilities for our children. If the children 
survive these, they will be stunted, or become disabled throughout their lives (Pavabuta 1993; 
World Bank 1993). 
The health problems of adults can be described as being in two main groups: diseases of afnuence and 
social pathology. Diseases of affluence include: obesity, diabetes, and hypertension; cardiovascular and 
cerebrovascular diseases; cancer; and reproduction-related diseases (NCI [I 9811; DHS [1988]; 
Department of Labour [1989]; NEB 1990a; Pavabuta 1993). Diseases related to social pathology are: 
injuries, violence, and crime; drug and alcohol abuse; occupational health problems; environmental 
pollution; and sexually-transmitted diseases including AIDS (Anon. 1993). Tuberculosis will continue 
to be a major problem. The rise of AIDS and drug resistance is bound to magnify the problem of 
tuberculosis. Malaria is one of the diseases that does not recognize national boundaries and, in some 
areas, is associated with migration and occupation (e.g., gem mining) @vision of Epidemiology 
[1991]). Drug-resistant malaria strains are prevalent along the border of Myanmar, Cambodia, Laos, 
Vietnam, and South China. The number of people in the infection zone is estimated at 300 millions 
with one-fifth being infected. 
The campaign against smoking has not been satisfactorily addressed, except for some effort in 
Singapore, Thailand, and Papua New Guinea. There is a rising trend of cigarette smoking is Asia 
compared to a lowering trend in the US, Canada, and Australia. In China alone, the consumption of 
cigarettes rose from 500 billion in 1978 to 1700 billion in 1992. If the trend persists, 2 million tobacco 
related deaths per year are projected for China (World Bank 1993). There is a long delay of lung 
cancer in US males with the increase in smoking in 1945. The main control strategies are not those of 
health care services but those of education, information, health promotion, and taxation. Smohng- 
related deaths in developing countries will rise from 1.7 million in 1990 to 4.5 million annually by 
2015. 
Health problems of old age are posing a greater burden to society. Aging will quadruple by 2030 with 
all its attendant ill health. The aged proceed along a continuum from healthy to unhealthy life. The 
objectives should be to prolong the healthy part of their lives and to enable them to cope with the 
increasingly unhealthy part of their lives (degenerative diseases, loss of mobility and perceptual acuity, 
mental problems, etc.). In addition, their care will require investments in housing and recreation. 
Medical approaches involve prevention, care, and cost control. With an increasingly higher proportion 
of elderly, health care costs will rise dramatically (Prachuabmoh Ruffolo 1993). 
The newly industrialized countries (NICs) are seeing a rapid increase in occupational injuries and 
diseases. The growing urbanization and the environmental threat will present major health challenges 
(HAPT 1981 ; Chunharas et al. 1990; Ngarmwuthiporn 1992). 
The epidemiological transition is also associated with a change in the social meaning of diseases: 
illness episodes are not only acute events but can be chronic and thus more likely to create 
stigmatization. The burden of illnesses includes not only prevalence and incidence, but also perception 
of people about their needs. 
Trends in the Social Demand for the Right to Health 
With education and unprecedented effectiveness of media, the people or consumers of health care will 
have more knowledge about their right to health care and can exert certain claims (Porapakkham 
1987). How can we promote positive changes based upon need and cost-effective interventions 
reflecting the collective will of the society? This will be a challenge. 
Technology Trends 
The social demand for the right and the development of more sophisticated and more expensive 
technology can increase health care costs drastically particularly if there is no consciousness of cost- 
effectiveness. Efforts must also be made to raise the responsibilities of the people which should come 
with their rights to reduce inequity and decrease polarization between subgroups. The disadvantaged 
would otherwise lose in the competition for resources (NEB 1990b; Chaudhury Roy 1993). 
The Responses to the Needs 
With the changes in health problems, there must be a corresponding change in health system response 
to reduce the gap between what is attainable and what is being attained. The policy, programs, and 
organization arrangements for and financing of health care delivery must respond to need and achieve 
equity, efficiency, and quality of care. Health transition is a continuous process. The response must be 
dynamic and specific to the transition situation. 
The Reasons and Objective of Responses 
There are many reasons behind the government response to health needs: 
First, the health market is a failure. If the market works perfectly, there is no need for government 
intervention. The market fails in health because the patients are ignorant and desperate and doctors not 
only sell services but also generate the demand for them. The health insurance market fails from moral 
hazard and adverse selection. The health care market fails as health is a public good. There is a high 
cost associated with giving relevant information to consumers as well as making the wrong choices. 
This suggests that the demand for health services is unlike the demand for other goods because society 
value people's health independently from what they are willing to pay for it. Hence, looking at health 
like any other commodity or using rules for public finance theory to subsidize it optimally is 
inappropriate. 
Second is the need to improve equity while reducing cost. Cost containment is working to some 
extent in Canada and Western Europe. The economic crisis led to reform in Latin America. Scarcity of 
resources has challenged Asian and African countries. 
The third reason is the right of the individual as a citizen of a society to have access to certain basic 
essential health services. The disabled and the disadvantaged should have equal opportunity to 
participate in the society; a functioning civil society requires participation by everyone. The 
government acts to ensure equity, efficiency, and quality of services. Individual preferences must be 
ovemdden by the government, e.g., drug abuse, the compulsory wearing of seatbelts and compulsory 
pension scheme. 
Fourth, governments intervene because of concern for future generations, e.g., preventing global 
warming, conserving rain forests, etc. 
Finally, political views and social values led to changes in the former Soviet Union and Eastern 
Europe while belief in the market mechanism over state intervention has dictated the American 
system. 
Health development consists of defining the targets and the means to reach them. Primary Health 
Care, Health For All, and Child Survival, health care financing, decentralization, and privatization are 
means to achieve targets. The most recent World Bank Development Report represents a major effort 
to quantify the global burden of illnesses and the cost-effectiveness of health interventions. These are 
also means to reach the targets. 
The target of health care responses include: 
Improving aggregate health status; 
Improving equity and reducing poverty; and 
Improving individual quality of life. 
These are the three poles. Most health care aims to include some of the three objectives. Each goal 
may have some elements which contradict with other goals in terms of the actions required. 
For improvement of health status, the Ministry has to adopt technology and programs which yield 
the greatest impact in health status. The government can use the analysis of burden of disease and 
cost-effectiveness to set priorities and choose interventions that will yield the most good to the public, 
i.e., maximize cost-effectiveness interventions to improve health status. An example of pure public 
goods is aerial spraying for mosquitoes. If the private sector can provide the service, the government 
should let them do so. For services which the private sector can gve, the government has to estimate 
the capacity of the private sector and provide service only to areas where the private providers cannot 
deliver it. This requires data on demand for public and private services as well as the efficacy of 
government and nongovernment services. 
For improvement of equity and reducing poverty, the most effective way is to target essential 
health s e ~ c e s  to the poor alone. The poor carry a higher burden of illness and they have the least 
capacity to purchase health services. Spending on general health for all usually does not work because 
of the leaking of benefits to the non-poor. Only cost-effective services should be given. 
For improvement of individual quality of life, the Ministry of Health invests in things that do not 
improve health per se but that will improve other things such as productivity and self sufficiency. For 
example, the ability to provide service with shorter time or in the evening will allow people to come 
for government service and free their time to work and earn their living, i.e., the government gives 
services which cannot be provided in the market, are cost effective, and improve the quality of life 
and not just health. 
Nature of Response 
Policy Response 
A Total System Response: Response should be made from the viewpoint of a total system and not 
only some of its components. For example, Primary Health Care is a movement leading to a consensus 
about financing and delivering of health care. But Primary Health Care is only a component of 
response system. The health system includes 
The units providing health services at various levels; 
The consumers of health service; and 
The interrelation between the providers and the consumers. 
The whole health system is different from the sum of its parts because of the tensions between interest 
groups within the system and its relations with its external environment. Therefore, the health system 
is complex. 
The Components of Policy Response: The policy of the government should address at least four 
issues: i.e., the target groups, the regulations and their enforcement, financing, and the delivery of 
services. 
Target Groups: If equity is what the government wants, then the policy must define 
disadvantaged groups most in need of health care who do not have the ability nor the incentives to 
pay for it. The basic care must be of high quality and cost-effective. The package must include 
interventions, both preventive and promotive, that can cope with the major disease burden. As 
citizens of the country, the disadvantaged groups are entitled to receive the services regardless of 
their ability and willingness to pay for the services. 
Regulations: The aim of policy response is to promote a positive interaction between providers 
and consumers of services. Such interactions are complex because provider and consumer do not 
act alone but belong to their respective organizations. Moreover, their relationships are not direct 
but mediated by actors such as the insurance company. Regulations are needed to ensure a fair 
and productive interaction. 
Financing: The aim of policy response is to ensure adequate financing of high quality, cost- 
effective, basic health services to the target groups. It involves the generation of fund, payment 
schemes, the population covered, benefits, and monitoring of the performance. 
Delivery of Services: The aim of policy is to ensure quality of the cost-effective services 
provided. The quality of cost-effectiveness packages have to be addressed not only in the 
professional sector (public and private), but also in the folk sector and the popular sector. 
Policy Implementation and Evaluation: This include the development of strategic program and 
operational plans according to the above policies. Designs of essential information of resources for 
implementation of cost-effective packages, information on quality of health-system performance, 
utilization, and change in health outcome will be needed. 
Strategic Program Planning 
The aim of strategic program planning is to maximize allocative efficiency of resources, such as the 
use of the national health expenditure account to help diagnose allocative inefficiency. 
Defining AUocative Inefficiency: In Thailand, the National Health Expenditure Account adjusted for 
1992 prices showed that the health expenditure was 4.5% GDP in 1982 compared to 5.9% in 1992 
(Hsiao 1993). Despite a very rapid economic development, the health sector has grown faster than the 
economic sector. The health expenditures almost tripled during the period (46,490 baht versus 148,455 
baht). However, the government expenditure has remained fairly constant or increased slightly. Most 
of the money spent comes from the private household expenditures. Therefore, Thailand is spending 
more on health; the spending largely came from the individuals; and the rate of increase is faster than 
the 6% enviable increase in income. Despite the highest spending of Thailand's GDP on health care, 
the country does have relatively poorer life expectancy and infant mortality compared to Malaysia 
which spent less of its GDP on health (3.5% of GDP). Therefore, the money may not be spent 
efficiently under the present structure of health care in Thailand. Part of the inefficiency may be due 
to the organizational inefficiency. This partly depends on the integration of private and public sectors. 
The private sector is growing very rapidly and is drawing away health personnel from the public 
sector because of a much higher compensation. The private sector is duplicating new and expensive 
technologies. So, there are duplications and competition between public and private sector because of 
the different compensation system. To what extent t h~s  results in greater or less efficiency in the 
delivery of health services remains to be determined. 
The allocative efficiency may be estimated by calculating the production function (health output 
versus expenditure). The databases required are 
Regional burden of illnesses such as DALYs; 
Cost-effectiveness estimate (marginal cost versus increase output); and 
Health resources in terms of the available human and physical infrastructure. 
The production function is used to optimize health gain at any budget level (allocatjve efficiency). 
From the optimal health gain, we can find the gap between reality and what should be optimal. The 
primary sources of the gap is the lack of adequate information on whether the resources are targeted 
towards delivery of the most cost-effective intervention to the priority burden of illnesses and 
inappropriate institutional management or strategy. 
Cost-Effectiveness Interventions for Significant Health Problems (Evans 1994; Jamison 1994): The 
Oregon Health Service Commission and the World Bank report introduced an approach to health 
development based on cost-effectiveness and allocative efficiency (HSC 1991; World Bank 1993). 
Although most cost-effective interventions are preventive and promotive, the analysis showed that 
some of the most cost-effective interventions can be curative while some cost-ineffective interventions 
are preventive or public health programs. Cost-effective interventions must be packaged because the 
effectiveness of some intervention may depend on the availability of other interventions. Examples of 
a public health package include EPI, expanded EPI, micro-nutrients, school health, family planning, 
nutrition, education, and AIDS prevention program. Clinical packages include short course 
chemotherapy for tuberculosis, management of a sick child, prenatal and delivery care, treatment of 
STDs, and limited care for emergency operations, e.g., appendectomy, minor trauma, and broken 
bones. The necessary basic service such as sanitation and water supply are also crucial. Essential 
health intervention packages include an appropriate balance between preventive and promotive 
strategies versus treatment and rehabilitation. Other development measures in fulfilment of nonhealth 
needs can also lead to health improvement. For example, the role of women on health and life 
prospects of their children is crucial. We then should find ways for them to be healthy: nutrition, 
education, understanding gender role, and practices. How would social and other nonhealth 
interventions affect the vicious cycle of poverty, ill-health, and the lack of social development? This 
general area will remain active for research in years to come. 
The use of the cost-effectiveness model together with the global burden of illness estimates is useful 
but has to be done with care since the model assumes that the individuals have an additive, 
discounted, multi-period utility function for purposes of generating health care demand and that the 
utility of extra life is equal to the utility of consumption within that period of time. The utility of 
function is then weighted by the quality of life or disability weight. Actually, there may be other 
reasons for extending lifespan than the opportunity it gives to consume more. People may want to 
extend their life for many reasons, e.g., seeing their grandchildren grow up or finish education. These 
judgements are not based on valuing additional years of health for life in terms of extra consumption 
but rather what they enable a person to do or be. The second implication of the cost-effectiveness 
model is that it implies a lower valuation of extra years lived by those with disabilities or people in 
the higher age groups. Extending the life of a disadvantaged person who is wheelchair bound counts 
for less than extending the life of enabled body person. This lower valuation may be contradictory to 
justice that priority should be given to the disadvantage or least well off. 
Organization Aspects of Health System: Maximization of allocative efficiency involves the whole 
health system: i.e., the public health facilities, the private sectors, folk sectors, the popular sector, the 
communities, workplace, families, and individuals. At the moment, a major part of allocative 
inefficiency depends on the integration of private and public sectors (Hsiao 1993). The private sector 
is growing very rapidly and is drawing away health personnel from the public sector because of a 
much higher compensation. The private sector is duplicating new and expensive technologies. So, 
there is duplication and competition between public and private sector because of the different 
compensation system. To what extent does this result in greater or less efficiency in the delivery of 
health services? Privatization will not facilitate universal access to health care. It must be brought in to 
free up resources for those who can pay for the services and freeing resources for the basic cost- 
effective quality services for those who could not pay. More active work and more cross-cultural 
comparisons are needed in this respect, particularly where more privatization is coming up in many 
countries, including Eastern Europe. How far these trends will alter the basic relationship between 
patients and health care professionals resulting in an impact on health and the quality of service is at 
issue. 
Since the major activities are still in the public sector, particularly in the Ministry of Public Health, 
the role of the Ministry must be redefined in the light of this new trust for essential cost-effective 
packages and the organization structure modified accordingly. 
Financing Aspect o f  Health System: In the World Development Report 1993 (WDR), the data 
showed that the health system is financed by public and private input and as income rises spending on 
health does increase. The world spends $1.7 trillion annually on health, less than 10% is spent in less 
developing countries (World Bank 1993). About half is spent by government and half by private. At 
the moment, the spending may not be efficient. Poor spending, internal inefficiency (e.g., spending 
money on salary in health station with no drugs), inequity, and cost escalation cause allocative 
inefficiencies. When the GDP increases, the amount spent on health also increases, both in the public 
and household sector. 
Since the private market will not provide public goods and goods with substantial positive 
externalities, the government should provide the minimum basic essential cost-effective package or at 
least pay for the package. However, a public good should be financed because it is cost-effective and 
not simply because it is public. Choosing to finance packages in decreasing order of cost-effectiveness 
is the way to maximize the health gain. However, the interventions must be "packaged" to exploit 
joint costs and synergies, particularly if a small number of interventions can deal with a large share of 
the disease burden. In low income countries, the current annual spending is US $14 per capita of 
whlch US $6 is public. In middle-income countries, the current spending is US $1 13 per capita of 
whlch US $60 is from public. The minimum package defined in the WDR cost US $12 per capita in 
low income countries, and US $22 per capita in middle-income countries (the differences in due to the 
different wages in the two systems). Therefore, most countries are capable of caring for the minimum 
essential package. 
There is little justification for public financing outside the package. We need to expand the insurance 
scheme for the purpose. Insurance coverage is crucial for more expensive interventions because people 
can pay out-of-pocket for cheaper services. The government need to intervene to ensure that freedom 
of choice in any insurance scheme does not contradict with cost-effectiveness principle within a given 
coverage. 
Also, the coverage is not inferior to an uninsured person paying out-of-pocket. Third-party insurance 
may not be cost-effective if 
Coverage does not include conditions with cost-effective interventions; 
There is moral hazard and adverse selection; 
There is an urge for maximization of health gain at the expense of third-party payment; 
The patients are ignorant and desperate; and 
A demand is created for services that are not cost-effective. 
By getting people's agreement to coverage for a set of interventions, insurance can be useful. Second 
party insurance particularly by the physician such as in Health Maintenance Organisations (HMOs) 
showed that it could control cost better without sacrificing health gains (Anon. n.d.). Government 
insurance can make a difference if it provides interventions which are cost-effective, cover the right 
target, waste no resources on delivery, and provide quality service so that people do not spend money 
elsewhere. Ideally greater public control of expenditure promotes value for money if they have good 
criteria for what to finance, who to finance. Cost-effectiveness should be one criteria. Governments 
should intervene when private markets fail. 
Individual and collective behaviour in seeking and paying for health care must be consistent with cost- 
effectiveness. Unfortunately, most individuals are not well informed about the probabilities of health 
outcomes given a set of interventions. Uncertainty about the outcome make it difficult to behave cost- 
effectively. There is no evidence that charging "user fees" will "rationalize" demand. The RAND 
experiments found that higher prices reduce demand but do not make the interventions more cost- 
effective. 
Monitoring of practice variation and use variations can be used to detect supply-induced demand as 
well as inappropriate utilization. Practice and use variations depend on which scheme health care 
providers are paid. In the USA, the rate of Caesarian section has been much higher than in England 
with no significant differences in infant and maternal outcomes. Therefore, it is not always true that 
more services lead to more coverage of those who are in need. On the other hand, the hospital might 
not give standard cost-effective services if they are costly if the capitation scheme is in place. The 
people who are under coverage of health care financing schemes might over- or under- utilize services 
depending on their perception of the right to get the services and the quality of the coverage under the 
scheme. 
We have to associate population denominators with the numerators, particularly where the people in a 
catchment area can use many service facilities for the same health condition. In thls general area, the 
topics of national salience are those of access, equity, and coverage. Access, equity, and coverage 
must be examined across several groups distributed by geography, income, age, sex, and occupation 
among others. 
The steps for maximization of allocative efficiency include: defining the important burden of illness, 
searching for cost-effectiveness interventions (or intervention packages), looking at resources 
(structure/manpower), calculating the optimal production function and subsequent allocative 
inefficiency, determining the causes of such inefficiency, and finally designing new alternatives to 
reduce inefficiency. 
Each of the various alternative models have their strengths and weaknesses. Each of them might be 
the most appropriate for meeting the needs of health service, depending on the situation. However, 
there are some common targets of all models of financing. These are equity, efficiency, stability, 
sustainability, administrative feasibility, and health impact as well as impacts on socioeconomic and 
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political system of a society. With the possible variations of the organization of resources with respect 
to the structures and financing of services, alternative models have to be developed, tested, and 
compared. 
Organizational Performance 
Organizational performance includes technical efficiency and quality. Both result from critical 
appraisal and optimal application of existing knowledge and from institutional management 
(incentives, reimbursement mechanisms, regulation, etc). 
With respect to technical efficiency, the cost for in-patient admissions vary between 1,000 and 1,500 
baht per admission to more than 3,000 baht per admission, i.e., there is a two- to three-fold difference. 
If we are treating similar diseases, why should there be such cost differences (RHD 1991; Hsiao 
1993). 
With respect to the optimal application of existing knowledge, a reason for variation is the amount 
spent on drugs. Japan spent US$412/person/year, while Mozambique only spent 2US$. About 60% of 
Thailand health expenditures are on drugs (World Bank 1993). People go to pharmacists and get their 
drug directly or they receive drugs from physicians and from the hospital (Hsiao 1993). Is the safety, 
efficacy, and efficiency of drugs being assured for the people? We have to think of how to implement 
the concept of essential drugs and revise essential drug lists using cost-effectiveness principles. 
For optimal application of knowledge and management, we need to use the concept of Total Quality 
Management (TQM) and setting standards (Sitthi-Amorn 1989; Berwick et al. 1990). When we spend 
money and organize the delivery of services, we have to ensure the best quality within the existing 
resources and organizational arrangement. Right now, Thailand does not have adequate monitoring of 
quality of services in the hospital. Thailand is growing rapidly and is a country in transition. The 
standard of service and the regulations are not keeping up with the economic trend. We must set up 
adequate standards for all types of providers (hospitals, clinics, and pharmacies). 
The field of clinical epidemiology, decision analysis, and clinical economics has made a great 
contribution for assessing performance and increasing technical efficiency. It is not only the expensive 
technologies that are analyzed. The inexpensive, moderately priced, every-day practices must be 
evaluated, including preventive activity, immunization programs, and screening for chronic diseases 
for which early treatments are available. 
Health providers must have skills to evaluate their own practices and be more accountable for their 
decisions. Research should empower these practitioners to ask questions about health care which leads 
not only to the heightened expectation and demand for quality, accessibility at reasonable cost, but 
also creates an environment in which health-care research has reason to grow. The emphasis in 
increasing health system performance must shift from a traditional study of inputs (e.g., personnel, 
facilities, procedures, appliances, and drugs) to the evaluation of health-care outputs. 
In addition to clinical epidemiology, the creation of competition through privatization is a measure to 
deal with the management component of institutional techca l  inefficiency. 
Capacity Strengthening (Frenk 1992; Ai tken 1993; CPH 1993) 
The possible personnel requirement is also an important issue. What are the appropriate proportion, 
types, qualifications, and distribution of personnel required to cany out cost-effective packages based 
on needs? An analytical framework for needs-based human resource development has been developed. 
Essentially, the implication of the basic essential package on human resources must be determined in 
terms of the role and function required, the capacity of personnel required to fulfil those roles and 
functions, and how to acquire those personnel. How far should the "unqualified" personnel be trained 
to support the system? What is the role of informal care and self care? If we can use more of the so- 
called "unqualified personnel, family support, and self care to deliver similar services, it would affect 
the resources needed to deliver the essential packages. Ideally, plans for new capacity strengthening 
must be based on skills and functions which are different but complementary and add to the functions 
performed by the existing working personnel. Within this context, we need to identify new and 
complementary functions before we can develop our programs. 
Since variations exist with respect to the health needs in the locality, public health personnel should be 
able to identify local problems distributed among various populations. They must be able to consider 
intervention packages which are cost-effective and can be delivered with high quality at reasonable 
cost. 
At a higher level of training, some local policy makers, administrators, and health care providers must 
be able to analyze factors influencing equity, efficiency, and quality of basic essential cost-effective 
health care. These include the political economy, social development, and laws and law enforcement. 
Social development has introduced behavioral changes in many respects. Economic development 
affects people's ability and willingness to pay for their health care, while the people have become 
aware of their rights and have begun to place various claims on the health system. Thus, public 
administration will be an important consideration in the government sector while business 
administration will be in the private sector. Management, marketing, and planning must be among our 
considerations. 
In the preparation of education for such needs, the key players are not only those in the Ministry of 
Public Health but also in other sectors such as the for-profit private sectors, international 
organizations, NGOs, and health-related businesses such as insurance companies. We may need to 
define educational objectives in terms of the behavioral capacities or skills which our graduates should 
have to work in the different organizations influencing health through needs-based cost-effective 
approach. Some examples of the skills include the technical skills, critical appraisal, a broad vision, 
leadership, planning and management, teaching, research, and the capacity to undertake continuing 
education. It should be noted that technical skills and skills for professional growth are different; those 
who can perform certain work may not necessarily be those who can also increase their professional 
capacities. 
We must define educational objectives in terms of knowledge, attitudes, and skills. Concerning 
knowledge, students will need to acquire both content and abilities. Content refers to knowledge or 
information whle ability refers to the processing needed to transform this information into decisions. 
Such abilities include those to acquire and evaluate information critically from both primary and 
secondary sources. Skills refer not only to those for information processing and decision making, but 
also those for acting upon decisions related to interpersonal communication, group work, community 
relations, and other professional skills. Attitudes refer to the affective qualities that are required for the 
students' work concerning associated ethical, philosophical, and legal issues. 
Knowledge and information Generation and Application (Aitken 1993) 
The key to information and research is to analyze health burden and setting priorities for health 
actions. Research is needed on appropriate information systems, surveillance, rapid assessment 
procedures, health financing, health manpower, facilities and health-service utilization, drug use, and 
health-care cost within the cultural context of the society. Most developing countries do not have 
information and research data The data available usually come from those who have access to health 
care. The underprivileged do not get represented. This will need some kind of "rapid assessment" 
technique. 
For diseases where cost-effective services are available, the challenge is to make the services 
acceptable, accessible, and affordable. Multidisciplinary research into how health systems in these 
countries can work effectively should be established. An important strategy is community 
participation. For diseases where cost-effective interventions are not yet available, more strategic 
research will have to be done, such as in areas of global microbiological threat. 
Strengthening of Appropriate Demand for Services 
The people can choose from the various sources of care: the professional, popular, or folk sector. In 
many instances, there are questions whether professional care offer better benefits. For example, it is 
questionable whether diazepam given by professionals to relieve sorrow of the hill tribes is better 
when compared with worshipping trees. Fortune tellers have been an important component of 
psychotherapy in many Asian societies (CPH 1993). 
Strengthening of community organization is important for sustainable development. A broader 
perspective can be achieved by involving the community who harbour needs. Many times, 
emphasizing health intervention alone is inadequate, since health improves as income grows, medical 
technology advances and knowledge spreads among the consumers and providers. The interaction 
between the three is more dramatic than the effect of one factor alone. 
The overall objective of strengthening the community is to make people able to participate in the 
identification of their own problems and help identify interventions and responsibilities of different 
actors in solving the problems. Several key factors were thought to be essential. 
First, the most dedicated health workers including government officials, community workers, and 
the people must be identified. 
Second, participation must be based on the collective identification of problems, defining 
alternatives, delegations of duties, responsibility to carry out the duties, evaluation, and reaping of 
benefit together. 
Third, a close interaction must be in place between local community with the government 
officials, the administrators, and the implementors in development of plans. 
Fourth, consistent education, supervision, monitoring, and feedback both for key individuals in the 
community (e.g . , women), the community organization, and government officials particularly 
during the development, implementation, and evaluation of the strategic and operational plans. 
Finally, whenever possible, the academic institutions should be involved in giving technical 
support and have their experiences implanted in public health life. 
In addition to strengthening the community, other roles of the government include finding ways to 
increase income for the poor, improve education for women and girls who will be important in taking 
care of child health, ensure a universal access to the minimum package of universal public health and 
clinical services, promote diversity and competition among providers, increase the efficiency of 
government spending on health, and regulate appropriately financing outside of government. 
Assessment of Health Outcomes 
Assessment of health outcomes is important to know whether the response to health needs produces 
any significant improvement in health status, equity, and quality of life (Evans 1994). 
As for assessment of health status, while morbidity and mortality are important outcomes, they do not 
take into account the impact of illnesses and death on the individuals or their families, as well as the 
economic and social well being of the society resulting from deaths and sicknesses. The death of a 
child in a family can be very different from the death of the mother. In many societies, such as those 
in Africa, the death of a mother might lead to the death of other children and disintegration of the 
whole family. Death of young adults have more impact on the production of the society than death of 
the incapacitated elderly. In the calculation of DALYs, social preferences were incorporated into 
health status, emphasizing young adulthood because the family has invested a lot more in the 
upbringing and education of grown-up children than in very young children. A set of relative values is 
used for adjustment of disability and healthy life. If someone is healthy until age 80 and then dies, he 
will lose no DALYs. What we do not know is how well this model can be applied across cultures. 
This needs systematic study. 
An exciting feature of health care outcome is the measure of functional health status and well being. 
Much time has been spent in measuring the inputs to health systems and not the outcome. More 
people are doing research on what it means to have a certain physical limitation. More research on 
quantitative measures of well being is needed. Methods must be developed to measure these not only 
in individuals but also in the community. 
Impact of Health Improvements on the Society and the Economy: In this general area are issues 
about the possible effect of health actions on the political and the socio-economic conditions of the 
country; eg. the competitiveness of national industry in foreign markets both in quality and price as 
well as the social harmony both within countries and internationally. 
Looking Ahead 
Equity, efficiency, and quality of interventions based on alleviation of health needs should guide 
reform. Countries should plan on a long-term goal, an intermediate goal, and step-by-step measures. 
No nations can carry out their reform in 5 years. We need at least 10 years. We need technical people. 
We need infrastructure. We need data and relevant information. 
Concerning affordability, we have three sources of funds. First, reallocation of the existing funds for 
more effective use is needed, e.g., allocate to a more cost-effective technology and allocate existing 
funds to the poor or the near poor. This is possible for most countries including Thailand with its 
Ministry of Health budget of 39,000 million baht. Second, additional funds can be generated either 
through direct or indirect taxes, such as taxing alcohol and cigarettes. Third is to improve technical 
efficiency through research and management such as giving the right incentives or organizing the 
services correctly to save money. 
Finally, there are questions of feasibility. Three aspects must be considered. 
First, the technical feasibility is at issue. The 1993 World Development Report is a major thought- 
provoking challenge, emphasizing the need for sound research and analysis. The report illustrates the 
possible use of new tools, provides the possibility to apply the tools, and opens new challenges to 
improve the tools. The economic tools are available but we question how applicable they are to many 
developing country situations, not only in terms of analysis but also experiments in countries. Thus, 
many tools, such as the global burden of disease, cost-effectiveness analysis for priority ranking, 
technology assessment, analysis of finance, and provision of health care, must be applied, tested, and 
improved. In addition, there are inadequate linkages between the tools: i.e. linking the burden of 
diseases with cost-effectiveness analysis, and translating them to incentives for providers to carry on 
their tasks to reduce health needs. Can cost-effectiveness analysis of the burden of illnesses create a 
clinic that everyone would want to go to? This means that all disciplines have to broaden their 
perspective to allow linkages to be developed. We also need to develop communication tools which 
will link analysis to the people to improve the ways and incentives which people can deal with their 
needs and demands. 
Second is the feasibility for organization changes. Thls includes the change in the role of different 
ministries; changing the roles of public and the private sectors. The World Bank report does allude to 
the need for political commitments and organizational changes. This is country-specific and therefore 
needs to be resolved locally. 
Third is the management feasibility. Is it feasible for the country to manage the system? Do we have 
the people? Do we have the Management Information System? What information do we have to 
collect? 
We need to work together and follow-up, enhance, sustain, and increase our focus on the WDR. 
Prime-movers to lead the way must be identified. Capacity strengthening is needed to use analyt~cal 
thinking. Immediate and long-term strategy for this is important. With this there is a need for 
institution development and support, especially for institutions in developing countries. An 
international forum to create objective exchanges will be important so that opportunities will be 
created for activists, scholars, officials, and practitioners involved to exchange experiences in a 
horizontal way with people and whlch is not tied to specific donor agenda or projects. Finally, the 
documentation of successful results is needed: i.e., it will be important to document where health 
development has made a difference in the health sector. 
The amount of donor aid represented 10% of health expenditures for sub-Saharan Africa and 1.4% in 
Southeast Asia. This is a small amount of money but crucial; and if it is well spent it can change 
things. The donors can promote more efficient intersectoral actions through repackaging resources, 
priority, and infrastructural linkages; and they can promote reorientation of the infrastructure to meet 
the goals which will influence management, direction, and accountability. Some form of debate must 
be created within countries to study the package of services and arrive at a consensus to accept, reject, 
or modify the package. Even if we do not have an answer now, we should propose a process so that 
the desired target will be acheved. 
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TECHNOLOGY ASSESSMENT AND THE WORLD DEVELOPMENT 
REPORT 1993 
Helen Saxenian' 
It is a great pleasure for me to be here with you this morning to discuss the 1993 World Development 
Report, Investing in Health. The Report examines one of the central issues of our times: how to design 
and implement public policies to improve the health of the world's five billion people, and especially 
the health of the more than one billion living in poverty. My presentation will not be a broad 
overview of the World Development Report. I encourage you to browse through the Report to get a 
fuller sense of the analysis and conclusions, particularly on health policy reform. Thls presentation will 
focus on the topic of technology assessment as it relates to the main findings of the World 
Development Report 1993. Within technology assessment, I will focus mainly on setting priorities by 
using cost-effectiveness and disease burden analysis. Thls is highlighted a great deal throughout the 
Report. The Report does not use the specific term "needs-based" technology assessment, but this 
concept and the concept of priority setting in the WDR are quite similar. But before turning to this 
specific topic, I would like to step back and sketch out very quickly why the World Bank did such a 
report on health, and what the main conclusions are. 
Let me begn by setting forth three reasons why health matters. 
First, health is a crucial part of individual well-being and welfare. 
Second, health status has economic consequences. Good health improves economic performance. It 
does this in several ways. Better health leads directly to better economic performance through 
improved work productivity. It leads to productivity gains infuture generations by improving 
educational outcomes. (More and more research is indicating the important links between health 
and educability and school enrolment rates.) And health investments can, in some cases, reduce 
net spending on health care. In some cases the savings in treatment costs alone are sufficient to 
justify investments to control disease as is demonstrated by calculations for smallpox eradication 
and A D S  control. 
Third, improving health is an effective way of reducingpmerty. The poor carry a disproportionate 
share of disease burden, and have the least capacity to purchase health services. Investments in the 
health of the poor raise their educability and their productivity - giving them both the assets they 
need to lift themselves out of poverty and the immediate welfare gains from relief in suffering. 
Health, then, was selected as the topic of the WDR 1993 because of its importance to welfare, 
economic development, and poverty reduction, and also because it is an area where the government 
must play a central role. 
I would now like to summarize the three main messages of the World Development Report 1993. The 
Report advocates a three-pronged approach to government policies for improving health. 
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First, governments should foster an economic and social environment that enables households to 
improve health. This requires pursuing pro-poor economic growth policies oriented to reducing 
poverty, expanding basic education, especially for girls, and promoting the rights and 
empowerment of women, given women's key role in promoting the health of the household. 
Second, governments can improve their own spending on health, by focusing public spending on 
assuring a national package of highly cost-effective public health interventions and essential 
clinical services. For many reasons the government cannot leave these services simply to market 
forces, if it wants to ensure good performance. At the same time, governments should greatly 
reduce public spending on sophisticated tertiary facilities, equipment, and specialist training - 
used for interventions that provide little health gain for the money spent. Governments can also 
take steps to improve the management of public health systems. 
Third, and last, governments can improve efficiency and quality in the health sector by promoting 
diversity and competition in the provision of health inputs and services. This can be done by 
policies to encourage insurance with regulations or incentives for equitable access and cost 
containment, to encourage competition in the supply of inputs such as drugs and equipment, and 
to generate and disseminate information on technology assessment, provider performance, and the 
like to improve decision making. 
Clearly technology assessment is central in the second and third key messages of the WDR. In the 
second message, technology assessment plays a role in the design of the national package. In the third 
message, technology assessment is key in improving decision-making in the health sector overall. 
I will focus the remainder of my remarks on these two areas. First, I would like to explain in more 
detail what we mean in the second message by the "national package." The national package concept 
is a framework for thinking about what clinical services and public health interventions governments 
should attempt to ensure to their populations, and what they should finance. No country in the world 
can provide health services to meet all the possible needs of the population. We argue that it is 
advisable to establish two main criteria for which services to try to ensure to the population - the 
size of diseme burden caused by a particular disease or condition, and the cost-eflectiveness of 
interventions to deal with it. These criteria can be used to design a national package, tailored to local 
conditions and resource availability. Disease burden alone cannot help us select interventions for the 
package; cost effectiveness alone cannot either. It makes no sense, for example, to include a highly 
cost-effective intervention in the package that addresses only a very tiny share of disease burden 
because it is administratively difficult to do so and diverts attention from bigger problems. Likewise, 
an intervention that addresses a major share of disease burden should only be included if it ranks well 
in terms of cost-effectiveness vis-a-vis other health interventions that also address major shares of 
disease burden. 
How Do We Measure Disease Burden? 
Often the relative importance of different diseases is assessed by how many deaths they cause. But 
there are many diseases or conditions that are not fatal, but cause a great deal of loss of healthy life, 
such as chronic depression and paralysis caused by polio. The Report quantifies the burden of disease 
in the world in terms of loss of disability adjusted life years (DALYs for short). In a perfectly healthy 




Table 1. Costs and health benefits of public health vackages in low- and middle-income countries. 1990 
Country group and component of package 
Low-income (income per capita = S350) 
EF'I Plus 
School health program 
Other public health programs (including family 
planning, health, and nutzition inf~rmation)~ 
Tobacco and alcohol control program 
AIDS prevention programe 
Total 
Annual cost ($) Disease burden 
avexted (%Ia 
Per Per capita Per DALY 
participant 
Middle-income (income per capita = %2,500) 
EF'I Plus 28.6 0.8 25-30 1.0 
School health program 6.5 0.6 38-43 0.4 
Other public health programs (including family 
planning, health, and nutxition inf~rmation)~ 5.2 3.1 C C - - 
Tobacco and alcohol control program 0.3 0.3 45-55 0.3d 
AIDS prevention programe 132.3 2.0 13-18 2.3 
Total 
Some: Wodd Bank (1993, table 4.7). 
Note: Numbers in parentheses refer to per capita cost as a percentage of income per capita. 
a. Although costs are estimated for 100% coverage, the health benefits are based on 95% coverage for EPI Plus and 80% 
coverage for the school health, AIDS prevention, and tobacco and alcohol programs. 
b. Includes information, communication, and education on selected risk factors and health behaviours, plus vector control 
and disease surveillance and monitoting. 
c. The health benefits fiom information and communication, and from disease surveillance are counted in the other public 
and clinical services in the health package. The health benefits from vector control are unknown. 
d Calculation of the potential disease burden averted through this program assumes no change in the prevalence of 
smoking and alcohol consumption; if such prevalence were to rise, the potential benefits would be larger. 
e. Excludes trsatment of STDs, which are in the clinical services package. 
could be reduced by about 30% in low-income countries, and by about 15% in middle-income 
countries. 
Let us look at the content of this minimum package (Tables 1 and 2). The minimum package 
reinforces the importance of many primary health care activities such as immunizations. But it also 
highlights some that have been relatively neglected, such as tuberculosis diagnosis and treatment and 
sexually-transmitted disease diagnosis and treatment. 
The minimum package includes several public health interventions - immunizations, school health 
programs, information programs, tobacco- and alcohol-control efforts, epidemiological monitoring and 
surveillance, vector control, and AIDS prevention - that make up about one-third of the cost of the 
package. It also includes essential clinical services in six key areas - TB treatment, a cluster of 
Table 2. Estimated costs and health benefits of selected pubtic health and clinical services in low- and middle 
income comtries, 1990. 
Couuby group and package Annual cod (ST Per capita cod Disease 
as share of burden 
Per case or per Per Per DALY per averted 
participant capita capita (%) (%Ib 
Low-income (per capita income = $350) 
Public health packagec 
Minimum essential package of clinical services 
Short-course chemotherapy for tuberculosis 
Management of the sick child 
Prenatal and delivery care 
Family planning 
Treatment of STDsd 
Limited care' 
Total, public health and clinical services - 12.0 - 3.4 32 
Middleincome (per capita income = $2,500) 
Public health packageC 
h 4 b h u m  essential package of clinical services 
Shortcourse chemotherapy for tuberculosis 
Management of the sick child 
Prenatal and delivery care 
Family planning 
Treatment of STDS* 
Limited care' 
Total, public health and clinical services - 21.5 - 0.9 15 
Source: Wodd Bank (1993, table 5.3.) 
Note: Figures assume coverage of 80% of the population. 
a. Average costs. 
b. Marginal benefits. 
c. Includes EPI Plus; school health including deworming, micronutrient supplementation, and health education; 
information on health, nutrition, and family planning; tobacco and alcohol control programs; monitoring and 
surveillance; vector control; and programs for prevention of AIDS. 
d Benefits were calculated assuming an A~DS epidemic comparable to that in sub-Saharan Afiica today. 
e. Limited care includes assessment, advice, alleviation of pain, treatment of infection and minor trauma, and treatment 
of more complicated conditions as resources permit. 
services which we call "management of the sick chlld," the cluster of services for pregnancy-related 
care, family planning, treatment of sexually-transmitted diseases, and something we call "limited 
care." Limited care is intended to give some response - often quite limited - for other health 
problems. This will sometimes be simply palliative, such as pain relief for highly fatal cancers. The 
cost-effectiveness of these interventions is very high. And these interventions would, as mentioned 
earlier, avert about 30% of disease burden if almost universal coverage could be achieved (Fig. 4). 
After defining the national package, we turn to the question: who should pay for the package? 
Governments must have a heavy role in financing the package. How much it finances and how 
generous the national package can become depends very much on resource availability and the degree 
to which societies will want to make their package more comprehensive and targeted to the poor 
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Let's focus for a few minutes on the government's possible role in disseminating health technology 
assessment information and how to prioritize where it should direct its efforts. I will use medical 
equipment as an example. This is certainly complicated by the difficulty of keeping up with the rapid 
pace of innovation in the field, and the limited capacity in developing countries to carry out 
technology assessment. In all countries the ability of the medical equipment industry to develop, 
produce, and promote new health care technologies has vastly exceeded the capacity of decision- 
makers to evaluate the clinical value of such innovations and their cost-effectiveness. And synthesizing 
information about available products in order to make rational selection decisions can be extremely 
costly for public and private health care providers. 
We argue in the Report that indicative "essential equipment lists" could be developed by an 
international agency or nonprofit organization along the lines of essential drug lists for use by many 
countries. These would need to be regularly updated by expert committees who evaluate new products. 
These lists would need further adaptation at the country level, tailoring the list to support the country's 
national package. Information costs about equipment technology and about specific products could be 
reduced by broader dissemination of technology assessment data bases and product comparison 
information developed by independent laboratories. Although international data bases could be helpful 
for decisions about health care technology, some technology assessment is still needed at the local 
level to evaluate equipment in terms of appropriateness and adaptability to local conditions. 
To close, I would like to return to the concept of the "national package" in the Report and report on 
the follow up work that has occurred in this area since the publication of the Report in July of this 
year. The idea of designing a national package, based on the two criteria of disease burden and cost- 
effectiveness, costing it, and directing public financing to that package, has generated a lot of interest 
from many countries. Many countries have requested assistance to develop such a package. 
Applications in progress vary considerably. One country has taken the minimum package presented in 
the Report and costed it. At the other extreme, another country is carrying out a full-blown disease 
burden estimation along with the calculation of intervention cost-effectiveness. It is using the results to 
design of a much more comprehensive national package. The notion of basic services is not new, but 
the systematic application of explicit criteria and the use of quantitative methods to design the package 
has sparked a lot of interest. One of the challenges we face is in developing and improving these 
methodologies and helping build the domestic capacity to carry out these analyses and link them to 
policy reform. 
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~SSUES AND CHALLENGES 
FOR 
NEEDS-BASED TECHNOLOGY ASSESSMENT 
Peter Tugwell' 
This conference provides the opportunity to bring out some technical issues around changing the 
paradigm of technology assessment from one of "supply-driven" to "demand-driven" (or "needs- 
driven"). 
First, the definition of technology assessment needs to revisited to set the boundaries of the topic. The 
Office of Technology Assessment (1978) specified "health technology" as "drugs, devices, medical 
and surgical procedures, and the organisational and supportive systems within which such care is 
provided." The concept of embodiment (Feeny et al. [1986]) is useful in classifying technologies and 
understanding their range; embodiment describes the degree to which a technology is contained in a 
drug or device. For example, a machine such as magnetic resonance imaging (MRI) or a drug such as 
Erythropoietin therapy are "embodied." A technology is "disembodied" if it is an idea or procedure 
that is available without a machine or drug; for example, counselling to stop smoking or early 
ambulation after surgery are "disembodied." Fuchs and Garber (1990) have emphasized that the field 
has evolved from the "old technology assessment" that focused upon the safety and efficacy of an 
intervention, to the "new technology assessment" that includes assessment of the higher order impacts 
that draw on multiple data sets, multiple investigators, and diverse methodologies to yield an 
assessment that is based upon a range of values and interpretations of the data. This "new technology 
assessment" reflects the importance of assessing impacts such as health-related quality of life including 
social and emotional health status, consumer and patient preferences, public, patient, and professional 
behaviour change. 
Currently for many reasons, the development, assessment, and diffusion is "supply-driven" rather than 
"demand- (or needs-) driven." The financial incentive drives the introduction of the majority of 
technologies - much of this is because of the enormous expense of the R&D of the "embodied" 
technologes, i.e., new drugs and devices. With profit being the primary incentive, combined with the 
fact that the disembodied technologies such as people skills are much more difficult to make attractive 
to investors of venture capital, it is perhaps not surprising that "supply" does not match "demand" or 
"need." Examples of this abound in the WDR 1993 Report; for example, how are developing countries 
to address the assessment of the 6,000 distinct types of medical devices, 750,000 brands and models, 
12,000 manufacturers are on the market currently; over 50 % of these are not working. Drugs are 
another major problem; whilst recogmsing the major benefits of drugs, there are 100,000 different 
drugs created from 5,000 active ingredients. Although drugs and devices represent the most rapidly 
growing sector of health care, less than 5% of these have been evaluated for their cost-effectiveness. 
Hospitals in most countries represent the largest cost and contain many of the most expensive 
technologies both in terms of people expertise as well as the use of the most expensive drugs and 
devices. There is evidence from Thrd World countries, such as Colombia, and from the USA that 
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over 50% of patients seelung care could have been given appropriate care at a lower-level facility. 
Likewise, the whole area of practice variation without differences in health status suggests that health 
needs are not driving use of technologies: the impressive videos that are being developed in the USA 
showing that if you show a patient who would normally be recommended for coronary artery bypass 
or a prostate surgery, up to 50% of those who would have gone for surgery say: "No, thank you, I'll 
wait." 
How about the disembodied areas such as human resources? Evans (1981) identified the importance of 
measurement, management, and monitoring as key competencies of health care workers of the future. 
This has been taken further through an initiative, "Educating Future Physicians in Ontario," in Canada 
and is also being developed through the International Network of Community-Oriented Educational 
Institutions for Health; the following disembodied technologies skills and competencies have been 
identified that will be needed for needs-based health care: community-needs orientation, clinical and 
community decision-making, communicator, collaborator, consumer advocate, coordination of 
resources, critical appraisal skills for the consumer of technology assessment, and continuing learner. 
As the Commission on Health Research for Development ( 0 )  noted: "there is a gross mismatch 
between the burden of illness, which is overwhelmingly in the Third World, and investment in health 
research, which is overwhelmingly focused on health problems on the health problems of the 
industrialized countries" (CHRD 1990). The concept of Essential National Health Research (ENHR) 
was developed by the Commission to redress this imbalance (Table 1). This issue is beginning to be 
better appreciated as industrialized nations are having to introduce cost-containment mechanisms to 
control the spiralling cost of health care. As Donaldson and Sox have pointed out, across-the-board 
efforts to control the use of procedures and other health technologes, such as through administratively 
imposed caps or cuts in programs may well increase the current inequities. The appropriateness 
research of Brooks and the variations research of Wemberg have shown that a more selective 
approach through discouraging use accepted as inappropriate by the clinicians themselves is feasible. 
Table 1. Essential national health research (ENHR) s t e ~ s .  
Promotion and advocacy Create a "demand" that is based upon health needs 
Establish the ENHR mechanism 
Xonty setting 
Capacity building and strengthening 
Networking 
Financing 
Create a pamership between the community, the 
health care givers, and the researchers 
Based upon targeting research to increasing health 
equitably 
Critical mass of expertise within country to implement 
country-specific research 
Within country to build multidisciplinary teams 
with existing resources 
International partnershipshinning 
For training to build a critical mass 
For projects 
Evaluation Structure, process and otltcome 
Table 2. Estimated costs and health benefits of selected public health and clinical services in low- and middle- 
income countries, 1990. 
Country group and package Annual cost (f)" Per capita cost Disease 
as share of burden 
Per case or per Per Per DALY per 
participant capita capita (94) (%)b 
Low-income (per capita income = $350) 
Public health packagec 
h4inimum essential package of clinical s e ~ c e s  
Short-course chemotherapy for tuberculosis 
Management of the sick child 
Prenatal and delivery care 
Family planning 
Treatment of STDS~ 
Limited care' 
Total, public health and clinical s e ~ c e s  
Middle-income (per capita income = $2,500) 
Public health packagec 
Minimum essential package of clinical s e ~ c e s  
Short-course chemotherapy for tuberculosis 
Management of the sick child 
Prenatal and delivery care 
Family planning 
Treatment of STDsd 
Limited care' 
Total, public health and clinical s e ~ c e s  
Source: World Bank (1993, table 5.3.) 
Note: F igms assume coverage of 80% of the population. 
a. Average costs. 
b. Marginal benefits. 
c. Includes EPI Plus; school health including deworming, micronutrient supplementation, and health education; 
information on health, nutrition, and family planning; tobacco and alcohol control programs; monitoring and 
surveillance; vector control; and programs for prevention of AIDS. 
d Benefits were calculated assuming an AIDS epidemic comparable to that in sub-Saharan Afiica today. 
e. Limited care includes assessment, advice, alleviation of pain, treatment of infection and minor trauma, and treatment 
of more complicated conditions as resources permit. 
In order to compare mortality with morbidity, the WDR authors have developed an index to combine 
morbidity and mortality, that they named the Disability Adjusted Life Year (DALY). Table 2 shows 
an example of how different conditions compare. A similar approach has been developed by Wolfson 
et al. at Statistics Canada to incorporate data from community surveys in order to calculate Quality 
Adjusted Life Years (QALY) - very similar to the DALY - and to measure the impact of 
interventions. Once again, each country or community needs to decide on the relative importance of 
quality of life versus mortality and although the numbers of patients dying and those with symptoms 
and disability can be measured in an acceptably standardized fashion, the relative contributions of 
these to an index such as a DALY or a QALY cannot be translated from one country to another 
automatically; it really has to be decided by the consumers, by the public, within the country 

Table 3. Comparative cost-utility results for selected programs. 
Programs Adjusted cosVQALY 
gained (US S 1983) 
PKU screening < 0 
Coronary artery bypass surgery for left main 4,200 
coronary artery disease 
Neonatal intensive care, 1,000-1,499 g 4,500 
T4 (thyroid) screening 6300 
Treatment of severe hypertension (diastolic t 9,400 
105 mm Hg) in males aged 40 
Treatment of mild hypertension (diastolic 19,100 
95-104 mm Hg) in males aged 40 
Estrogen therapy for postmenopausal 27,000 
symptoms in women without a prior 
hysterectomy 
Neonatal intensive care, 500-999 g 3 1,800 
Coronary bypass for single vessel disease 36,300 
with moderately severe angina 
School tuberculin testing program 43,700 
Continuous ambulatory peritoneal dialysis 47,100 
Hospital hemodialysis 54,000 
Source: Torrance 1988. 
contrast), and lastly those that cost more and result in no benefit (e.g., MRI or CAT scan for headache 
without any clinical neurological signs, laboratory screening for abnormal liver, renal, and cardiac 
function as part of the periodic health exam in individuals not at increased risk leads to labelling, 
anxiety, and increased costs of unnecessary further investigations, immunisation with a failed cold- 
chain, transfusion with HIV-infected blood). 
It is important to look at cost-eflectiveness (i.e., does it work in practice) and not cost-eflcacy (can it 
work in an artificial study context), if the result is to be relevant to policy decisions in that we come 
up with are going to have credibility. Table 1 shows examples of important country-specific research 
identified by the ENHR Task Force that focus on solving the pragmatic problems to ensure the 
success of interventions that have been shown to work in ideal circumstances. 
Consensus on the benefit to be expected from interventions based upon the best evidence available is 
needed. Poorly designed studies often result in overestimates. There is an important international 
initiative to address this and to produce quality estimates for health care decision-makers across the 
world - the Cochrane Collaboration (Sackett 1992). Iain Chalmers has put together a group in 
Oxford, UK, which has developed into an international network with Centres elsewhere in Europe, 
North America, and Australia. Kathy Bennett from McMaster is coordinating this for developing 
country initiatives and there will be a major discussion of h s  at the INCLEN meeting this coming 
January [I9941 in Thailand. Teams or reviewers are established for each disease area with an editorial 
team who use agreed-upon criteria to develop a database of systematic reviews. The approach that has 
been used in many situations where the data is appropriate, is meta-analysis. This is a valid technique 
for combining the results for homogeneous small trials that are not statistically significant to coming 
out with an overall result as well as for trials showing different degrees of benefit to produce the best 
estimate and to reduce the confidence limits. These overviews will be published in international 
journals as well as being made available in the Journal of Online Medicine which is available 
worldwide to anyone who can dial into electronic mail; it will also be available on CD ROM. 
There are a number of important differences in economic evaluation when implementing cost- 
effectiveness studies internationally - some of these clearly relate to the available dollars for health 
care - the cutoff of Canadian $20,000 per QALY (US $15,000) recommended by Laupacis et al. 
(1992) for Canada are clearly going to be very different (even adjusted to make DALYs equivalent to 
QALYs) from the $350 per DALY maximum in low-income countries for the Third World WDR 
technologies, listed in Table 2. Other differences include difference in effectiveness modifiers (access, 
diagnosis, and provider and patient compliance as discussed above), indicators, differences in the way 
patients are managed (called "ingredients" by Laupacis et al.), the costs of each ingredient themselves, 
the relation between costs and the economy of the country (Drummond et al. 1993). Guidelines for 
economic evaluation are being developed in various countries - evidence of the increasing expertise 
in this area and the potential for those working in technology assessment to contribute across the 
world. 
Other Relevant Initiatives 
There are various other relevant ongoing initiatives that the Technology Assessment Community 
should collaborate with in tackling these challenges: 
The Puebla Group Lnitiative: A group of networks agreed to discuss ways of coordinating input 
into ENHR. Members are the International Health and Public Policy Program, the International 
Clinical Epidemiology Network, National Epidemiology Boards, Network of Community Oriented 
Educational Institutions for Health Sciences, Epidemiology and Health Management Network, 
WHO Program on Health Systems for Research, Field Epidemiology Training Network. 
The Primary Health Care Management Program of the Aga Khan Foundation. 
The needs-based funding experience such as that recently implemented in the Canadian province 
of Saskatchewan. 
The setting research priorities for evaluation of improved health care such as that by Donaldson 
and Sox in industrialized nations (Table 3). 
The assessment of the potential cost-effectiveness and impact upon health when funding research 
projects. 
Conclusion 
This paper has reviewed a number of issues relevant to making needs-driven technology assessment a 
realistic strategy that can be adapted by those in different settings. There are more similarities than 
differences in these discussion among leaders working in this field in countries at all stages of 
development; these could be usefully integrated with the methods being developed in the ENHR 
strategy to form a "Tool Kit" for technology assessment that consists of written and computerized 
material on (i) needs assessment; (ii) efficacy, community effectiveness, and economic evaluation; and 
(iii) consensus-building methods. This would also provide a focus for encouraging individuals around 
the world in the technology assessment community to join this global challenge of "good health at low 
cost." 
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S. Yunkap Kwankam' 
Developing countries have come to accept that science and technology are important to national 
development. But, more often than not, the pivotal role that technology plays in development is not 
fully understood. Hence, the minuscule amounts spent on science and technology in national budgets. 
Technology, the key to industrial and economic growth, is either endogenous or is acquired. 
Technology acquisition is a very complex subject. Some people go as far as contending that despite 
the attention it receives, technology transfer is not to be counted upon; the owner of the technology 
has too much vested in his relative advantage to wish to hand this over without extracting substantial 
benefits from the recipient. 
Technology transfer, however, does exist in some sectors. Aid projects in the fields of health, human 
resources development, and agriculture usually are the most likely to result in the transfer of 
technology. One can argue that if a technology is acquired and adapted to suit local conditions and 
institutionalized to ensure its sustainability, it can be considered an endogenous technology. 
Endogenous technology, either locally developed or acquired and adapted is more likely to be cost 
effective and more likely to lead to development. 
Visionary Individual Effort - An Alternative to Consensus 
Development 
Consensus development is recognized as a precondition for the transfer of technology in several 
countries (Coe and Banta 1992; Foltz 1993; Vian et al. 1993). Whether in its traditional form as 
developed by the Office for Technology Assessment (OTA) or in the form of a forum (Perry and 
Wilkinson 1992), it involves general agreement among major players or stakeholders. Although this 
has been used in Cameroon in national programs based on imported technology (Oral Rehydration 
Therapy - ORT, Expanded Program on Immunization - EPI, etc.), Cameroon appears to have come 
up with an alternative to consensus development - a techmque whch we term "visionary individual 
effort or VIE." It is appropriate in circumstances where the number of persons with sufficient 
knowledge about the technology is too limited to give the tern consensus meaning. A one- or two- 
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person consensus would otherwise not be uncommon for transfer of state-of-the-art or emerging 
technologies to developing countries. The VIE method is responsible for two instances of health 
technology transfer in Cameroon. These are 
Development of local capacity in biotechnology at the Immunology-Biotechnology Laboratories 
(IBL), Faculty of Medicine and Biological Sciences of the University of Yaounde I; 
Local production of an HIV dipstick at the Institute of Medical Research and the Study of 
Medicinal Plants ClMpM). 
It is unlikely that either the technology developed at IBL and described below, or the HIV dipstick 
project would exist, or survive, without its principal investigator. These researchers are "prime 
movers," indispensable to promotion and advocacy, the first element of Essential National Health 
Research (ENHR) (Task Force on Health Research for Development 1 991). 
Development of Biotechnology at IBL 
The Need For Diagnostic Tools 
The World Bank suggests that a priority area for research and development (R&D) work is low-cost 
and efficient diagnostic technologies for use in health centres in developing countries (World Bank 
1993). Walsh (1988) proposes the following desirable features for such diagnostic tools: 
Simplicity of use; 
Adaptability to local conditions; 
Stability; 
Minimal need for instrumentation, can be performed even in home of community health worker; 
Lowest possible cost; 
Speed (for patient care less than one hour, longer time acceptable for epidemiologic surveys); and 
Accuracy. 
IBL's interest is in the area of diagnostic tools for parasitic diseases. 
State-ofitheArt Cornpeten ce 
The laboratory has developed local competence in state-of-the-art biotechnology techniques. They are 
able to 
Screen genomic and cDNA libraries; 
Express genes in procaryotes (e-coli) and in eucaryotes (yeast) systems; 
Develop DNA probes; and 
Use other molecular biology tools for more basic research (gene regulation, etc.). 
In the area of onchocerciasis, their main focus, the laboratory work compares favourably with that of 
leading laboratories in Europe and North America. However, due to the competitive nature of the 
work, IBL has not been keen on giving details. It is our understanding that several publications in the 
pipeline will provide significant scientific and technical details of this work. These include, Cloning 
and High Level Expression in Yeast of Onchocercal SpeciJc Antigens, Use of C27 and C71 
Recombinant Proteins in ELISA-based Detection of Onchocercal Antibodies, and A Dipstick 
Immunobinding Assay for Detecting Those at Risk of Blindness from Ophthalmic Microfilariae. 
IBL Development Strategy 
From beginnings in clinical research the laboratory, which is now IBL, has changed focus as 
technology has evolved. Emphasis in epidemiologic research followed the clinical research phase. The 
focus later shifted to immunology, and in 1985 the laboratory was designated a WHO Collaborating 
Centre for Immunology. Its development program is based on the experience of the laboratory director 
in developing human resources using the concept of institution strengthening. As Vice Chancellor of 
the University of Yaounde, he instituted a number of programs and measures. A new operational 
structure which took into account the essential and diverse components of a teachinflearning system 
as shown by Ngu and Kwankam (1992) was put in place. These measures resulted in the emergence 
of a number of competent research groups and laboratories. These same measures, which recognize 
the interaction of forces in the life of a teachinghesearch organization (Ngu and Kwankam 1992), 
were applied to IBL. 
As to the choice of which technology to transfer or develop, biotechnology was a logical progression 
from IBL's background in immunology. However training was needed to learn this new technology. 
Training at IBL 
The major instrument employed in the development of this know-how has been innovative institutional 
linkages, involving commercial companies as well as the traditional university and research 
organizations. These ties were facilitated by the laboratory director's international contacts. 
Opportunities'offered by participation in such groups as the Scientific and Techca l  Advisory Group 
(STAG) for the WHO program on Human Reproduction (HRP), the Board of Directors of the 
International Centre for Insect Physiology and Ecology (ICIPE) in Nairobi, Kenya, and the Governing 
Council of United Nations University with headquarters in Tokyo, were exploited to promote 
collaboration between IBL and research organizations in industrialized countries. Links were thus 
developed with the following leading institutions in the field 
Chiron Corporation, Emeryville, CA, US. (which now includes Cetus Corporation, famous for the 
discovery of the polymerase chain reaction [PCR] for amplification of DNA sequences, and which 
won a Nobel prize); 
New England Biolabs, Boston, MA, USA; 
Elixir Biotechnology (LXR), San Francisco, CA, USA; 
The University of California, San Francisco, CA, USA; 
The Biotechnology Centre, Uppsala, Sweden; 
London Hospital Medical School, London, UK; 
Institute of Child Health, London, UK; and 
Haddassah Medical Center, Jerusalem, Israel. 
Eight years ago, IBL instituted a program for rapid training of molecular biologists, locally and with 
its collaborating institutions abroad, to provide a pool of competent scientists. Detailed number of 
person-months of training at various facilities since then are shown in Table 1. 
At the local level, IBL has favoured a multidisciplinary approach through collaboration with local 
laboratories such as the Automation and Control Laboratory of the School of Engineering and the 
Organic Chemistry Laboratory of the Faculty of Science. The latter, which has distinguished itself in 












the area of medicinal plants provided plant extracts, while the engineering laboratory has been 
invaluable in the areas of equipment selection and maintenance, communications, and computer 
modeling and simulation. 
Financing 
The bulk of the Laboratory's funding has come through competitive research grant schemes sponsored 
by three organizations: WHO (TDR), the EEC (Science and Technology for Development), and 
USAID (Program in Science and Technology Cooperation). Other support has come from sources such 
as the Edna McConnel Clark Foundation and the Hoffmann-LaRoche Foundation. Government of 
Cameroon support has also been obtained through funding from the University's budget and bilateral 
cooperation. 
Table 2 shows levels of funding for IBL and the biotechnology centre, a sister group also founded by 
the director of IBL. 
Table 2. Grants to biotechnology obtained from various 
sources. 




Edna McConnel Clark Foundation 
New England Biolabs 
Government of Cameroon" 
Bilateral Cooperationa 
Hoffman LaRoche 
a. Grants made to the biotechnology centre. 
Transfer of HIV-IIHIV-2 Dipstick Technology 
HIV Dipstick Technology 
In response to the need for a diagnostic tool for the detection of HIV-1 and HIV-2 antibodies, which 
meets the developing country requirements cited above, the Program for Appropriate Technology in 
Health (PATH) has developed a low cost high sensitivity and specificity dipstick. The test, which has 
a sensitivity of 99.5% or greater and a specificity of 98.2% or more, uses "HIV peptides attached to a 
comb-shaped piece of plastic to capture specific HIV antibody in serum, plasma or whole blood" 
(PATH Canada 1993). A red spot on the plastic dipstick indicates the specimen is positive. 
The technology is particularly attractive do developing countries as the targeted manufacturing cost is 
about $0.50 per test or less, compared to $2.00 or more for commercially available tests. The test 
takes approximately 20 minutes, about one-sixth the time required for ELIZA methods. A corporate 
decision at PATH was made not to manufacture the test but to transfer the technology to developing 
countries for local production. 
Chronology of Events 
In late 1990 the prime mover suggested that the AIDS program at the Centre de Cooperation 
Internationale en Sante et Developpement (CCISD) at Laval University, Quebec, Canada support the 
transfer of dipstick technology to Cameroon. In November 1990, CCISD opened discussion with 
PATH, and an initial visit by a team from PATH and CCISD was made to Cameroon in March 1991 
to ascertain local interest and possible collaborators. This led to a needslfeasibility assessment mission 
in August 1991. The mission did an analysis of the health context, financial and market issues, 
technical requirements (staff, equipment, supplies, facilities, reporting, and regulatory), and 
administration and management structures. Three alternative hosts for the new technology were 
considered. The private sector in Cameroon has better management skills than the public sector but, as 
of now, does not have the technical know to support such a technology. The Ministry of Health has 
some know-how but an HIV dipstick project based there would be fraught with management 
problems. A good compromise was found to be a university or research organization. IMPM has both 
technical know-how and some management expertise. The one drawback, however, is that like the 
ministry universitylresearch organization it suffers from problems with marketing and sales. 
In February 1992, a proposal was made to CCISD. This received initial approval in April 1992 and in 
September 1992 the project work plan was approved and funds released. The work plan was revised 
and the budget reduced in May 1993, due to cutbacks at the Canadian International Development 
Agency (CIDA) which is funding the project. 
Local Production 
Although most of the materials are produced in Cameroon, some components are bought from abroad 
because they are less expensive and of better quality than if they were made locally. One such item is 
packaging, due to the poor quality of locally available paper. 
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Fin an cing 
The project is wholly funded by CIDA with a total budget for the project of CA $1 million divided 
equally among three headings: 
Facilities and local use; 
Equipment; and 
Purchase of components. 
OUTCOMES 
A High-Tech Tool Appropriate For The Developing World 
When IBL set out to develop a diagnostic tool for the detection of onchocerciasis, it fixed on certain 
characteristics. They are similar to those described above by Walsh. IBL's criteria for a diagnostic 
technology appropriate to developing country environments are that it should 
Provide rapid and accurate diagnosis on a large scale so that the best therapeutic or rehabilitative 
measures can be put into place to avoid unnecessary deaths and alleviate suffering; 
Be inexpensive, so as to be affordable by most (if not all); and 
Permit forecasting (prediction) so as to enable planning of preventive measures. 
For infectious diseases a cost effective approach is prevention. Hence the need for tools for predicting 
outbreaks. Samples collected from large numbers of people, need rapid, accurate, user friendly 
diagnostic tools, which can be employed under primitive conditions. IBL believes that its work has 
produced laboratory prototype diagnostic tools with these characteristics. 
Coincidentally, what sparked initial interest in the HlV dipstick project in Cameroon were 
considerations similar to these. It is a diagnostic test designed to meet specifications for developing 
countries: 
Stability at room temperature (no refrigeration required); 
Ease of use; 
High insensitivity to humidity; 
Long storage periods - up to 6 months; and 
Small sized packages, not large bulky ones. 
The test kit includes 10 items, from peptide antigen combs, through various control sera to reagents 
and wash tray. Use of the kit requires additional items such as timer, disposable latex gloves, and pen 
and pencil. There is also nine-step test procedure for administering the test and a decision tree for 
interpretation of results. 
Potential Health, Social, and Economic Benefits 
The technology developed by IBL provides rapid, early, specific, and sensitive diagnosis for 
onchocerciasis. Conservative figures put prevalence of the disease in endemic areas at around 92%, 
with over 18 million persons infected worldwide, and over 90 million at risk, worldwide. There are 
over 40,000 new cases of eye lesions each year (see WHO-Tropical Diseases Research, 1 lth 
Programme Report 1993). Although we do not have figures for the reduction in the quality of life due 
to blindness, it is clear that there are considerable Quality Adjusted Life Year (QALY) benefits to be 
gained from preventing blindness. 
Cases of immune-complex nephritis which may lead to chronic kidney failure (Ngu and Soothill 
1982), which can result from onchocerciasis, require hemodi-alysis which, in Cameroon, costs about 
US $35,0OO/patient per year, or continuous ambulatory peritoneal dialysis (CAPD) where costs are 
about US $18,00O/patient per year. 
Sustainability 
Threat Of Early Abandonment 
The life cycle of a technology, as adapted from Banta et al. (1981) by Panerai and Pena Mohr (1989), 




Wide utilization; and 
Abandonment. 
In the case of technology transfer, the term "introduction" is more appropriate than "innovation" as a 
descriptor for the initial phase. When transfer is to a developing country, abandonment is likely to 
correspond to the end of donor support. In such cases, the rate of abandonment would be much steeper 
if the QALY concept is applied to the technology's decline. Some technologes continue to survive, 
after withdrawal of external funding, but at significantly reduced intensities of use. Problems with 
human resources as evidenced by the transfer of Health Management Information System @MIS) 
technology to Niger (where of the six persons trained to master's or doctoral level, only two remain 
with the project mock et al. 19931) and the need for recurrent costs to be borne by donors even after 
the technology has reached its wide utilization phase as in Chad (Foltz 1993), tell only part of the 
story. Foltz (1993) refers to larger issues in the administrative environments of Afiican countries 
which impinge on the sustainability of a the transferred HMIS technology in Chad. In the same vein, 
problem trees developed for health in Cameroon by Brinkman. (1992) and for health care technology 
by Kwankam et al. (1993) show political instability, absence of clear and effective policy, and lack of 
information as root causes of ineffectiveness and inefficiency in the health sector. These are likely to 
adversely affect the sustainability of any transferred technology. The same is likely to be true of other 
subSaharan African countries. 
A Model For Sustainability Of A Transferred Technology 
Mock et al. (19993) see the sustainability of HMIS (automated information system as they call it) in 
Niger as depending on two factors: 
Financial sustainability - annual computer-related recurrent cost, including replacement of 
equipment is US $30,000; and 
More importantly, human resources to maintain and upgrade the system. 
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While financial and human resources are key determinants of sustainability in any system, the model 
is too general to provide direction as to how to go about ensuring tlus sustainability. Kwankam and 
Ngundam (1994) have developed a model for maintainability of equipment in what they term 
"suboptimal environments." The model views maintainability as belonging to a four-vector space, 
namely spare parts, facilities, know-how, and documentation. Whereas the final output is a quantitative 
measure of system maintainability, the mathematics are kept very simple, consisting mostly of addition 
and multiplication of binary operands. 
Similar considerations suggest a model for sustainability, based on four factors: 
User know-how: training and documentation; 
Consumables: cost and supply network; 
Diffusion: market (opportunity) and affordability (cost); and 
Institutional backing. 
It is clear that for a health technology which is medical device dependent, maintainability of the 
device is indispensable to sustainability of the technology. 
Here, know how now refers to skills needed by people who operate the technology, which as in the 
model for maintsllnability, are enhanced by training and how well documented the technology is. 
Consumables are analogous to spare parts, and depend not only on cost but the existence of supply 
networks. How well diffused the technology is influences its sustainability. Wide utilization and 
diffusion generally mean: 
A broad market base due to successful commercialization or charitable distribution; 
Deep penetration levels geographically or, in terms of societal siata; and 
Existence .of mechanisms for promoting the technology. 
Once widely diffused and utilized, societal inertia becomes a force against rapid abandonment. 
The key element in this model is institutional backing. Although the other three elements can 
collectively make up for its absence, they often owe their existence to it. In a developing country, this 
usually means government support. In developed countries, one form of support is reimbursement and 
or subsidization by government or insurers for use of the technology. Government support has a 
positive impact on diffusion. National programs or campaigns based on the technology are the most 
common ways of getting wide utilization. Government bachng can strengthen training programs and 
provide access to information on the technology, thus promoting user know-how. Institutional support 
can be instrumental in acquisition strategies for consumables to reduce costs through 
Bulk purchases; 
Purchase of drugs by generic type; and 
Use of international agencies, such as IDA for pharmaceuticals. 
Institutional backing in some cases is analogous to "orphan technology" status, as proposed by 
Wagner (1 992). The two conditions for this status are 
Commercial viability criterion, technology would not be developed by private sector due to lack of 
commercial viability; and 
Cost-benefit criterion; benefit to be derived exceeds cost of development and production. 
How Does IBL Plan To Sustain This Technology? 
IBL has registered an affiliate commercial company for entrepreneurial purposes. Multicentre trials are 
envisaged, and it is seeking partners for joint venture further development and commercialization of its 
products. Free et al. (1993) advocate this as a means of ensuring successful transfer of health 
technologies. Meanwhile contract work provides financial supplements to grant funds. IBL is on 
contract to the Lindsley F. Kimball Institute, New York Blood Center, to perform cloning and high 
level expression of a cysteine protease inhibitor of 0. volvulus (onchocystatin). 
Long-Term Sustainability Requires Growth 
IBL is also involved to a lesser extent in agricultural biotechnology, where their main interest is in 
two areas; micropropagation and growth factors to enhance micropropagation. They have so far 
identified a growth factor which is believed to be more effective than most commercially available 
ones. Their strategy for long-term sustainability is based on commercialization and response to market 
forces. This implies growth. This is true for Pakistan, where Burney (1993) claims that sustainability 
of vaccine production needs growth in terms of 
Diversification of the line of products (basic capacity exists); and 
Adaptation to changing health conditions; as interventions spread and programs succeed, markets 
for specific products decrease (need to go from 10-dose vial to single-dose vial). 
Long-term sustainability of the IBL technology and the HIV dipstick will be based on 
commercialization and response to market forces. These are good generic products. Others of the same 
type will follow. The market is unlimited for the foreseeable future. IBL is, even now, interested in 
the dipstick method for parasitic diseases in general. 
Nurturing En vironment for Technology Sustainment 
Cameroon has a model for institutional support to ENHR. This is the National Epidemiology Board, 
which is set up to act as a liaison between the Ministry of Health and the research community. It was 
created with the encouragement of the Rockefeller Foundation and funded almost wholly by the 
Foundation. The Board could provide a nurturing environment for the sustainment of technologies in 
Cameroon. 
Conclusion 
Visionary individual effort was responsible for identifying biotechnology and the HIV dipstick as the 
subjects of technology transfer. The outcome of this vision and ensuing development strategy are 
diagnostic tools adapted to developing country conditions and local biotechnology capacity for further 
development. These tools will permit early and rapid diagnosis of onchocerciasis and the HIV virus, 
thus provihng health, social and economic benefits through prevention of blindness and other 
complications of onchocerciasis, and the prevention of the spread of A D S .  These technologies are 
likely to be sustainable, as all elements for their sustainability appear to be in place. 
The model for sustainability of transferred technologes and the IBL and HIV dipstick experiences 
could be helpful to other developing countries. 
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This case study of technology transfer in the Cameroon relates to the transfer of diagnostic technology 
for two prevalent conditions: onchocercias is and HIV. Manufacture for diagnostic tests had essentially 
been nonexistent in Afnca up to now. 
The paper presented the establishment of a biotechnology centre soon capable of developing 
diagnostic tests for onchocerciasis and then went on to describe the transfer of the technology 
required for the local manufacture and regzonal dissemination of an HIV dipstick, in collaboration 
with PATH, Canada. 
Whereas there was a formal needs-assessment for the HIV dipstick technology transfer, this was not 
the case for the work on onchocerciasis diagnostic test development. 
Whose Needs? 
One of the key questions raised during the discussion of this case s t u e  was 
m o s e  needs are being addressed? 
Participants in the discussion pointed out that needs could be defined quite dzfferently depending on 
the stake-holders: the community, the consumers of health services, the providers of health services, 
those involved in public health and policy. 
Who sets the priorities? Needs-based assessment can be quite dzficult because of the number of actors 
with conflicting priorities and competing local, indigenous, national, and global needs and priorities. 
The group recognised the importance of considering local priorities. 
There are more than just health needs. Needs-based assessment must be considered quite broadly in 
terms of health, technical, economic, and other elements, using an integrated approach. 
The discussion then turned to the issue of community-identified needs versus the role of a visionary 
individual (Visionary Individual Effort or VIE described in the paper). The group concluded that both 
were needed: a community-based approach appears essential but you need a champion to be an 
advocate and ensure the success of the endeavour. 
The HIV diptick was created in response to the need for a simple, no-instrumentation, low-cost 
diagnostic test of an important condition where diagnosis and screening are key to controlling the 
AIDS epidemic. 
Even if onchocerciasis was relatively low in the ranking of conditions according to burden of disease 
in Afnca, using the methodology presented in the I993 World Development Report, it nevertheless is a 
disease that causes much suffering and that deserves international priority. 
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Needs Assessment Methods 
Needs assessment methods should emphasize prioriiy setting (burden of disease, cost-eflectiveness of 
intervention, feasibility, and community concern). The issue of s ustainability appears particularly 
important and probably has not received in the past the attention it deserves. 
Even if the burden of disease may appear relatively low, such as in the case of AIDS in Cameroon at 
the time when the needs assessment for the HIV dipstick was carried out, we should consider long- 
term needs, in this case the evolution of the AIDS epidemic. In this case we should consider the 
potentially important prevented mortaliiy and morbidiiy and the cost savings from having limited the 
ultimate size of the epidemic. 
The weak health in@astructure in rural areas should be taken into account: this is where a simple 
device such as the HIV dipstick has a significant comparative advantage. 
Com mercializa tion 
Recognising the importance of needs-based technology assessment, the group felt that it was important 
to also cany out demand-based assessment: will there be sufJicient demand locally (national&) and 
internationally at a reasonable selling price based on the cost of manufacture, i.e., what will be the 
local and global markets for the product. 
It was pointed out that, ofren, for technology targeted to the specific needs of developing countries, 
there is insuficient financial incentive to attract private commercialfirms. In these cases, parastatal 
agencies, less dependant on the profit requirements, or internationally subsidized initiatives, may have 
a particular role in developing and initially marketing such products. 
What will be the commercial viability of the technology? Will the product be competitive in price and 
in quality with similar products produced elsewhere? An example was given of a developing countty 
polio vaccine development project which lead to the production of an uncompetitive vaccine. 
Will there be sufJicient demand from individuals, NGOs, governments, or international agencies? What 
price subsidization will be required to make the product accessible to the poorer populations of 
developing countries? (Will the demand be solvent or insolvent?) Who will cover the cost of this 
subsidy? The example of the dlfJiculty of developing new vaccines of particular relevance for 
developing countries was given. 
Three solitudes were identified: research, indurtry, and investment, each working in isolation. To 
ensure success of such ventures, one must combine the three and consider international linkages, 
patents (to ensure sufJicient return on investment), the manufacturing potential, and finally marketing 
and dism'bution). 
In the case of the HIV dipstick, the domestic market in Cameroon was su#cient to make the project 
financially viable. The export potential, studied in collaboration with Lava1 University, Quebec, 
Canada, also appeared signzficant, especially within the Afncan region. 
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It was pointed out that the needs-based assessment carried out for the HIV dipstick had been 
extremely costly. However, this needs assessment carried out early in the product development cycle 
was one of the key elements to the success of the project. 
Did Technology Transfer Take Place? 
When looking at the question as to whether technology transfer took place or not, it is clear that this 
has already occurred in the case of the HIV dipstick In the case of the onchocerciasis project, the 
project was designed to set-up in country a biotechnology centre capable of developing simple 
diagnostic tests for onchocerciasis. In this case, the technology transfer occurred earlier in the 
product development cycle, thus requiring a longer time period to product availability. The centre is 
up and running and work is in progress in the development of such diagnostic tests. 
What Were the Links to Policy? 
The group then turned its attention to the question whether the case study was linked to policy 
making. In the case of the onchocerciasis project, there are not yet any links to the policy making 
process. However, the HIV dipstick project has clear and important links to health policy and 
programs as regards to access and cost of HIV diagnosis and screening. 
OZher Benefits 
The participants then discussed the other benefits accrvedfrom these projects. Aside from the new 
diagnostic technique for HIV and for the new biotechnology centre in the Cameroon, a local capacity 
has been built which should provide a core platform to address more indigenous needs and national 
priorities. Although it is difJicult to quantlfy its value, most felt that this capacity building process was 
important for the country, especially when one takes the long-term view to health systems 
development. 
Needs-based assessment is usefil in setting priorities and in project planning; it makes one look ahead 
and determine sustainability. 
A network has begun to develop in country to carry needs-based technology assessment. This should 
contribute to the increasing use of this methodology and in the long run to more cost-eJective health 
services. 
Ana Rita Gonzalez and Janet Hatcher R o b e d  
In spite of real progress in health care facilities and equipment innovation in the past decades, the 
health systems of the countries of the English-spealung Caribbean are not optimally organized to apply 
the primary health care strategies endorsed by all the governments. Many of the basic health needs of 
the population are not met at all; others are met at high costs; still others are met with inappropriate or 
excessively costly treatments. 
Many of the deficiencies and inefficiencies of primary health care in the regon are the result of 
management problems, in particular the management of health technologies. In general, mechanisms 
and procedures to assure access to the appropriate level of health care are faulty. Specifically, the 
distribution of equipment within the health sector is unsystematic. The selection of medical devices 
both at the time of purchase and at the moment of treatment is often inappropriate. Problems of 
technology management are exacerbated by the rising costs and sophistication of imported medical 
devices. 
Current financial constraints in these countries make the replacement of many medical devices 
impossible. The development of management systems for health technology would help support more 
cost-effectivecare particularly at the local level. 
Management of health technology was defined for the purposes of this project as "appropriate 
selection, acquisition, positioning, maintenance and replacement of all types of health technology, 
including equipment instruments and specialized health personnel." 
The countries involved in the research project are Dominica, Jamaica, St. Lucia, and Trinidad and 
Tobago. The National Institute of Higher Education, Research, Science and Technology (hTHERST) 
was contracted to coordinate and administer the project. IDRC and PAHO are cofunding the project. It 
began in 1990 and should conclude in early 1994. 
Ana Rita Gonzalez is Hospital Administrative Advisor to the Caribbean Project Coordinating Office of the 
Pan American Health Organization, Bridgetown, Barbados, W.I. Prior to this appointment, Dr Gonzalez had 
8 years experience in managing hospitals. She received her PhD in health policy and management fiom Johns 
Hopkins University. Her research interest include efficiency and productivity. 
Janet Hatcher Roberts, a Registered Nurse, holds a BA in Anthropology and an MSc in Epidemiology. She 
has contributed to research related to health care delivery, development and evaluation of health indicators, 
community-based environment and health projects, and occupational health. She was an Assistant Professor, 
Department of Community Health and Epidemiology at Queen's University, Kingston, Ontario, worked with the 
Government of the Province of Ontario as Project Director of Strategic Health Planning (Health Goals for 
Ontario), as a policy analyst at Health and Welfare, Canada and as Deputy Director of Research for the Royal 
Commission on New Reproductive Technologies. She is currently Senior Program Officer, Health Sciences 
Division at the International Development Research Centre (JDRC). 
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The overall goal of this project is to develop a regulatory and a management system for health 
technology. 
The specific objectives are 
To describe the present situation of the management of health technology for local health services 
of Dominica, Trinidad and Tobago, and St. Lucia; 
To analyze the use and performance of selected technologies relative to the capacity of the 
technologies to meet the needs of the population using a national sample of community health 
centres in the participating countries; 
To analyze the use, frequency of use, and performance of selected technologies at the hospital 
level; and 
To analyze the problems identified in technologies at the community health centre and at the 
hospital as they refer to deficient regulations and management systems. 
The policy related objectives of this project are 
To design blueprints for national policies to improve the regulation of health technology; 
To develop and test specific management and information systems for planning, selecting, 
purchasing, using and maintaining health technologes and when appropriate, developing the 
necessary computer software; and 
To identify national training needs for the improved management and regulation of health 
technologies and design and implement programs to help fill these needs. 
The discussion session involved as cochairs Dr P. Manga (University of Ottawa), Dr Pena Mohr 
(PAHO), Dr Michael Cooper (Health Canada) - formerly Medical Devices Dvision, and Ana Rita 
Gonzales (PAHO) by phone hook-up and myself from IDRC as the two current people responsible for 
the project. Drs Mohr and Cooper were the originators of this project. 
56 - HEALTH TECHNOLOGY ASSESSMENT 
H a t  are the Elements of a Needs-Based Approach? 
CommunityBased Surveys and Data 
It was agreed that these should be reflective of needs at the community level. 
The Inter-American Development Bank has funded a project to address problems associated with 
the relevance of information in health data collection. Of concern here is the difficulty of 
determining community needs if surveys are primarily collecting data on individuals accessing the 
health care system (utilization-based data). Hospital-based data for instance, tends to be reflective 
only of those who access, thus not grving a true picture of community based health staius. 
Patient satisfaction should be examined as part of the health sewice data collection. 
Emergency room use in small geographic areas such as islands may be quite useful in assessing 
local need for this service (iydistances are short and direct and indirect costs very low). 
The health services provide disagregated data which are often dtfficult to relate to a given 
population. 
Present data tends to focus on what exists (e.g. age) and not what is requiredfrom a community 
perspective. 
Whose Needs Count? 
Politicians, practitioners, companies, institutions, communities, patients/users, and industry? Need 
is usually defined by seekers of care and providers of care. 
Consensus definition: mortality and morbidity. 
Due to access problems financial and geographic barriers to access), volume of services may not 
reflect community needs; these should be determined through household level surveys (concern 
was expressed concerning the raising of expectations in a community by conducting surveys). 
Equipment: Are people able to use the equipment? Is the human resource support sufficient to use 
it? Are purchases based on needs? The answers to these questions are dependant on political 
imperatives which may or may not reflect assessed needs. 
In some cases, regional needs and institutional goals dzfler signzficantly. Feedback on 
successes/failures would be useful. 
As well, it is dzficult to do long-term planning in the face of political instability. The ability of 
organizations to set research priorities and determine existing or emerging needs may be 
adversely aflected. 
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Has This Case Study Taken a Needs-Based Approach? 
Yes, but in a narrow sense only - the project began as an equipment/technology overview more 
than an assessment of technologies in relation to population or community needs. As well, our 
definition of needs-based technology assessment (7VBTA)- has shzfed since 1988-89 when the 
project began. 
Interviews invohed users only, did not utilize community participation approaches. 
Project driven by perceived needs based on mortality and morbidity and by institutional needs. 
Alternative sources such as health associations or NGOs could have been included in the project. 
What Were the Needs-Based Methodologies Used in This Case Study? 
Questionnaires reflected utilization and were designed for primary health care clinics, planners at 
the health ministry level, and hospitals. 
The data analysis was primarily descriptive. 
The interpretation and utilisation of data wnr carried out through a consensus conference. 
Preparation of questionnaires involved participantr from health administrators; ministries of 
health; Health Canada; and IDRC. 
The questionnaires were pretested with Permanent Secretaries and other senior stajf and refined 
in two- to four-stage iterative approaches. 
What Are the Emerging Overall Methodologies or Approaches to Needs-Based 
Technology Assessment? 
Ethical Issues: Addressing the ethical issue of providing services and technology investment which 
will have an impact in the population. How to make technology investment ejfective in the face of 
scarce resources? 
Quantifiing burden of disease: Dzjferent issues of assessing needs based on DALYs, QALYs etc. 
How should a project such as this analyze data that has been collected. Is it possible to 
understand the relationship between certain technologies and the outcomes as measured in QALYs 
or DALYs etc. ? 
Consumer priorities: Is it possible to incorporate consumer priorities into these analyses; i.e. 
what indicator of health status do they value more? Which would make more sense in terms of a 
needs-based analysis? 
Relation to decision-making: We are increasingly thinking about what decisions are these 
findings related to? We now know that there is a need to track our process. 
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Clinical trials: Clinical trials associated with the interventions may be usefil in this regard. 
Evalualion: An evaluation of the minimum package versus the costs of maintaining existing 
specialized technology would be usefil. 
Complimentary methodologies or emerging trends identified included efficacy studies, meta- 
analyses, and literature reviews. 
These should be a reflection of community-based burdenheed. 
Some concern was expressed regarding the possible problem of misintetpreting NBTA as an end 
in itself rather than applying it as an nnnlyticnl means to determine community needs. 
The use of consensus methodology for decision mahng (consensus conferences, etc.). 
Given These Emerging Trends, What Would You Incorporate Now That Was Not Done in This 
Study? 
Incorporate ethical issues of equitable distribution and resource allocation. It may be that such an 
addition can be incorporated later in the study: once the analysis happens, it can be folded into 
the resource allocation decisions. 
Consider the issue of productivity versus renl use and utility (appropriate use, the issue of false 
productivity). 
Did the Technology Transfer Actually Take Place? 
Yes, in the broadest sense in that the research on Health Technology Assessment (HTA) as a 
methodology was transferredfrom the North to the South. 
General comments: Knowledge/technical transfers from North to South ofien have a strong impact 
on how research agendas are determined. In order not to lose focus, increased attention should be 
paid to Primary Health Care sectoral needs in the South. 
Were the Case Study Results Linked to Policy Making? If So, How? 
NBTMpolicy link is crucial. 
From the beginning, the project involved ministry officials, hospital officials, CEOs, chief medical 
officer of health, permanent secretary, etc. 
The research project tied into other eflorts such as hospital streamlining, and therefore involved 
administrators and CEOs. 
Policy makers involved are included in the consensus conference process. 
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As well, study results will be presented to CARICOM, the regional association of Caribbean 
governments. This will move the issues identified in the study to the policy agenda of each member 
state and of the region. 
Public servants should be lobbied to ensure that HTAs are included in 5-year plans. As well, 
ministers need to know that HTAs are available for the primary health care level. 
Key Issues ldentjfied Through This Case Study 
There was strong involvement of the policy makers right from the beginning: an early meeting of 
the policy makers of the Caribbean identrfied important health sewice problems. From this, a 
second meeting with researchers was organised to define the research priorities and designs. 
The emphasis was placed on primary care: health centre and district hospital levels. 
The project was not really need-based but rather based on utilisation data (demand-based versus 
needs-based). 
The project collected dz#erent types of information: demographic data for each locality covered by 
the health facilities; mortality & morbidity data; utilisation data; identification and study of each 
type of technology @om preventive to rehabilitation) that is applied and used; volume of use of 
these technologies; the type of devices and drugs used. This provides a very good example on how 
to study a "package" of technologies and services m d  to analpe the dzflerent "packages" that 
could be related in the analysis to some population information. 
The dzficulty of building the database; it is a mixture of methodr from surveys andfrom case 
studies: 
- At the local level: Information from medical histories; data from patients to get some input on 
patient satisfaction; interviews with doctors, nurses m d  other providers; and 
- At the ncztional level: Data closely related to the issues identified by the policy makers 
(problems of resource allocation to see what policies were in place and what methodologies 
and what information were used: maintenance, regulatory and import problems, education 
in formation, stafing information, etc.). 
A database was designed to put this information together: this will be an important database for 
whomever would like to do some further analysis. 
Turning to the utilization of the information, one weak part is the methodology for the analysis: to 
date, it is mainly in the stage of descriptive type of work; it is not yet to the stage offinding 
relations between technology and some health indicators; researchers are welcome to study the 
database and to see if the information base will permit this type of analytic inferences. 
Afrer the research is finished, a few dz#erent consenszrs conferences will be held with policy 
makers and researchers. The idea is to use information as a base to support decision-making in 
relation to the issues submitted by the policy makers to the research community. 
Issues which are likely to come out of this process include: the variety of technologies found at 
the same level of the health system; what technologies should be available at each level; what is 
the pattern of referral and where should n specific technology be located. 
All those issues will be submitted in an organised agenda for discussion and for policy making 
purposes. Some technical groups will follow these discussions in terms of implementing and 
building some systems for national and local plnnning. 
CASE STUDY 3. 
RELATIONSHIP BETWEEN NEEDS-BASED TECHNOLOGY 
ASSESSMENT AND ESSENTIAL NATIONAL HEALTH RESEARCH - 
EXPERIENCE IN THE PHILIPPINES 
Tessa Tan Torres' 
The Philippine Health Situation 
In 1990, the Philippine population stood at 60.7 million, increasing rapidly at a growth rate of 2.3%. 
Life expectancy at birth was 64.6 years. Among the top five causes of mortality (1988) were 
pneumonia, diseases of the heart and cardiovascular system, tuberculosis and malignancies. The 
distribution of causes illustrates clearly the transition phenomenon where the system has to cope with 
the infectious disease burden of the past simultaneously with the growing threat of non-communicable 
diseases inflicted by the present. 
There are not enough health professionals in the Philippines. The professional: population ratios are 
listed as follows: one doctor for every 3,125 population, one nurse for every 2,259 population, one 
midwife for every 3,926 population and one dentist for every 10,799 population. Facility wise, there is 
one bed per 692 population. Within the country itself, there is significant variation in distribution of 
expertise and facilities. Access is severely compromised as reflected by the low rates of medically 
attended births (55%) and deaths (40.6%). The national infant mortality rate stands at 30.1/1,000 live 
births but in certain regions, the rates are two or three times higher. 
Health expenditures constitute only 1.9% of the Gross National Product, translating to an amount of 
US$5 per capita. Half of this amount is from the government of which 60% goes to the hospitals. The 
remaining half comes from the private sector with less than 6% from insurance providers. More than 
40% are out-of-pocket payments. 
In summary, the Philippines has a rapidly growing population, exhibiting the transition phenomenon 
and with the few resources expended in health unevenly distributed within the country. Despite the 
recently-gained political stability, no major improvements in the field of health can be expected. An 
economy struggling to recover cannot as yet fuel a nationwide development leading to less poverty 
and better health status. Thus, direct investments in health are needed. 
' A member of the Clinical Epidemiology Unit, Department of Medicine, Philippine General Hospital, 
Dr Tan Torres' research interests include clinical economics, infectious/tropical diseases and quality 
management. These interests are reflected in her on-going research, whlch includes a grant from the Rockefeller 
Foundation to undertake a before and after study of the costs and outcomes due to an institution and intensive 
care service. She is also involved in a Philippine Institute of Development Studies project entitled A Study of the 
Relative Eflciency and Efectiveness of Delivering Primary Level Care Services from the Rural Health Unit and 
from the Provincial Hospital. As a Rockefeller Foundation sponsored speaker, Dr Tan Torres gave a paper at the 
INCLEN annual meeting in January 1993 on ''Determining the Optimum Number of Views in the Radiographic 
Diagnosis of Sinusitis." 
Essential National Health Research 
The first years of the present administration ushered in two significant events. The first is the 
appointment as Secretary of Health of Dr Juan Flavier, a man who has extensive experience of 
working in the field of health and development in the rural areas. The second event is the devolution 
of services, including health, to the local governments. The current administration of the Department 
of Health @OH) is steadily steering the department away from its role of direct provider of health 
services to providing technical, administrative and managerial services to the local governments 
toward a vision of "putting health in the hands of the people." 
One of the main strategies in achieving th s  vision is essential national health research (ENHR). 
ENHR was started as the local counterpart of a global movement by the previous secretary of health, 
Dr A. Bengzon. A practising neurologist, he characterized health research in the country as a mass of 
convulsing neurons and saw ENHR as a method of coordinating research activity to provide 
information which would lead to better decision-malung and improved health services delivery. 
To do this, ENHR embarked on three major activities: defining a research agenda based on the 
people's health needs, ensuring that agenda-driven research be undertaken and inputting research 
results to the decision making process. Achieving success in these endeavours required that the people, 
the academe and the policy makers participated. 
ENHR Philippines recently came out with its research agenda for the next 2-3 years (see Table 1). 
The agenda is a result of a one-and-a-half year process of direct consultation with policy makers and 
program managers, focus group discussions with individuals from non-governmental organizations and 
people's organizations and review of existing literature by the academe who subsequently defined gaps 
in knowledge. The ENHR is now reviewing proposals based on this agenda and sourcing the funds to 
carry out the research. At the same time, it is strongly engaged in advocacy to create an environment 
where the policy makers in the DOH will use the results of the research to be produced. 
Table 1. ENHR ~ r i o r i t v  short list. 
l a  Study on indigenous beliefs and practices in health (culture specific) 
(Phase I) 
l b  Relationship of culturdreligioos beliefs to healtb messages (Phase Q 
2 Studies on the effectiveness of sectoral linkages in the implementation of 
Department of Health (DOH) Programs utilising the primary health care 
approach 
3 Assessment of training needs of DOH Local Health Board Members 
4 Baseline studies on epidemiology of mental health problems 
5 Baseline or intervention studies on Infectious Diseases of public healtb 
importance not covered by other funding agencies 
6 Study on health problems of special marginalized groups (street kids, 
children in armed conflict, victims of violencehntemal refugees, political 
detainees, victims of natural calamities, and disabled) 
7 Studies to develop effective strategies to rationalize drug use in hospitals 
Needs-Based Technology Assessment and ENH R
ENHR requires that technology assessment be needs-based. Talung the broad view of technology as a 
"set of techniques, drugs, equipment and procedures used by health care professionals in delivering 
medical care to individuals and the system within which such care is delivered," assessment of such 
underlies each item in the research agenda. ENHR emphasizes that the assessment should always be 
agenda-driven, and therefore needs-based, and that the existing expertise and resources for carrying 
out technology assessments be devoted primarily to the ENHR agenda. 
The following are two examples of technology assessment. The first is an example of successful 
assessment of a disembodied technology, the World Health Organization-Acute Respiratory Infection 
(WHO-ARI) algorithm. The second, Urine Screening, represents a failure of policy to be guided by 
needs-based technology assessment. 
Case A: WHO-ARI Algorithm 
Acute respiratory infections (AM) encompass pneumonias, which is one of the top causes of mortality 
especially among children aged 5 and below. The WHO-ARI algorithm depends on two simple signs 
of respiratory distress to guide management: rapid respiratory rate of >50/minute is an indication for 
use of antibiotics and chest indrawing for hospitalization. Its simplicity and non-dependence on 
instruments allow the algorithm to be implemented by health professionals other than doctors, thus 
improving access to services. The WHO-ARI algorithm was pilot tested for 5 years in Bohol, southern 
Philippines, and compared with the standard provider (in this case, a doctor) dependent approach of 
treating ART. There were 10,000 chldrenlgroup in eight municipalities. Results show that WHO-ARI 
was more cost-effective compared to the provider-dependent approach. In addition, it brought the 
technology into the hands of village health workers and trained mothers. The results of the project 
became the basis for a nationwide Control in Acute Respiratory Infections program of the DOH. 
Case 6: Nationwide Urinalysis Screening Program 
In its enthusiasm to promote preventive services, the Department of Health launched a nationwide 
urine screening program. Nephrologists cite chronic glome~lonephritis as the most common cause of 
end stage renal disease (ESRD) in the country. Treatment, in the form of dialysis or transplant, is 
expensive and can be offered only to a few patients. On the assumption that screening of urine by 
dipstick will detect proteinuria and prevent cases from progressing to ESRD, it was proposed that all 
schoolchildren be screened. Although recommended by the American Academy of Pediatrics, a review 
of literature reveals paucity of rigorous evidence showing the efficacy of screening for proteinuria to 
prevent progression of renal disease to ESRD. Thus ultimately, the program, despite its good 
intentions, may end up consuming more resources and straining the limits of the health care system. In 
this particular case, ciose monitoring and early reassessment are needed. 
Summary 
These two cases illustrate the importance of needs-based technology assessment. The first case 
addresses a major burden of illnesses and used an algorithm validated in local and foreign studies to 
be cost-effective and simple to use. The second technology has been promulgated into policy without 
undergoing any rigorous assessment. ENHR's role is to promote more Case A's and exercise its 
influence in preventing more Case B's from occurring. Through needs-based technologies assessment, 
both may be accomplished. 
How Do We Define a Needs-Based Technology Assessment Approach? 
The discussion started with how to de$ne need. Need is subjective and may dzfler according to whose 
perspective is taken: the consumer's or the provider's or both. The perceived need may depend on 
one's background lcnowledge and belie@; these mcry sometimes be inadequate or inappropriate, e.g. 
the perceived need of some communities to stop feeding a child when shehe has diarrhoea may be 
entirely inappropriate. 
Has This Case Study Taken a Needs-Based Approach? 
This case study illustrates a need-based approach. People's need were prioritized and gaps in 
knowledge for cost-eflective action were idenopen, using ENHR methodology. The WHO-ARI study 
was an example of an excellent needs-bmed technology assessment: ARI is responsible for a large 
burden of disease for which there is an eflective intervention. The study tested rigorously a diagnosis 
algorithm based on physical signs which mothers could easily identlfL (iy respiratory rate > 50, then 
use antibiotics; if indrawing, then go to the hospital) compared with usual care. 
The other example used, screening for proteinuria to prevent end-stage renal disease, clearly showed 
how a program implemented without a scieno$cally rigorous review, was both ineflective and very 
costly in a country with limited resources for health. 
The contrast of these two examples underscore the need for NBTA. 
What Were the Needs-Based Methodologies Used in This Case Study? 
The need-based methodologies used in this case study were 
A country ENHR strategy with clear priority setting; and 
A community-based randomized controlled trail (RCT) to test a diagnostic algorithm. 
What Are the Emerging Overall Methodologies or Approaches to Needs-Based 
Technology Assessment? 
There was discussion that the disability adjusted life years-based (DALY) method of de$ning need may 
be insuflcient especially in developing countries, because 
It is exclusively quantitative; 
The economic values of the country may not be properly reflected in the DALYs calculations; and 
Of the serious risk of underestimating problems which are dificult to quantzfL or under reported, 
such as violence against women, for example. 
Several participants felt that both qualitative m well m quantitative methods should be used. 
Epidemiologists and social scientists should join h m d  and use interdisciplinary approaches to needs- 
based technology assessment (7VBTA). 
Methods for priority setting for research and action may have to be different. FV%ile the disease 
burden may be adequate for research priorities, both disease burden and cost-effectiveness should be 
considered for action and should be combined with community perception (community concern). 
It is important to be aware of] and prepared for, resistance and opposition to the rational priority 
setting methodr from various interest groups; for example, some pharmaceutical industries mmay object 
to the concept of an essential drug list. At the same time, it may be prudent to invohe the industries in 
the technology assessment (TA) as they may support the activities and may help in meeting the 
objectives of TA. The industries have felt the need to get involved in the process because they are 
increasingly being asked to produce evidence for cost-efectiveness of interventions which they may 
come up with. An example of successfil collaboration was between WHO and manufacturers of cold 
chain equipment. 
NBTA should preferably be carried out before, rather than after, the production program for a new 
technology is started. 
Work is needed to develop better methods and skills to involve communities in needs assessment and 
in taking ownership of their health and health services. A potential problem may be the lack of a 
common language between various researchers, policy makers and communities. 
Did the Technology Transfer Actually Take Place? 
Yes. In the WHO-ARI example, the low cost technology of ARI management was successfilly 
transferred from usual providers to village health workers and to some extent even to mothers of the 
children. 
Were the Case Study Results Linked to Policy Making? If So, How? 
The WO-ARI management scheme is being considered for wider dissemination across the country by 
the Government. This is apparently easy and the main reason for this was the involvement of the 
policy-makers in the project from its very beginning. As a result the policy makers were already 
primed to the results of the study: they were already prepared to make it a policy if the results of the 
project were positive. 
Key Issues Identified Through This Case Study 
This case study reminds us that we are just beginning to address needs-based cost-efective health 
care: in the Philippines, despite a recent increase in emphasis on primary health care, still 60% of its 
health dollars continue to go to hospital care. 
Rigorom research methods (in this case a well executed community-based randomized controlled ttial) 
can provide clear answers about the cost-efectiveness of new interventions or management strategies. 
The needs vary depending on who is doing the assessment; whether it is the provider versus the 
community, one might come up with very d~fferent assessment of the needs. An almost universal 
opinion of the participants was that the communities should be involved in needs assessment and that 
community perception was the most important aspect of idenhfying needs. Nevertheless, the comment 
was that the community was a multisegmentnl entity, full of distinct interest groups; it is important to 
recognize and describe this phenomenon. One therefore needs signlficant qualitative research to sort 
out the belie$ and the priorities of the community. 
An excellent example was presented during the discussion of nn HIV prevention project in Haiti in 
which qualitative research found out that nctunlly n signlficant number of individuals in Haiti believed 
that AIDS was a curse; and ifyou believe that AIDS is n curse, you are not necessarily going to think 
that condoms are going to work. Knowing this then allowed the more rational design of quantitative 
studies and intervention programs targeted nt reducing HIV transmission. 
How do you prioritize needs? From a national perspective one would want to look at the burden of 
disease using standard epidemiological techniques (mortality, morbidity, etc.) but also examine the 
issues of concern to the communities. 
If in these high-burden illnesses, there is evidence of cost-effective interventions (both treatment and 
preventive interventions), one might want to go ahead and introduce these interventions as one may 
not need do a lot of local research. It was pointed out, however, that we may have evidence about the 
cost-eficacy of an intervention but that the cost-effectiveness in an individual community may not be 
known and therefore there might still be the need for some local research. However, if one does the 
research in too small a community, the results mny not be generalizable to the whole countty and the 
study may not be that usefil from a more general point of view. 
If the evidence for cost-effectiveness does not exist, one probably should do research in areas where 
there is as reasonable likelihood of success. Having a high-burden illness is not in-and-of-itself 
suflcient to warrant research; you need n reasonable prospect for a cost-effective, acceptable 
intervention. 
To ensure sustainability, community involvement is crucial; opinion leaders and finders must also be 
invohred. There is, however, open a problem with lack of common definitions & goals. Also, one open 
tends to focus on the process nnd less on the outcome. 
Methods of communication need to be improved from the community to the health care sector and 
from the health care sector to the community. New methods and approaches need to be developed in 
this area. 
To date, little has been done to evaluate the cost-effectiveness of the Essential National Health 
Research (ENHR) process. There is still relatively little emphasis on quality adjusted life years 
(QALYs) or disability adjusted Ife years (DALYs) nnd often one is confronted with a paucity of good 
epidemiological data. 
CASE STUDY 4. 
PART I - THE COMMUNITY-ORIENTED PROGRAMME FOR THE 
CONTROL OF RHEUMATIC DISEASE 
Jolr~z Darmawan' 
Abstract 
The WHO-ILAR-APLAR COPCORD is a program on community-based epidemiology, treatment, and 
prevention of rheumatic disease. It is divided into three stages and each stage is subdivided into 
several phases. The completed phases in Stage I indicated the appropriateness of the skilled 
manpower and time and cost estimates. Stage II addresses the manpower problem and patient 
education. Stage III looh into the etiological aspects of common chronic rheumatic diseases. 
Stage I has identified the following five health problems: 
Perceived need for treatment of more than 80% of the patients with recent musculoskeletal pain; 
Primary health care was inadequate for management of patients with chronic rheumatic disease 
due to lack of undergraduate rheumatolog teaching of the primary health care professionals, lack 
of laboratory and rehabilitation equipments, and the limited supply of antirheumatic drugs; 
The majority of rheumatic patients resorted to nonoflcial health care inclusive of self-medication, 
which proved unsatisfactory; 
Rheumatic disease entities, which were thought to cause major health problems were low back 
pain, osteoarthritis, gout, and osteoporosis, due to their high prevalence rates; 
There was rampant abuse of corticosteroids and their combinations with local and imported 
antirheumatic herbs in capsules. 
A pilot study to test the feasibility of COPCORD Stage II and III on gout is ongoing. 
Introduction 
During the seventies the International League Against Rheumatism (ILAR) urged the World Health 
Organization (WHO) to launch a major programme for control of rheumatic disease. On the request of 
ILAR, World Rheumatism Year was declared in 1977 by WHO. WHO is principally interested in a 
world-wide programmatic approach of disease control with emphasis on the majority of the world 
population living in the rural areas of developing countries. Their main concern is  with the common 
rheumatic disorders such as osteoarthritis and extra-articular rheumatism (low back pain). These 
musculoskeletal disorders are believed to be the major cause for most of the suffering and pains 
(Frank 1993; WHO n.d.a, b;). 
' Dr John Dannawan is currently Director of the Rheumatology Clinic, Seroja Arthritis Center, Semarang, 
Indonesia. He is also a Member of both WHO Advisory Panel on Rheumatic Disease and the WHO 
International League Against Rheumatism Comnunity Oriented Programine for the Control of Rheumatic 
Disease (COPCORD) International Team. He is editor of various rheumatology media in Indonesia and member 
of editorial boards of several international rheumatology journals. He has also published on the epidemiology of 
rheumatic disease in many of the international journals. 
In spite of the importance of musculoskeletal disorders both to society and to the many individuals 
affected, attention generally tended to focus on disorders associated with hgh  mortality rate in the 
developing countries. It can be foreseen that improving life expectancy within the coming decades in 
most developing countries will increase the burden of chronic conditions such as rheumatic diseases 
with all the psycho-socioeconomic consequences. Evidently, but not realized, chronic musculoskeletal 
disorders may already have partially hndered the development of thud world countries. 
Status of Arthritis Care 
Between 70 and 75% of the world populations live in the developing countries (Nakajima 1992). What 
is the status of arthritis care for more than four billions people in the developing world? The psycho- 
socioeconomic burden of rheumatic disease has been established in some developed countries (Pmcus 
et al 1989; Eklund and Fuglmeyer 1991; Eklund et al. 1991; Barquero et al. 1992; Frank 1993). The 
results of COPCORD Stage I revealed rheumatic pains are ubiquitous when age and sex adjusted 
@mawan et al. 1992b). 
WHO-ILAR-APLAR COPCORD 
WHO-ILAR-APLAR COPCORD (World Health Organisation, International League Against 
Rheumatism, Asia Pacific League Against Rheumatism, Community Oriented Programme for Control 
Of Rheumatic Disease) is a comprehensive three-stages program for the assessment of the need for 
arthritis care and the short term and long term solution of the problems for the developing world. It 
consists of three stages (Grabauskas 1983) and each stage may be subdivided into several phases. 
COPCORD Stage I 
Stage I is the collection of epidemiological data on rheumatic disease and comprises three phases. The 
main reason for the different phases is saving of manpower, time and cost, which is mandatory in 
developing countries. Phase 1 is the screening of a minimum of fifteen hundred people 15 years of 
age and over of the total population of a designated area for recent (within one week) and past 
rheumatic pain. A simple questionnaire, which queries musculoskeletal pain, disability, and help 
seeking behaviour is applied by Primary Health Care Workers in illiterate or self-administered in 
literate population samples. The minimal sample size of fifteen hundred people 15 years and over 
provides adequate statistical power and 95% confidence interval for the analysis of the prevalence rate 
of the various common rheumatic disorders. 
In COPCORD Phase 2, the respondents with rheumatic pain are interviewed with a more detailed 
questionnaire by a nurse to select the serious or chronic arthritis cases for physical examination by a 
physician who is familiar with rheumatic disease in Phase 3. Depending on the local availability of 
skilled personnel and resources, Phase 1 and 2 can be combined into one phase and Phase 3 can be 
extended with serology and radiology if funding is available. Serology and radiology are applied to 
arrive at more definite diagnoses. 
Of the 1,500 respondents interviewed by the primary health care workers or self-administered in 
Phase 1, approximately 25% (* 375 subjects) needed to be reinterviewed by the nurse in Phase 2. In 
Phase 3, less than 5% (fewer than 75 patients) had to be physically examined by a physician skilled in 
the management of commonly encountered rheumatic disease. A sipficant saving of personnel (nurse 
and physician skilled in handling common rheumatic disease), time, and costs were achieved in the 
completed COPCORD Stage I study. 
Analysis 
Analysis of the data of COPCORD Stage I has identified the following five health problems 
@mawan 1988; Darmawan et al. 1992a, 1993a). 
There was perceived need for treatment of more than 80% of the patients with recent 
musculoskeletal pain. 
Primary health care was inadequate for management of patients with chronic rheumatic disease 
due to lack of undergraduate rheumatology teaching of the primary health care professionals, lack 
of laboratory and rehabilitation equipments, and the limited supply of antirheumatic drugs; official 
health care comprises visit by the patient to the community health center and to the physician, the 
nurse and primary health care workers. 
The majority of rheumatic patients resorted to nonofficial health care inclusive of self-medication, 
which proved unsatisfactory; nonofficial health care covers treatment by self-medication, masseur, 
acupuncturist, acupressurist or reflexologist, traditional healer, herbs, faith healer, etc. 
Rheumatic disease entities, which were thought to cause major health problems were low back 
pain, osteoarthritis, gout, and osteoporosis, due to their hgh prevalence rates. 
There was rampant abuse of corticosteroids and their combinations with local and imported 
antirheumatic herbs in capsules. 
Arthritis care is inadequate or nonexistent for most of the people in the developing and less developed 
countries. The main reasons are lack of manpower, service infrastructure, supporting resources, and the 
absence of undergraduate and postgraduate rheumatology and patient education. In most developing 
and less developed countries Western trained and local self-didact rheumatologists can be counted 
with the fingers. Rheumatology health professionals (rheumatology physiotherapists, occupational 
therapist, and social workers) are nonexistent. The primary and secondary health care centres are not 
equipped to cope with rheumatic disease. Only a few tertiary health care centers, whlch are 
understaffed, have some facilities for rehabilitatioil of chronic arthritis. Inadequate and lack of social 
security and health insurance make treatment of chronic disease a hit and run operation. Nonexistent 
or fledgling arthritis foundation is not of much help. The state and the number of teaching 
rheumatology units in several Asian countries preclude the training of adequate number of 
rheumatologists in the short term (Table 1). China with a population of 1.2 billion people may be 
Table 1. State teachine rhewnatolow and private rbeumatolos- units in some Asian nations. 
India China Iran Taiwan Japan Paki- Bangla- 
stan desh 
Total rheumatology units 7 - 6 4 129 - - 
Total divisions of rheumatology 7 30 20 14 111 - - 
Total divisions and units 14 30 26 18 240 - - 
Units ldon population 57.1 36.7 2.6 0.9 0.5 - - 
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satisfied with two understaffed teachins rheumatology units. India with almost 900 million people has 
only one understaffed rheumatology teaching unit. Indonesia with 186 million people has only one 
rheumatology teaching unit. Pakistan and Bangladesh, each with more than 120 million populations 
have no rheumatology unit. The table shows the average number of people per million served by one 
rheumatology unit. 
COPCORD Stage 11 
The other option left is to carry out a feasibility study in a pilot project on the appropriateness, cost- 
effectiveness, adequacy, and efficiency of rheumatology undergraduate teaching for primary health 
care professionals in COPCORD Stage II. COPCORD Stage LI comprises education in primary 
arthritis care by primary health care professionals and patient's education, and the attempted 
identification and control of environmental risk factors of musculoskeletal disorders. 
Identification of the most frequent used coping strategies applied arbitrarily by patients with chronic 
arthritis may induce the development of improved coping techniques. If education in primary arthritis 
care improved quality of primary health care through improved knowledge, and controlled of 
environmental risk factors by improved coping strategies reduces morbidity, and disability, then the 
model COPCORD Stage I1 education can be disseminated in the developing countries. This includes 
the printing and distribution of the field-tested education booklets, each separately for the education of 
primary health care physicians, the paramedics, and the patients. 
Arthritis Community Education adjusted to the local culture such as by the leather puppet shadow play 
(wayang kulit) improved knowledge of the patients compared with controls (Darmawan et al. 1992~). 
Therefore, coping strategies of patients with chronic arthritis should be adapted to the local cultural 
characteristics, beliefs, values and language of the people to ensure successful application. 
COPCORD Stage 111 
Stage I has shown that chronic interactions between an environmental risk factor and a predisposed 
individual can induce the manifestation of a musculoskeletal disorder (Darmawan et al. 1993b). By 
cooperation with an advanced research center, COPCORD Stage III will attempt to identify genetic 
risk factors of rheumatic disease by molecular biological or other technology to attain a better 
understanding of the chronic process(es) of interaction(s) between or among environmental and genetic 
risk factors in the causation of the manifestations of chronic rheumatic disease. Due to the high 
prevalence rate of gout in adult males, a pilot study has been launched on December 18, 1993, in the 
province of North Sulawesi, Central Indonesia, to test the feasibility of COPCORD Stage I1 and ID. 
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Marcos Bosi Ferraz' 
There is an urgent need for high quality data about the magnitude and impact of rheumatic disorders 
in developing countries, especially in Latin America. Such data can bring attention to the substantial 
health impact of this group of disorders and can inform decisions regarding appropriate services for 
detection and treatment. 
In order to evaluate the burden of illness attributable to rheumatic disorders in Latin America, a group 
of rheumatologists and clinical epidemiologists (all members of the International Clinical 
Epidemiology Network Program) decided to use the WHO-ILAR-COPCORD (Community Oriented 
Program for the Control of Rheumatic Diseases) approach. 
It consists of three stages: 
Stage 1 : Epidemiologcal data of rheumatic diseases are collected; 
Stage 2: The primary health care professionals are educated in the management of the most 
common rheumatic diseases; 
Stage 3: The aim is the improvement of heath care and health status. 
The COPCORD Questionnaire is a single screening instrument intended to identify individuals with a 
high probability of rheumatic diseases who are referred for a further detailed clinical examination by a 
rheumatologist. Therefore, the goal of the selection is to maximize screening accuracy through the 
selection of items with a predictive value, rather than to ensure comprehensive sampling of all 
possible domains and/or items. 
The domains related to rheumatic diseases included are 
Pain and symptoms; 
Disability; 
Coping; 
Seeking behaviour; and 
Treatment. 
After initial group hscussions, the original COPCORD Questionnaire was slightly modified aiming at 
the achevement of a greater face and content validity when applied to a latin-american environment. 
A Pan American League Against Rheumatism (PANLAR) English version was defined. 
Associate Professor, Department of Medicine, Division of Rheumatology and Clinical Epidemiology Unit, 
Escola Paulista de Medicina, Sao Paulo, Brazil; Chainnan of the Clinical Epidemiology Committee of the 
Panamerican League Against Rheumatism; Member of the International Clinical Epidemiology Network 
(INCLEN). He holds an MD, an MSc in Rheumatology, an MSc in Clinical Epidemiology, and a PhD in 
Rheumatology. 
As every crosscultural project involves the uses of language and potential problems may arise with the 
translation of the most simple sentence, the investigators decided to translate the instrument into 
Portuguese and Spanish as well as to evaluate the new instrument measurement properties. 
The following study phases were conducted in Brazil, Chile, and Mexico: 
1. Translation of the instrument 
Primary translation; 
Evaluation of the primary translation; 
Evaluation of cultural equivalence; and 
Definition of the Portuguese/Spanish version. 
2. Evaluation of reliability - Hospital based sample 
Intra-observer; and 
Test-retest. 
3. Community validation study 
Sensitivity; 
Specificity; and 
Number of physical exams avoided. 
I will now present the results of the study entitled "Validation of ILARICOPCORD Core 
Questionnaire (ICQ) against physical examination" that was performed in Embu, Sao Paulo, Brazil. 
The objective of this study was the evaluation of the sensitivity and specificity of the Portuguese 
version of the ILARKOPCORD Core questionnaire in terms of screening rheumatic diseases. 
Six streets of one district of Embu were randomly selected and had 76 houses chosen also at random 
and visited by interviewees. 204 individuals were interviewed and examined (1 10 females, age 16-81, 
mean = 38 years and 94 males, age 16-79, mean = 41 years). One hundred and seven individuals 
reported pain, tenderness, swelling or stiffness in their bones, muscles or joints (50 at present and 57 
in the past). Of these, after the physical examination, 68 individuals had 72 rheumatic diseases 
chagnosed. The following diagnoses were made: lumbago, 18 patients; hand osteoarthritis, 9 patients; 
wrist tenosynovitis, 6 patients; painful shoulder, 6 patients; knee osteoarthritis, 5 patients; tension neck 
syndrome, 3 patients; rheumatoid arthritis, rheumatoid syndrome, gout, and rheumatic fever, 1 patient 
each; and other diagnosis 21 patients. 
In addition, 18 individuals reported some disability due to the rheumatic disease at the time of the 
interview. The Health Assessment Questionnaire Scores ranged from 0.1 1 to 1.88, with a mean value 
of 0.71. 
Based on these data, the Portuguese version of the ICQ presented a sensitivity of 92% and a 
specificity of 70%. The prevalence of rheumatic disease in the population screened and examined was 
36.2% and the positive predictive value of the ICQ was 63.5%. By using this screening questionnaire, 
476 physical exams/1,000 individuals interviewed can be avoided. 
The conclusion of this study was that the Portuguese version of the ICQ is able to accurately screen 
rheumatic diseases. 
Similar studies with coinciding conclusions were reported in Chile and Mexico. 
The following problems still remain to be solved before starting the full scale COPCORD Stage I 
survey: 
Diagnosis criteria for the soft tissue diseases; 
Diagnosis criteria for back pain; and 
Diagnosis of cases screened with normal physical exam at the time of examination. 
The Clinical Epidemiology Committee of the PANLAR is presently working to solve the remaining 
methodological problems and soon the full scale COPCORD stage I survey will be launched in some 
Latin American countries. 
76 - HWTH TECHNOLOGY ASSESSMENT 
The beginning of attention to rheumatic diseases in developing counbies dates back to 1977 when 
WHO declare 1977 World Rheumatism Year. The WHO Community Oriented Program for the Control 
Of Rheumatic Diseases (COPCORD) was conceived in 1980. The first field testing of survey 
instruments occurred in 1981 in the Philippines and followed in 1982 by further testing in Indonesia. 
What war; the rationale for focusing on this specific categoiy of diseases? Perhaps the rationale 
became obvious in the presentation by Helen Saxenian, earlier in the Conference entitled "Technology 
Assessment and the World Development Report 1993" because indeed in the 1993 World 
Development Report, there is very little attention paid to rheumatic diseases. 
One of the explanations for this absence of attention to rheumatic diseases was given as being that 
there is little information on the epidemiology of rheumatic diseases in developing countries: it has 
not really been quantified to any extent. This lack of data, therefore, prevents rheumatic diseases from 
competing for attention with other diseases in the policy making context, such as infectious diseases, 
cardiovascular diseases, cancer, and AIDS. It was felt that some quantification of these problems 
would certainly be extremely helpful. 
This case study presented information on two countries in which this program was implemented: 
Indonesia and Brazil. 
In Indonesia, this program occurred in three stages. 
The first stage was quantification of the burden of illness; the survey instrument that had been 
developed in the early 1980s underwent several validation exercises and reliability assessments. This 
being done, it was possible to come up with some prevalence estimations of these diseases and it was 
found that osteoarthritis and low back pain were the two most important problems in Indonesia; this 
was also verified in other developing countries,. With respect to low back pain, the prevalence 
estimates were 20% and 25% in rural and urban areas respectively. 
Through this stage of the project, the emphasis was on the use of quality of life measures and more 
specifically disability indices as opposed to using mortality indices and this was becoming extremely 
important in view of putting rheumatic diseases on the policy agenda in competition with other 
diseases that would use mortality indices as a measure of burden of illness. Also, it became extremely 
apparent that when we think of rheumatic diseases, the socioeconomic impact of these diseases is 
extremely important in all countries. 
They then moved to the second stage of the study, stage in which the focus shifred to 
The study of interventions (eflcacy, eaectiveness, and eflciency or cost-eaectiveness); 
Manpower issues, that is what type of health care professionals would be needed to provide 
services for these conditions: physicians, nurses, traditional healers; and 
A specific focus was on the issue of self-medication, over-the-counter medications, and abuses of 
medications (such as steroids) with respect to these specific diseases. 
This latter focus of attention lead to some policy action. 
Andfinally, the third stage is currently unfolding; the focus here is much more on the development of 
etiologrcal studies to try to understand what are the etiologic factors, genetic and environmental, with 
respect to these diseases. 
What is the policy context in Indonesia right now with respect to these diseases? Indonesia is in a 
phase of change, that is the policy making process which was mostly "political" is progressively 
becoming more "technical" or "technocratic." It is therefore believed that the gathering of this 
information will probably become much more usable in any future policy debate. 
The same project is unfolding in Brazil, although at a diferent pace; it is currently in the first stage 
(validation of the survey instruments and quantjication of disease). The second and third stages of the 
Program are in planning. Again, concerning the policy making context, it is observed that this context 
is changing and that probably the policy makmg process will become more technocratic in the next 
5-1 0 years. 
This discussion focusing on a speczjic issue carried as the ultimate objective to refIect on the 
utilisation of technology assessment as a tool for decision making. The startingpoint for this rejlection 
is to realize that in some ways, what is at issue here, is whether we are able to cross this bridge 
between knowledge and decisions and to what extent we can really use objective information in the 
policy making process. In the case of rheumatic diseases in fact, we have started to gather information 
on the burden of disease through these survey instruments, prevalence is being documented, quality of 
Ii$e indices are being used, the focus is on osteoarthritis and low back pain and increasingly studies 
dealing with the efectiveness of the interventions are being developed. Issues of manpower are being 
looked at, the etiology of diseases is being examined, and policy issues are being increasingly 
addressed. 
Now in thinhng of policy making, we could view the policy making process as a spectmm; a spectrum 
that goes from a process that is purely technical and in which technology assessment information 
(TAI) would certainly be welcome to aprocess that would be absolutely political in which TAI would 
not be welcome. 
Now given that TA can be viewed as an instrument for policy making in which the technical 
component is important as the policy making style of countries moves from being a political process to 
aprocess that will give more space to the technical component. 
From what we have heard during the Conference, it is clear that in several countries around the 
world, there are changes occurring, changes that will allow the technical component of decision 
making to become more important. 
Key issues identified through this case study 
Chronic conditions such as rheumatic diseases, which cause considerable sufering, are highly 
prevalent and may have important socioeconomic repercussions through lost productivity, have 
received little attention until recently as compared to diseases which have been important cawes of 
mortality. Although indicators such as Disability adjusted life years (DALYs) should take this 
morbidity into account, the lack of quantitative information on the magnitude of these disorders may 
have lead to a signzjicant underestimation of the burden of disease cclused by these conditions. 
We are only beginning to study the eflectiveness and cost of interventions for chronic conditions such 
as rheumatic diseases in developing countries. 
Many countries are evolving from a purely "political" to a more "technical" process for decision 
making, thus providing fertile ground for needs-based technology assessment as a tool for decision- 
making and, in so doing, enabling us to cross the bridge between knowledge and decision-making. 
CASE STUDY 5. 
PRACTICAL TOOLS FOR IMPROVING NEEDS-BASED HEALTH 
MANAGEMENT AND TECHNOLOGY ASSESSMENT - 
THE PHC MAP SERIES 
Ronald G. Wilson' 
Need for Information for Health Management and Technology 
Assessment 
The Primary Health Care Management Advancement Program (PHC MAP) was initiated by the Aga 
Khan Foundation (AKF) five years ago in response to a major conclusion of the "Intemational 
Workshop on Management Information Systems and Microcomputers in PHC" that improved 
management information systems are needed to enable PHC program managers to take 
informed management decisions, being fully cognizant of constantly changing health 
conditions, health status of the local population, health risks, priorities for health actions, 
service coverage, and the effects and outcomes of health activities and interventions. 
In the same year (1987), the World Health Organization's (WHO) report on the global "Evaluation of 
the Strategy for Health For All by the Year 2000" concluded that there was (and, indeed, there 
remains today) a crucial need for improved information for needs-based management of health 
programs: 
The main constraint reported by practically all countries is inadequate information for the 
managerialprocess ... to provide systematic and analfical information for continuous 
assessment of the situation, determination of priorities, improvement of management, and 
evaluation. The Health for All strategy demands an integrated managerial approach ... and also 
monitoring and evaluation with a view of modification or readjustment of the strategy as part 
of a continuous cycle .... The information generated by the traditional health system is in most 
countries quite insufficient. 
By 1989, the situation had worsened: a WHO report on The World Economic Situation and the 
Prospects for Health for All by the Year 2000 confirmed that, in addition to inadequate information 
for the managerial process, inefficient management was compounding problems of shortages in the 
health sector created by the deteriorating economic situation. 
Dr Ron Wilson joined Aga Khan Foundation (AKF) in Geneva as Program Officer in 1982. Prior to his 
appointment, Dr Wilson worked as a project manager and USPHS Chief-of-Party with the Lampang Health 
Development Project, through Thailand's Ministry of Public Health. He has been a PHC and training consultant 
with USAID, WHO, and various universities in Southeast Asia. His most recent publication is a coauthored 
paper entitled "Health Policy and Strategy Implications of Lessons on Primary Health Care Effectiveness, 
Impact, Management, Sustainability, and Technology" in GIobal Learning for Health (National Council for 
International Health, Washington, DC, USA. 1992-93). 
Economic trends since the Declaration of Alma Ata have retarded progress towards health for 
all in many countries. In developing countries, expenditures on health have fallen while 
demands have continued to increase. The impact on health services is increasingly 
conspicuous, and the effects on health status give cause for serious concern. Shortages of 
resources in the health sector are often made worse by inefficient management. 
In 1993, the need for improved information and for practical tools to generate information for needs- 
based management and technology assessment was highlighted by The World Bank's World 
Development Report 1993 - Investing in Health (see "Generating Information and Strengthening 
Research," p. 148-155, in Chapter 6, ''Health Inputs," and sections in Chapter 7, "An Agenda for 
Action"). 
... Simple management information systems for measuring costs, inputs, and production could 
be helpful for monitoring program efforts over time and for making decisions about how to 
combine inputs efficiently. Yet many public facilities operate without such information 
[p. 1511. 
... Governments have a twofold role in health information systems and operational research: 
generating the information necessary to guide health policies and public spending and 
providing certain types of information about provider performance that would be too costly for 
consumers to collect. To this end, governments can 
Gather and synthesize epidemiological and other information necessary to monitor 
health status, detect disease outbreaks, and guide public policy and program design; 
Support research, where needed, to generate local solutions to local problems; 
Facilitate standardization of information about health production and health outcomes 
by district health systems and other major health providers; where necessary, 
synthesize and publicize this information to aid consumers in making informed choices 
about health care [p. 151-1521. 
The PHC MAP Series was developed and field-tested in 13 countries of Asia, Africa, Latin America, 
and the Caribbean to help meet the crucial need for practical tools to generate high-quality information 
for the managerial process. Because the PHC MAP Series focuses on both health services and 
management services, and contains useful "what-if" analyses of cost and susdnability variables 
(among other variables), these tools can contribute substantially to the design of more effective, 
efficient, and affordable health programs, as well as to the assessment of health service and 
management service technologies and to the preparation of highly valuable presentations for effective 
advocacy of improved health policy and reform. 
What is Included in the PHC MAP Series? 
The PHC MAP Series contains 21 printed volumes and 3 high-density computer diskettes with 
compressed files; these products are organized around nine thematic modules, each of which includes 
a User's Guide, a Facilitator's Guide, and computer programs, such as Epi-Info. 
The PHC MAP Series can collectively enable health management teams to assess the effectiveness, 
efficiency, equity, quality, costs, and sustainability of both health services and management support 
services. And the "what-if' analyses contained in the modules on Cost Analysis and Sustainability 
Analysis enable health management teams to assess the effectiveness, efficiency, equity, quality, costs, 
and sustainability of alternative options in terms of health services and management support services. 
Therefore, the PHC MAP Series can have both strategc and tactical applications, and the "what-if' 
analyses included in the modules on Cost Analysis and Sustainability Analysis can be used as 
powerful tools for advocacy with: 1) the policy-making "generals"; 2) the middle-level "corporals" 
who provide management support services, and; 3) the "lieutenants" who lead the front-line tactical 
operations of health service delivery and of management service support for front-line health workers 
and volunteers. 
Modules 
1 Assessing Information Needs 
Helps health program managers identify information needs; set priorities; and use modules. 
2 Assessing Community Health Needs and Program Coverage 
Tools to help gather data on community health needs for planning strategies and resource use; 
and assessing program effects on health status, knowledge, behaviour, and coverage. 
3 Planning and Assessing Health Worker Activities 
Helps supervisors and managers to assist health workers plan their work; set realistic targets; 
assess performance; and take corrective action. 
4 Surveillance of Morbidity and Mortality 
Describes basic indicators of morbidity and mortality, how to set up surveillance systems, how 
to identify causes of mortality and morbidity, and how to use that information to improve 
program planning and implementation. 
5 Monitoring and Evaluating Programs 
Indicators and guidelines for monitoring service and management activities, and constructing a 
project-specific "mini-MIS." 
6 Assessing the Quality of PHC Service 
Checklists of essential service resources and processes to use to assess the quality of care 
provided and set priorities for improving service. 
7 Assessing the Quality of PHC Management 
Checklists for assessing management functions, e.g., planning, training, and supervision. 
8 Cost Analysis 
How to set up simple cost accounting systems to monitor costs and to project future income 
and costs. 
9 Sustainability Analysis 
Guidelines and tools on developing and analyzing alternative strategies for sustaining health 
improvements, services, processes, and the related human and financial resources. The "what- 
if '  analysis used in Modules 8 and 9 can help managers design a sustainable program, as well 
as produce powerful presentations for purposes of more effective advocacy. 
Guides 
1 Problem-Solving 
Helpful hints from PHC managers on solving common problems; e.g., how to help illiterate 
health workers, how to be sure there are enough supplies. 
2 Better Management - 100 Tips 
Helpful hints from managers and management experts on how to become a better manager; 
how to get the most out of staff; conduct meetings; monitor and assess activities; plan 
operations. 
3 Computers 
Up-to-date information on how to select the most appropriate computers, printers, related 
equipment, and computer software; and handy hints for making sure it all works. 
Computerized Version of the PRICOR Thesaurus 
A computerized list of key steps in the provision of each type of PHC service, with suggested 
questions, indicators, and data sources for monitoring the steps in each process. 
Technical Reviews and Field Tests of the PHC MAP Series 
As PHC MAP aimed to develop and field test practical tools to help management teams collect, 
process, and analyze information needed for the managerial process and thereby enable them to 
improve coverage, effectiveness, efficiency, and sustainability of their health programs, a broad range 
of international health experts and health program managers reviewed the PHC MAP materials 
independently and through participation in such workshops as the AKF-sponsored "International 
Workshop on the Management and Sustainability of PHC Programs" in Thailand in 1992, hosted by 
the Ministry of Public Health. Technical reviewers of the PHC MAP Series have included health 
professionals at the University of Ottawa and McMaster University in Canada; the Ministry of Public 
Health, the Somboon Vachrotai Foundation (SVF), and the ASEAN Institute for Health Development 
(AIHD) in Thailand; the Aga Khan Health Service and the Indian Institute of Management in 
Ahmenabad, India; the Ministry of Planning, the Aga Khan University Faculty of Health Sciences, and 
the Aga Khan Health Services in Pakistan; the African Medical and Research Foundation (AMREF) 
and the Aga Khan Health Services in Kenya; the Center for Disease Control in Atlanta; and WHO 
headquarters and the AKF Head Office in Geneva. 
Field tests were conducted by PHC management teams operating in a variety of settings (urban, rural, 
and remote areas) and with different levels of managerial experience and technical sophistication in 13 
countries of Asia, Africa, Latin America, and the Caribbean, where health conditions and resource 
limitations compel health organizations to try to operate more effectively and efficiently: Bangladesh, 
Chile, Colombia, Dominican Republic, Guatemala, Haiti, India, Indonesia, Kenya, Pakistan, Senegal, 
Thailand, and Zaire. 
The PHC MAP Series, whlch can be used with or without microcomputers, has been shown to be 
highly valuable to NGO and government health service management teams serving small populations 
(10-20 thousand), medium size populations (20-50 thousand), entire districts (50-500 thousand), and 
provinces (0.5-1 million+). 
PHC MAP Training in Asia and M i c a  
In August 1993, a 3-week PHC MAP Master Trainer's course was conducted by AIHD in Thailand, 
sponsored by AKF, SVF, and UNICEF. Some 30 participants from Bangladesh, China, Mongolia, 
Myanmar (Burma), Nepal, Pakistan, Philippines, Thailand, and Vietnam took the course and judged 
the PHC MAP Series to be highly relevant and useful. Significantly, participants from Bangladesh, 
China, Mongolia, Myanmar (Burma), Thailand, and Vietnam have recommended the broad application 
of the PHC MAP Series by the government health services in their respective countries. The PHC 
MAP Master Trainer Course has been institutionalized by AMD and, with support from UNICEF, will 
be offered again in August 1994. 
In East Africa, the African Medical and Research Foundation (AMREF) plans to launch a PHC MAP 
Master Trainer Course for the government's District Health Management Teams in Kenya. AMREF 
and other organizations are also considering the development of similar training programs in Uganda, 
Tanzania, andlor Zanzibar to enhance the capacities of District Health Management Teams to improve 
the effectiveness and efficiency of Qstrict health services in these countries. 
Broad Applications of and Growing Demand for the PHC MAP Series 
The finistry of Public Health in Thailand has indicated that it will use the PHC MAP Series 
nationwide at provincial, district, and subdistrict levels. In Bangladesh, the Directorate of PHC in 
Bangladesh plans to use the PHC MAP Series in Government health programs. The American Refugee 
Committee is using the PHC MAP Series in its worldwide refugee assistance program. In India, two 
premier institutions - the Indian Institute for Health Management Research and the Indxan Institute of 
Management, Ahrnrnedabad - are using the PHC MAP Series; the US Agency for International 
Development (USAID) is promoting the use of the MAP Series among many PVOs (PVOs = NGOs), 
and the World Bank has expressed its interest for the States implementing the India Population 
Projects. And many other health training institutions and technical assistance groups are finQng the 
PHC MAP Series highly useful. 
It is worth noting here that all printed PHC MAP material and computer programs are in the public 
domain and can be freely copied and distributed. 
The demand for the PHC MAP Series has grown substantially since the field-test period when over 
120 copies of the draft PHC MAP modules were shared with many NGOs and government health 
services. 
W i h n  5 months after the first order of 5,000 sets of the PHC MAP Series had become available, 
nearly 4,000 sets had been requested by over 507 institutions in 50 countries. Only about 1,000 sets of 
the 21-volume, 3-HD diskettes MAP Series are now available from the distributor, the Somboon 
Vacharotai Foundation (SVF) in Thailand. 
Given this limited supply, orders should be placed quickly with the Somboon Vachrotai Foundation. 
Kindly use SVF7s fax number and coordinates, given at the end of this article, should you wish to 
place an order. 
Summary and Conclusion 
The PHC MAP Series can collectively enable health management teams to assess the effectiveness, 
efficiency, equity, quality, costs, and sustainability of health services and management support 
services, as well as the health care and management technologies applied. The "what-if' analyses 
contained in the modules on Cost Analysis and Sustainability Analysis enable health management 
teams to assess the effectiveness, efficiency, equity, quality, costs, and sustainability of alternative 
options in terms of health services, management support services, and the health care and management 
technologies applied. 
Now that the PHC MAP Series has become available, what is most needed is to broadly promote the 
use of the PHC MAP Series by health training institutions, health consultants, the development and 
donor communities, and, most important, NGOs and government health services who are in the 
business of providing management support services and health care services which are equitable, 
effective, efficient, affordable, and sustainable. 
Don or Acknowledgement 
PHC MAP has cost over US $1.7 million, which has been provided by AKF(Geneva), AKF Canada, 
CIDA, the Commission of the European Communities, the Rockefeller Foundation, the U.S. Agency 
for International Development, and AKF USA. 
Dedication 
The PHC MAP Series is dedicated to Dr Duane L. Smith (1939-92), Associate Director of Health 
Programs, AKF Geneva, formerly of WHO Geneva's Division of the Strengthening of Health 
Services; and to Dr William B. Steeler (1948-92), Director of PHC, Secretariat of His Highness the 
Aga Khan in France; and to all other health leaders, managers, and workers who follow their example 
in the effort to bring quality health care to all in need. 
One of the strongest motivations for ensuring the quality of information being collected is a 
personal interest in its local use. Improving the understanding and use of information by those 
who collect it, particularly in communities, at health centres, and among the district health 
management teams, thus contributes not only to better management, but also to improving the 
quality of information itself." (Dr Duane Smith, 1987, at the International Conference on 
Management Information Systems and Microcomputers in PHC). 
How to Obtain PHC MAP Materials 
Information on acquiring PHC MAP materials is available from the distributor: 
The Honorary Secretary-General 
Somboon Vacharotai Foundation 




TEL: (00662) 448 60 50 / 448 69 42 / 448 64 61 
FAX: (00662) 448 64 62 / 448 6662 
Shipping costs vary by destination but should be about US $40 by surface mail or US $100 by air. 
Note: All PHC MAP material has been placed in the public domain by its producers: it is therefore 
free of copyright. Both software and text components can therefore be reproduced freely for 
noncommercial use, with the appropriate acknowledgement of its producers. 
Unlike previous case studies, the emphasis here is on management advancement of health programs. 
PHC UAP is a management tool for improvingprimary health care management. It is ofien forgotten 
that in d imion  and appropriate utilisation of technology, the management aspect is essential. 
Furthermore, one is more likely to find policy levers in the management aspect of the technology, thus 
contributing to policy development. 
This case study illustrates a broad range of areas in which technology assessment can play an 
important role in improving health services: from the qualitative analysis of patient satisfaction to the 
more intricate and controversial aspects of developing practice guidelines to change provider 
behaviour. 
The PHC W was designed to be flexible and easily adapted for local use. While a computer is not 
necessary, it mmakes the Cost analysis and Sustainability analysis modules more useful and can save 
considerable time and energy in the adaptation of the material for local use. 
PHC UAP has identified ways to reallocate health workers ' time to more eflective use, e.g., growth 
monitoring without services for individuals identified as not growing is of dubious value. 
In the Sustainability analysis, one attempts to capture policy climate, community involvement, etc. in 
addition to the usual financial issues related to sustainability. 
The discussion concentrated on the information centred modules modules 5, 6, and 7) where the 
focus was on systematically soliciting and developing an information basis to support the management 
decisions being made. 
It was mentioned that the information collected should be relevant to the needs of persons collecting 
data and not just to another level higher up. The relevance of the data at the local level (at the point 
of collection) will increase the likelihood of its high quality and of the sustainability of the information 
system. 
The group noted that the planning and assessing health worker activities was one area in great need 
for TA. 
Like other groups, this group also raised and discussed the questions of: whose needs? and what 
needs? The group wentfurther in addressing the following issues: how are community needs to be 
reconciled with the mismatched skills for service/program provision? How does that idenfification of 
needs feed into the training of care providers and managers so that, in the future, they will be better 
prepared to meet those needs? 
The important role of supervision in the training of PHC managers was highlighted. Community 
Health Worker (CHW) retention is enhanced by supportive interaction every f m  months and 
opportunity for CHWdefined training needs, particularly in curative services. 
In considering community involvement and participation, how are reasonable expectations to be 
elucidated, particularly given the emphasis on hospitals? For donors, stressing sustainability after 
donors depart may lead to better decision making in the allocation of scarce resources for health. 
So conceptualising PHC MAP as a technology pointr to the need for assessment; to date, this has 
included extensive pretesting in 13 countries on several continents. 
Assessing PHC M4P as a technology requires evaluating outcomes of PHC U4P use; this would 
address elementr such as 
To what extent does PHC MAP increase the quality of information available to managers who use 
it? 
To what degree are managers able to improve their functioning with use of PHC MAP, 
speczfically, can quantitative evaluations of management performance be undertaken in locations 
where PHC MAP is being used? 
What is the efect of using PHC M4P on the health of the populations served by managers using 
PHC W? 
The Aga Khan Foundation is interested in the quantitative evaluation of the usefulness of information 
in management; to what extent will this material improve management performance? So again, this 
present. a big challenge to the field of TA, in terms of designing the kind of study that would be able 
to actually relate the information technology to not only management performance but ultimately to 
changes in health outcomes. 
THE GVHS EXPERIENCE 
Donald KM. Jutwishin' 
It is a pleasure for me to have been invited to describe the technology assessment process and its 
application to the introduction, implementation and evaluation of laparoscopic cholecystectomy at the 
Greater Victoria Hospital Society. I will first describe the development of technology assessment at 
the GVHS, describe how it functions, provide a case study of the assessment of laparoscopic 
cholecystectomy and finally describe some of the politics, myths and pitfalls that are common in 
technology assessment. 
Why is Technology Assessment Necessary? 
The following example of uncontrolled technology acquisition in a large nonteaching urban health care 
setting illustrates the problems surrounding the diffusion of new technology. 
A core of physicians would like to see a new technology introduced into their hospital. The physicians 
are well intentioned, high achievers in their speciality and risk takers when it comes to adopting new 
technology which is promulgated to ease the burden of illness in the community. The advocate for the 
group is soon considered the expert on this technology in the organization after a visit to a symposium 
in California The physicians search for studies describing the success and problems with h s  new 
technology. The literature contains nothing conclusive - only that the jury is still out, but that the 
technology shows promise. However, the hospital administration is now perceived to be speaking 
against a new technology merely by asking critical questions about a technology for whch there is yet 
not proven evidence of benefit for the community. 
Some of the physicians attend conferences where users of the technology describe the results of their 
experimental work and the preliminary results appear positive. The advocate is given the opportunity 
to visit the factory overseas where the technology is manufactured and is given hands-on experience. 
The vendor, seeing an opportunity for the introduction of a new technology in Canada, provides 
brochures and any information requested. 
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In the meantime, the hospital administration searches the literature and polls other facilities whlch are 
exploring the application of the same technology. Nothing helpful is uncovered other than that the 
technology is still at a developmental stage and unproven. There are no plans underway to evaluate 
the effectiveness of the technology. The province's Ministry of Health has no policy on this type of 
technology, nor will it support the acquisition. The provincial health association is not able to provide 
any advice on the need for this kind of technology. The price of the technology is identified and made 
common knowledge. The technology becomes a capital equipment request for the department in the 
next fiscal year. 
With the knowledge gleaned so far, the physicians begin to identify patients who might benefit from 
this technology. These patients are ones who would not benefit from the conventional methods 
currently available, and are therefore at some risk and would have "nothing to lose" in trylng an 
"unproven" technology. There may also be another class of patients who may wish to reduce their 
risks involved with existing treatment modalities. 
As the momentum for the adoption of the new technology increases, a few influential citizens and 
opinion makers in the community (some of whom may benefit from the new technology) decide to 
mount a fundraising campaign to ease the financial burden for the hospital. The fundraising would 
provide visibility to the philanthropic activities of the individuals, as well as add an impressive piece 
of equipment to the city's hospital, which would be one of the first in Canada to provide h s  service. 
The media is recruited by the specialists to provide coverage of the fundraising activity. The hospital 
administration, while reluctantly appreciative of the community support, is still uncomfortable with the 
lack of hard empirical data to support the acquisition. The fundraising is an unprecedented success, 
and raises h e n t i r e  amount necessary to purchase the equipment. The presentation of the cheque for 
the full amount is made to the hospital board chainnan who expresses appreciation to the community. 
The equipment is identified in the capital equipment list for the next year, and is approved for 
purchase under the following conditions: there are to be no additional operating costs resulting from 
the introduction of the technology and the equipment is to receive Canadian Standards Association 
approval before it is commissioned and used on a patient. Continued insistence by the administration 
for hard data showing the benefit of this equipment is met with disdain by the medical staff who 
perceive it as an unnecessary bureaucratic step which is irrelevant to the fact that the technology is 
"needed." In spite of these concerns, the new technology is installed and commissioned. 
It would be a pleasant surprise if anyone reading this scenario could not identify with some of the 
facts of this fictitious example which illustrates how we have not yet learned to control technological 
diffusion. 
Technology Assessment at the Greater Victoria Hospital Society - 
the Process and the Benefits 
The Greater Victoria Hospital Society originated in 1984 as a result of a legislated amalgamation of 
two acute care facilities in Victoria, British Columbia, the Royal Jubilee Hospital and the Victoria 
General Hospital which had a downtown long-term care satellite, the Fairfield Health Centre. The 
Gorge Road Hospital, a rehabilitation facility, was added to the corporation in 1985. The multihospital 
structure is now thought of as one hospital on four sites. The organization has 5,600 staff, 700 medical 
staff, with 1,016 acute care beds and 750 extended and continuing care beds. The Society has an 
operating budget of $265 million in 1993-94 and a capital equipment allocation of $4.5 million. The 
initial request for equipment, however, starts at about $8 million. 
Technology Assessment 
The technology assessment process was initiated in 1989, sparked by the leadership of the President 
and Vice-President, Medicine who came to realize that there was not a rigorous framework for 
evaluating the appropriateness of new technology. A Technology Assessment Committee (TAC) was 
established to assess all methods used to prevent, diagnose or treat illness. Technology was interpreted 
in its broad sense to include drugs, devices, medical or surgical procedures used in clinical care, as 
well as the organization and support systems within which such care is provided. 
Responsibilities 
The responsibilities of the TAC are 
To review proposals for new patient care services and programs with regard to their technological 
impact - a "Technology Assessment Instrument" has been developed based on the New York 
State technology assessment methodology; 
To assess the impact of new technologies on medical staff, credentialling, and other significant 
aspects; 
To screen proposals to the Hospital Executive Committee (HEC) for technological impact, and 
accept referrals from the HEC as appropriate. The HEC is the senior planning and decision 
making body in the organization, made up of the executive, clinical chiefs and functional officers; 
Upon referral from Pharmacy and Therapeutics, to review recommendations of the Director of 
Pharmacy concerning new drugs and pharmaceutical products with significant cost or 
organizational impact; 
To review recommendations from the support services concerning new hospital supplies and 
products with significant cost or organizational impact; 
To conduct pre- and post-review of new technologies and their impact on staff, space and resource 
utilization; 
To keep abreast of relevant literature on technology assessment; and 
To facilitate the creation of a communication network to promote the exchange of technology 
information between hospitals, researchers, and policy makers. 
Membership and Accountability 
The membership of the TAC is intended to be multidisciplinary and broad in its representation. The 
chair is held by the Assistant Vice-Resident, Diagnostic and General Services, and is supported by the 
Director of the Quality Improvement Resource Office who acts as secretary of TAC and chair of the 
Technology Assessment Working Group (TAWG) which will be described in greater detail later. Other 
members are the Vice-Presidents of Medicine, Finance and Patient Care; the Chair of the Medical 
Advisory Committee; three medical staff representatives, one of which is a member of the credentials 
committee, Director of Pharmacy and the chair of the Research and Review Committee. 
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The TAC is accountable to the Corporate Executive Committee, which is the senior policy making 
entity in the organization. The TAC also has liaison relationship to the Hospital Executive Committee 
and Medical Advisory Committee. The TAC also makes periodic progress reports to the Patient Care 
Committee of the Board of Trustees. 
Progress Report 
In order to ensure timely and effective communication to all managerial, mehcal staff and employees 
of the organization, a TAC Progress Report was developed. The progress report identifies along the 
vertical column all of the technologies which have been or are being considered for introduction and 
on the horizontal row we identify the orignator of the request, the date on which it was presented to 
TAC and the current status of the technology. The progress report has become a focal point in the 
organization of disseminating the developments taking place around technologies being reviewed. If 
management or staff identify a technology about which they want more information, they are able to 
contact the originator or a member of the TAC for further information. The Progress Report, which 
serves as an attachment to the TAC agenda, is to help members of the committee keep informed of 
developments. 
Technology Assessment Working Group 
It is the TAC which considers the broad questions of the appropriateness of introducing a new 
technology in the GVHS, but it is the Technology Assessment Working Group (TAWG) that does all 
the work to ferret out all of the clinical, operational and financial implications of introducing a new 
technology. The role of the working group is to research the outstanding issues and questions 
surrounding the health care technology in question. 
The group's membership is comprised of the Drector of the Quality Improvement Resource Office as 
Chair, representatives of nursing, biomedical engneering, the capital equipment manager, director of 
patient placement and registration, a case mix analyst and resource people as necessary to respond to 
specific issues or problems. 
The group conducts its business of assessing a technology through the application of a TAWG 
"Framework of Analysis" which was developed by the TAC based on the New York State technology 
assessment methodology. 
Technology Assessment and Medical Administration 
One of the major challenges in the last several years has been to work with medical administration 
and medical staff to ensure that a good working relationship was established between the TAC process 
and the medical staff. This effort was made a priority because of circumstances that would arise when 
a medical staff member would simply attempt to raise the need for a technology outside of his or her 
department. 
A process is now being established that requires a physician to introduce the concept of the 
technology at a section level and then with consensus take it through to the appropriate department 
where support must also be solicited. The clinical chief then has the responsibility to introduce the 
technology at Medical Advisory Committee meetings for information, explore issues of credentialling, 
develop a standard for the application of the technology with the Quality Improvement Resource 
Office and then finally make a presentation to the TAC. 
If the technology arises outside of the medical staff, it must work its way through the formalized 
organization structure to the TAC. A checklist has been developed which itemizes all of the steps 
necessary to formally introduce a technology and this has been shared with the clinical chiefs in an 
attempt to standardize the approach, and a policy and procedure is currently being developed to 
formalize the structure. 
I will now describe an example of a technology , laparoscopic cholecystectomy, which was assessed in 
GVHS and then approved for implementation. The case study highlights the problems and issues 
encountered during the process of assessment, implementation and evaluation. 
Laparoscopic Cholecystectomy: a Case Study 
The treatment of gallbladder disease by laparoscopic surgical removal of the gallbladder was 
introduced to the Greater Victoria Hospital Society in February of 1991, a year after it was introduced 
in the first facilities in Canada. The Technology Assessment Committee of GVHS, as a condition of 
the approval for introduction of laparoscopic cholecystectomy (lap. chole.), requested an evaluation of 
the first year since the introduction of the procedure and the procedure's impact on the Hospitals' 
resources, the operating rooms, the nursing units, the surgeons and on the patients. Input was 
requested fiom the various areas impacted by the introduction of the technology. The following is a 
compilation of the input received from Health Records, Patient Registration and Placement, Case Mix 
Analysis and Reporting, Biomedical Engineering, Nursing, the Surgeons, Medical Imaging, Infection 
Control and the Quality Improvement Resource Office. 
Impact on Hospital Resources 
Volume of patien Wlength of hospital stay 
The statistics set out in this section were obtained using the MedisGroups reporting system resident in 
the Health Records Department. MedisGroups (Medical Illness Severity Grouping System) uses 
objective clinical findings, such as lab tests, as a basis for classifying a patient's severity of illness at 
admission and as a basis for identifying the patient's health outcomes. 
Pre-introduction 
In the year immediately preceding the introduction of laparoscopic cholecystectomies (1 February 
1990-31 January 1991), a total of 545 patients had open cholecystectomies as their principal 
procedure. Their average age was 54.3 years and their average length of stay was 8.9 days. The 
average length of stay is broken down into an average pre-operative LOS of 2.0 days and an average 
post-operative LOS of 6.9 days. 
Post-introduction 
D u n g  the first year following the introduction of laparoscopic cholecystectomies (1 February 
1991-3 1 January 1992), the total number of patients having cholecystectomies as a principal procedure 
was 575, an increase of 5.5%. Of these 575 patients, 163 (28.3%) had open cholecystectomies as their 
principal procedure and 412 (71.7%) had laparoscopic cholecystectomies as their principal procedure. 
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The 163 patients who had an open procedure had an average age of 61.5 years, an average length of 
stay of 13.1 days, an average pre-operative LOS of 2.8 day. The 412 patients who had their surgery 
performed laparoscopically had an average age of 51.7 years, an average length of stay of 3.2 days, an 
average pre-operative LOS of 0.9 days and an average post-operative LOS of 2.3 days. 
Of the 4 12 patients who had laparoscopic cholecystectomy , 72 (17.5%) patients were admitted through 
the Emergency Department and 340 (82.5%) patients were admitted through the O.R. elective booking 
system. The average length of stay of the 72 patients who were admitted through the Emergency 
Department was 6.7 days, with an average pre-operative LOS of 2.7 days and an average post- 
operative LOS of 3.9 days. The average length of stay of the 340 patients whose laparoscopic 
cholecystectomies were elective bookings was 2.4 days, with an average pre-operative LOS of 0.5 
days and an average post-operative LOS of 1.9 days. 
Second year post-introduction 
During the second year following the introduction of laparoscopic cholecystectorny (1 February 
1992-3 1 January 1993), the total number of patients having cholecystectomies as a principal procedure 
was 604, an increase of 10.8% over two years. Of the 604 patients, 96 (15.9%) had open 
cholecystectomies as their principal procedure and 508 (84.1%) had laparoscopic cholecystectomy as 
their principal procedure. 
Impact on Booking Model/Operating RoodPosf-Anaesthetic Recovery Room Time 
Skin-to-skin time 
Using a random sample of 50 patients who had an open procedure during the year preceding the 
introduction of laparoscopic cholecystectorny, the average skin-to-skin duration of the surgery was 
55 minutes. The average skin-to-skin duration of laparoscopic surgery for a random sample of 50 
patients during the first year of the procedure was 76 minutes, an average increase of 21 minutes. It is 
expected that this difference would have decreased during the second year of the procedure as 
surgeons and O.R. staff became more experienced. 
Anaesthetic time 
The average anaesthetic time for open procedures in the year preceding the introduction was 83 
minutes, while post-introduction the average anaesthetic time increased to 111 minutes for 
laparoscopic procedures. 
Post-anaesthetic recovery-room time 
The average time spent in the Post-Anaesthetic Recovery Room, however, decreased from 139 minutes 
prior to the introduction to 109 minutes for laparoscopic procedures. 
O.R. staffing 
In anticipation of the commencement of laparoscopic cholecystectomy, it was proposed that the O.R. 
staffing budget be increased during the first three months by 0.23 FTE to allow for a second 
"circulating" nurse, deemed to be essential due to the unfamiliar instrumentation and procedure. 
Procedure set-up time 
Initially, the set-up time was increased, however, with experience the set-up time decreased to the 
designated changeover time for a regular cholecystectomy procedure. Generally, the equipment needs 
constant attention. There are more components to each instrument to be included in the instrument 
count and more attention must .be given to replacement of washers, springs, etc. 
Educaiion of O.R. nurses 
Nurses attended inservice sessions to learn about the procedure; 
Two nurses (General Charge Nurse and O.R. Instructor) attended Saskatoon City Hospital to 
observe procedures, set-ups, preparation, etc. 
Head Nurse worked with suppliers to establish equipment requirements, including identification of 
all the accessory equipment. 
Onentation of some nursing staff for involvement with the evaluation of bid equipment. 
Onentation of nursing aides to cleaning and preparation of the new equipment. 
O.R. Instructor involvement with documentation of total procedure from identification and 
cleaning of equipment, to setup and use of equipment, to development of equipment traclung 
system. 
Liaison with other departments, such as Biomedical Engineering for equipment check before use. 
Participation in practice sessions by surgeons and nurses to allow for familiarization of each 
supplier's equipment. 
Onentation of all nurses to use of equipment. 
Impact on Surgical Nursing Units 
Short length of stay 
The surgical nursing units involved in the post-surgical care of the patients are 7A and 7B at Victoria 
General Hospital and 3 Royal at the Royal Jubilee Hospital. Nursing reported that in their experience, 
the majority of the patients who stayed longer than 24 hours stayed because of complaints of nausea. 
Complaints of shouldertip pain, from retained CO, used in insufflation, are now rare; initially these 
complaints occurred more frequently. 
PatienUnurse raiio 
The shorter length of stay of patients having laparoscopic surgery made it possible to close several 
beds which in turn served to decrease the patiednurse ratio and make the workload on the unit more 
manageable. This benefit was realized on 7A when four beds were closed in the period from 
June-December 1991 and on 7B since July 1992 when a fifth bed was closed. The patient/nurse ratio 
decreased from 6:l to 5:1, thus decreasing the need for workload relief on 7B. The laparoscopic 
cholecystectomy patients are very suited to a short stay program (2448 hours LOS); however they do 
serve to lighten the heavy workload felt on the General Surgery units. 
Issues 
Shave preparation. Patients are advised in the Pre-Admission Clinic not to shave at home if they 
do not have an electric razor. As most of the laparoscopic cholecystectomy patients are Same Day 
Surgical Admissions, this can cause a problem with those male patients who must be shaved 
"Nipples to Pubic Hairline" when they arrive 2-3 hours pre-op. Since few laparoscopic 
cholecystectomies are converted to open choles, consideration should be given to modifying the 
prep manual or the wording of the procedure. 
Patient teaching. 
Because patients see four puncture wounds instead of a long surgical incision, many patients 
view the surgery as a "minor procedure" rather than as abdominal surgery. As a result, 
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patients fail to be conservative in progressing their diet and ensuring that their bowels move 
pre-operatively and regularly post-op, sometimes resulting in readmission due to impaired 
bowel function. Extra emphasis on patient teaching in PAC and on the unit is needed. A 
printed patient instruction sheet would be helpful for patient reference post discharge and 
physician instruction regarding bowel care pre and post-operation would also alleviate this 
problem. 
A number of patients comment on their way to the O.R. about the videotape that they are 
shown in PAC or on the unit pre-operatively. The video shows an actual surgery being 
performed and is too technical and graphic for patient-teaching use. Consideration should be 
given to a video outlining what the patient can expect to happen pre-operatively and a 
description of the procedure using diagrams would be more useful and less threatening to the 
patient. 
lmpact on Biomedical Engineering 
The purchase of the laparoscopic cholecystectomy equipment resulted in an increase in the total 
medical device inventory because it did not replace existing equipment. It is anticipated that the yearly 
cost to GVHS to support thls equipment will be approximately $15,400.00. 
lmpact on Medical lmaging 
Cholangiogram 
In the year preceding the introduction of laparoscopic cholecystectomy (February 199GJanuary 1991), 
of the 545 cholecystectomies performed, 378, or 69.4%, of the patients also had an intraoperative 
cholangiogram . Dunng the first year of performing laparoscopic cholecystectornies (February 
1991-January 1993), 163 open cholecystectornies were performed. Of these patients, 101 patients, or 
62.0%, also had an intraoperative cholangiogram. Of the 4 12 laparoscopic cholecystectomies 
performed during the first year since its introduction, 83 patients, or 20.2%, also had an intraoperative 
cholangiogram . 
c - A m  
Based on the above statistics, there has been a significant decrease in the number of cholecystectomies 
requiring Medical Imaging services. However, all laparoscopic cholecystectomies require the C-Arm 
set up because of the possible need for fluoroscopy. The technologist requires approximately 10 
minutes to set up and if the case does not need fluoroscopy, no procedure count or workload units are 
generated. A review of the need for all cases to have C-Arm set up should be considered because of 
the need for C-Arm availability for other O.R. procedures. 
E. R. C.P. 
According to the Radiology Information Management System (RTMS), during the year prior to the 
introduction of laparoscopic cholecystectorny, a total of 186 E.R.C.P. procedures (177 inpatient and 9 
outpatient) were performed in the Medical Imaging Department. During the first year of performing 
laparoscopic cholecystectorny, a total of 31 1 E.R.C.P. procedures (292 inpatient and 19 outpatient) 
were performed, an increase of 125 procedures, or 67.2%. 
However, in linking the E.R.C.P. procedures to those patients who had had a cholecystectorny, it was 
reported that in the year preceding the introduction of laparoscopic cholecystectomy, of the 545 
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patients who had had a cholecystectorny, 28 (5.1%) patients also had an E.R.C.P., either during a 
previous admission, during the same admission as the cholecystectorny, or in a subsequent admission. 
In the year subsequent to the introduction of lap. chole. (February 1991-January 1992), of the 163 
patients who had had an open cholecystectorny, 20 (12.3%) patients also had an E.R.C.P., again either 
during a previous admission, during the same admission as the cholecystectorny, or in a subsequent 
admission. Dunng the same timeframe, of the 412 patients who had had a laparoscopic 
cholecystectorny, 48 (1 1.7%) patients had also had an E.R.C.P. procedure. Based on the total of 575 
cholecystectomies during the period, 68 (1 1.8%) patients also had an E.R.C.P., an increase of 6.7%. 
lmpact on Laboratory Medicine 
The Department of Laboratory Medicine does not currently have a mechanism for comparing 
workload statistics or testing costs on a procedure-specific or test-specific basis. The logical 
assumption would be that the longer length of stay of those patients who had an open cholecystectorny 
would give rise to an increased frequency and extent of laboratory testing. However, at the present 
time, no data is available to support this assumption. 
The laboratory tests currently being ordered (serum amylase, bilirubin, alkaline phosphatase, SGOT, 
LDH and HGB) would be the type of analysis expected in patients suffering from biliary disease. Prior 
to a laparoscopic cholecystectorny in an otherwise normal individual with no clinical evidence of 
obstructive disease, it is important to rule out pancreatitis or pancreatic obstruction: a bilirubin test 
confirms the presence or absence of major obstruction; an alkaline phosphatase test confirms the 
presence or absence of minor obstruction. The alkaline phosphatase test is used to discern any 
evidence of cholestasis. If LDH and SGOT tests are used for assessing hepatocellular disease, these 
tests could be replaced with Alanine Aminotransferase (ALT) and SGPT. Hemoglobin and hematocrit 
would be used to assess the state of the patient's hemodynamic and quantitative status, and a white 
count could usefully monitor cholecystitis. 
It is therefore recommended that, within 48 hours of laparoscopic cholecystectorny, a serum amylase, 
bilirubin, alkaline phosphatase, alanine aminotransferase (ALT), hemoglobin, hematocrit and white 
count would be the appropriate testing panel. Providing there are no clinical indications subsequent to 
the laparoscopic cholecystectomy procedure, there should be no need for further laboratory 
investigations prior the patient's discharge. 
lmpact on patient registration and placement 
Re-admission clinic 
The present standard requires that all laparoscopic cholecystectorny patients who are admitted either 
the night before their surgery or on the same day as their surgery be seen in the pre-admission clinic. 
This is new workload for the clinic, but to date has been accommodated within the existing staffing. 
As the majority of these patients fall into the ASA I or ASA I1 categories, this level of PAC 
involvement may not be required and should be examined. 
O.R. booking 
Wait list. The volume of cases that are suitable for this procedure appears to be higher than 
anticipated and, as a result, the wait lists are growing despite a greater number of cases being 
performed. The current wait time for laparoscopic cholecystectorny is up to a year. 
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0.R times. For a standard open cholecystectomy, 45-75 minutes of O.R. time is booked; 
however, for the laparoscopic procedures up to 2 hours total time is booked. This represents a 
significant increase in O.R. hours. 
Impact on Health Records 
The major impact on the Health Records Department has not resulted from the introduction of the 
technology but rather from the evaluation process, including both the GVHS evaluation and GVHS7s 
contribution to a national database being compiled by Dr. Litwin in Saskatoon. 
Data retrieval 
The data was accessed 19 times between October 1991 and October 1992, at a cost of 64.5 hours 
labour. 
Record ietrieval 
Patient records were pulled three separate times for data collection, using two systems. The record 
review process, using the incomplete record system (PRT), processed 300 records at a cost of 75 hours 
labour. The record retrieval process, using sign-out slips, processed 61 1 records at a cost of 71 hours 
labour. 
Administra!ive support 
Both Health Records managers spent at least 4 hours each facilitating these activities in the 
Department. The Health Records analysts, primarily through meetings with QIRO staff, spent at least 
the equivalent of 5 days each. 
Nonmonetary impact 
Other data requests were deprioritized; and difficulty was experienced in accommodating requests 
made outside the established record retrieval procedure. 
Recommendations 
Continue to involve data providers at the earliest possible time in the process. 
Continue to determine specific information needs in the planning phase of implementation. 
Budget for cost to support departments of implementing new technologies. 
Evaluate, or establish, formal approval process for participating in external databases, such as 
the National database. 
Continue to monitor quality control procedures in Health Records to ensure accuracy of data. 
Capital Expenses 
The purchase of the laparoscopic cholecystectomy equipment was approved by the Hospital Executive 
Committee on 13 January 1991, and was incorporated into the 1991192 Capital Budgeting process. A 
Decision Package was submitted for startup and ongoing instrurnentfsupply costs and for an additional 
0.84 FTEs. The staffing increase was not approved. The following amounts (Table 1) were included in 
the 1991/92 Operating and Capital Budgets for the purchase of laparoscopic cholecystectomy supplies 
and equipment for the Operating Rooms and the Royal Jubilee Hospital and Victoria General Hospital 
(combined). 





Cameras, light sources, etc. 82,000 
Instnunents 139,000 
Sutures, staples, and clips 15,000 
Medicdsurgical miscellaneous 15,000 
Total 1991192 startup 251,000 
Annual ongoing cost estimate 
Operating supplies Instmments 15,000 
Sutures, staples, and clips 15,000 
Medicdsurgical miscellaneous 15,000 
Estimated annual operating costs 45,000 
Laparoscopic cholecystectomies are a success, in financial terms, when the incremental costs in the 
O.R. are less than the actual savings in the nursing units. While the potential savings are significant, 
actual savings will only be achieved if the nursing unit staffing is downsized proportionally to the 
lower occupancy. To date, while some savings may have been achieved in Relief costs, no 
adjustments related to these procedures have been made to the Nursing StdEng budgets. 
Case Cost Comparison 
Open cholecystectomy cases cost approximately CA $3,700 per case, while laparoscopic 
cholecystectomy cases represent about CA $1,750 per case. This comparison does not include 
pharmacy or laboratory cost components. It is important to note that the difference between the two 
cost figures does not represent actual recovered dollars. The difference represents the high end of 
potential recoverable costs. Impact on hotel and institution related services (food services, 
housekeeping, nursing administration, finance) are marginal and do not translate into significant 
recoverable dollars. 
Bed day savings are sigruficant. More than 2,300 bed days were saved when the 412 laparoscopic 
cholecystectomy cases (average LOS 3.2 days) are compared to the average length of stay for an 
equivalent number of open cholecystectomy cases (average 8.9 days LOS in 1990191). 
Impact on Quality Improvement Resource Office 
The introduction of laparoscopic cholecystectomy has been a major focus in the Quality Improvement 
Resource Office (QIRO). The staff assisted the Section of General Surgery to develop and record the 
criteria for the procedure, to develop and coordinate the credentialling process, and to coordinate the 
data collection for the credentialling and evaluation processes. 
In the initial phase, preparatory to the introduction of the technique, the major resource allocation was 
in the time spent by the QIRO associate, with secretarial support, in preparing the criteria, the 
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credentialling process, and in liaison with other GVHS Departments. Once the credentialling process 
was underway, resource utilization shifted to the QIRO analyst. The analyst liaised with the Health 
Records Department with requests for data using the MedisGroups reporting system. The data was 
used to monitor the impact of the technique on an ongoing basis and was also used by the surgeons on 
an ad hoc basis for presentations made to various organizations. The analyst also played a role in 
organizing the pulling of charts from Health Records to obtain data for evaluation of the procedure for 
two data collection systems: the Section of General Surgery's evaluation process; and GVHS7s 
contribution to a national comparative database situated in Saskatoon, Saskatchewan. Once the data 
was collected, the information was entered into a computer in the Quality Improvement Resource 
Office and reports were run, again for a twofold purpose: the Section of General Surgery evaluated the 
experience on an ongoing basis using surgeon specific data; the information was also utilized for the 
purposes of the evaluation process. 
Surgical Process 
In the planning stages of the introduction of the laparoscopic technique, the Department of General 
Surgery developed a data collection form with which to track certain elements of the surgery. Each 
surgeon would fill in the surgery-related portion of the form at the time of surgery and then complete 
the outcomes portion of the form at the time of chart completion. The data were then entered into a 
computer and reports were run on an ad hoc basis to provide the surgeons with feedback. The 
following is a summary of the first year of laparoscopic cholecystectomies. 
Volume 
In the first year following the introduction, completed forms were received for the 448 laparoscopic 
cholecystectomies which were attempted; 41 1 (91.7%) were successfully completed laparoscopically 
while 38 (8.3%) were converted to open procedures. 
Duration of Procedure 
When the laparoscopic technique was initially utilized, procedures frequently took 1.5-2.5 hours to 
complete; however, over the course of the first year, the average duration of the procedure was 
brought down to 76 minutes. It has been noted that during the second year, many laparoscopic 
procedures are done in less than 30 minutes; it is therefore anticipated that the average duration of the 
procedure will also be decreased further. 
Indications for Procedure 
Of the 41 1 patients who had laparoscopic cholecystectomies, 91.7% had biliary colic as an indication 
for the procedure, 79.6% had radiographic evidence and 47.0% had recurrent chronic cholecystitis 
cited as indications for the procedure. Far fewer (17.3% and progressively less) patients had acute 
cholecystitis, intermittent jaundice, ERCP evidence, and so forth, cited as indic&ons for the 
procedure. 
Complications of Technique 
The most commonly cited complication of the surgical technique was perforation of the gall bladder: 
75 patients, or 18.2% had their gallbladder perforated during the procedure. There were 6 (1.5%) 
incidents of bleeding of the liver, and 6 (1.5%) incidents of bleeding of the cystic artery; 3 (0.7%) of 
the patients suffered a laceration of the liver, 2 (0.5%) of the patients had a laceration of the common 
bile duct and 1 (0.2%) had the bowel perforated. 
Post-Operative Complications 
Of the 411 patients who had laparoscopic cholecystectomies, 17 (4.1%) patients complained of 
referred shoulder pain as a complication of the surgery, 12 (2.9%) patients developed pyrexia greater 
than 38S°C., 6(1.5%) patients had bile peritonitis and 3 (0.7%) patients suffered delayed haemorrhage. 
Pathology 
Of the 41 1 laparoscopic procedures, 93.7% of the patients had evidence of gallstones at surgery, 
15.1% of the patients had evidence of acute inflammation, 7.8% had obstruction and 1.2% had 
evidence of internal infarction. Eighteen (4.4%) patients had other outcomes, such as a gangrenous 
gallbladder. 
Outcomes 
The MedisGroups database was utilized to obtain information comparing outcomes prior to the 
introduction of laparoscopic cholecystectomy to the outcomes of the laparoscopic procedure. 
Pre-Introduction 
Of the 545 patients who had a cholecystectomy in the year immediately preceding the introduction of 
laparoscopic cholecystectomy, 503 patients, or 92.3%, were nonmorbid (or clinically stable) post 
surgery, 38 patients, or 7.0%, patients suffered morbidity or major morbidity (a degree of clinical 
instability) post surgery, while 4 patients , or 0.7%, died. 
Post-Introduction 
Of the 412 patients who had a laparoscopic cholecystectomy during the first year after its introduction, 
403 patients (97.8%), were nonmorbid post surgery, 7 patients (1.7%) were morbid, and 2 patients 
(0.5%) died. 
Con versions 
Of the 37 patients who were converted to an open procedure, the two most commonly cited reasons 
for conversion were the patient's anatomy and the presence of stones in the common bile duct. Sixteen 
(43.2%) patients were converted because their anatomy precluded laparoscopic surgery and 6 patients 
(16.2%) had stones in their common bile duct. 
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Infections 
The Infection Control Practitioners at Victoria General Hospital and Royal Jubilee Hospital track 
surgical wound infections. During the year preceding the introduction of laparoscopic 
cholecystectomy, they captured 8 infections in patients who had had a cholecystectomy. During the 
first year since the introduction of laparoscopic cholecystectomy, 7 infections were captured in patients 
who had had an open procedure and 3 infections were captured in patients who had had a 
laparoscopic procedure. However, due to the short length of stay associated with the laparoscopic 
procedure, post-operative infections would likely only be captured if the patient required readmission 
to hospital for treatment of infection. 
Procedure Validation 
The MedisGroups reporting system, in addition to providing a tool to measure a patient's severity of 
illness on admission and response to treatment, uses objective criteria to document validation of 
procedures. The Health Records Department and the Quality Improvement Resource Office are in the 
process of introducing to the various Medical Departments the use of MedisGroups' Procedure 
Monitoring Reports as one tool to assist in evaluating quality patient care by monitoring conformance 
to the validation criteria. As the timing of the introduction of laparoscopic cholecystectomy coincided 
with the timing of the introduction of the Procedure Monitoring Reports, the cholecystectomy was 
chosen as the procedure with which to introduce the Reports to General Surgery. In view of the 
evaluation of the laparoscopic cholecystectomy, Health Records differentiated the results between the 
laparoscopic procedures and the open procedures. 
Using MedisGroups Procedure Monitoring Reports to identify the non-validated cholecystectomy 
procedures, the Health Records Department conducted an analysis of the charts of patients who had 
had a cholecystectomy but whose procedure was not validated according to the MedisGroups 
validation criteria. Although a different timeframe and a different sample of patients was utilized (any 
patient who had had a cholecystectomy as either a principal or a secondary procedure), it was felt that 
the practice trends would not have radically changed during the timeframe of the evaluation. The 
analysis indicated that, using MedisGroups validators initially and then further applying GVHS 
validators, 10% (82 of 817) of the cholecystectomies were not validated. The MedisGroups 
comparative database, consisting of the combined databases of all contributing hospitals, indicates a 
comparative rate of 9.2% non-validated procedures. Of the 10.0% which were not validated, 58% were 
laparoscopic procedures and 42% were open surgeries. 
The charts of the non-validated surgeries were reviewed for the pathological diagnoses: 61% of the 
patients had chronic cholecystitis; 16% had a normal gallbladder; 7% had cholesterosis; 5% had mild 
inflammation; 5% had benign cholesterosis; 5% had other diagnoses; and 1% had no pathology report 
on the chart. The sample was not limited to those patients whose cholecystectomy was the principal 
procedure; a further review of the charts is planned to ascertain the impact of the principal procedure 
or diagnosis. The Section of General Surgery is also currently reviewing the radiographic indicators 
for surgery. 
Impact on Surgeons 
In preparation for the change of surgical technique and as part of the credentialling process, a copy of 
which is annexed, each general surgeon attended an out-of-Province course on laparoscopic surgery. 
Upon completion of the course, the surgeons performed their respective first 12 surgeries under the 
supervision of a surgeon who had already been credentialled. This credentialling procedure was 
difficult for surgeons and their patients, particularly those surgeons coming "on stream" later in the 
process, as it was difficult to find a previously credentialled surgeon who was available to supervise. 
For the supervising surgeon, there were also financial implications in this process of booking two 
surgeons as the supervisor was neither compensated for his time nor was he available to his own 
practice. 
When the procedure was initially instituted, the long duration of the procedure limited the number of 
surgeries, either cholecystectomy or other, that could be booked into the available boolung model. 
This has now ameliorated to some degree due to the greater speed with which the laparoscopic 
cholecystectomies are completed. 
Impact on Patients 
As part of the evaluation process, a telephone survey of 25 randomly selected laparoscopic 
cholecystectomy patients (18 female and 7 male) was conducted. The average length of stay for the 25 
surveyed patients was 1.8 days (1.9 days for females and 1.6 days for males). 
Sixteen of the patients (64%) did not require medication for pain following their discharge from 
hospital, while 9 (36%) patients did require pain medication. 
Thirteen (52%) patients were able to return to their normal diet within one day of their discharge from 
hospital; 6 (24%) patients returned to their normal diet within 2-4 days of discharge; 3 patients (12%) 
required 1 week, and 2 patients (8%) required longer than 1 week. 
Twenty (80%) of the surveyed patients indicated they have had no recurrent symptoms of gallbladder 
disease, but 5 (20%) of the patients responded in the affirmative. 
Four patients (16%) returned to their normal daily activities within one day of discharge; 7 patients 
(28%) resumed their normal activities within 2 4  days after discharge; 5 patients (20%) took 1 week 
and 5 patients (20%) took 2 weeks to resume normal activities; 3 patients (12%) took 3 weeks or 
longer to resume normal daily activities, and 1 patient did not know. (Of the 2 patients who required 3 
weeks to return to normal activities, 1 had been readmitted for jaundice and 1 followed the 
recommendation of his surgeon). 
Out of the sample of 25 patients, 12 did not work outside the home. Of the 13 patients who did work, 
4 were able to return to work within 2 days of discharge; 2 patients were able to return to work within 
4-5 days of discharge; 1 patient returned to work within 1 week, 4 patients returned to work within 2 
weeks and 1 patient returned to work within 3 weeks of discharge. There was also 1 patient who 
returned to work 6 weeks post discharge, but the patient stated that this was on the recommendation of 
his surgeon and was not necessarily required by the patient. 
When queried as to whether the patients had had any problems with their surgical wound after 
discharge, 19 patients (76%) said they had no problems. Six patients (24%) stated they had had a 
problem, for example: redness/infection; aching; aggravated area; allergy to stitches; staple poked 
through wound; and one patient stated that the "dissolving stitches do not dissolve easily." 
Overall satisfaction with the surgery was expressed by all the patients surveyed. 
Recommendations Appurtenant to Laparoscopic Cholecystectomy 
Consideration should be given to including laparoscopic cholecystectomy patients in the Short 
Stay Program and to booking them into the Short Stay beds. 
Unless post-operative symptoms indicate otherwise, patients should be routinely discharged withln 
24 hours post-operatively. 
The level of involvement of the Pre-Admission Clinic should be examined as to whether or not it 
is necessary to screen all laparoscopic cholecystectomy patients who are part of the Same Day 
Surgical Admission Program. 
Upon reviewing the skin-to-skin operative times from the second year of data on laparoscopic 
cholecystectomies, the O.R. booking times should be reviewed to coincide with the average shn- 
to-skin times. 
onsideration should be given to modifying the "preparation" manual as it pertains to shave 
preparation of laparoscopic cholecystectomy patients who are admitted under Same Day Surgcal 
Admissions Program. 
d e n t  information pamphlets appurtenant to the laparoscopic cholecystectomy procedure and 
process as practised at GVHS should be made available. The information pamphlets should 
address, inter alia, pre and post-operative bowel care and diet progression. 
patient teaching video outlining pre- and post-operative expectations and the minimal access 
surgery process as practised at GVHS should be made available. 
he Department of Medical Imaging should monitor the number and impact of ERCP's and 
Cholangiograms so that their Booking Model could be reviewed and any appropriate changes 
made as necessary. 
The Deparbnent of Medical Imaging should review with the Department of General Surgery the 
current practice of C-Arm setup. 
Consideration should be given to making tests for serum amylase, bilirubin, alkaline phosphatase, 
alanine aminotransferase (ALT), hemoglobin, hematocrit and white count, conducted within 24 
hours prior to the procedure, as the appropriate pre-operative testing panel for laparoscopic 
cholecystectomy . 
Distribute identified issues and recommendations to the appropriate Departments for followup. 
Recommendations for Future Technological Advances 
Consideration should be given to the reallocation of staffing for the procedure and the 
instrumentation in any future changes in minimal access surgeries. 
Consideration should be given to the education requirements of nursing and nursing aides, both in 
the Operating Rooms and in the Nursing ward. 
The credentialling process should be identified prior to the .introduction of technological changes, 
followed, evaluated and revised as necessary. 
An evaluation framework should be developed prior to the introduction of any technological 
changes and the procedures should be monitored within the framework. 
Infection monitoring should be incorporated into the current Infection Control Program process. 
Procedure validation should be linked to the evaluation framework and process. 
The Impact Analysis Process of the Technology Assessment Committee's Working Group should 
be followed. 
Biomedical Engineering should be linked with the Technology Assessment Committee's Working 
Group process and should coordinate with the Purchasing Department and the Operating Rooms 
for the assessment, trialing and purchase of equipment. 
Continue to involve data providers at the earliest possible time in the process. 
Continue to determine specific information needs in the planning phase of implementation. 
Budget for cost to support departments of implementing new technologies. 
Evaluate, or establish, formal approval process for participating in external databases. 
Continue to monitor quality control procedures in Health Records to ensure accuracy of data. 
Continue to distribute identified issues and recommendations to the appropriate departments for 
followup. 
The recommendations identified point to the need to treat the technology assessment process within 
the organization dynamic so that it is able to respond to new information acquired. 
Organizational Politics and Technology Assessment 
In Canada, the acquisition of technology is partially controlled by the allocation of funding to health 
care facilities. The concern is that there is not a rational strategy to ensure that technology is 
introduced based on need. In a recent paper, three University of Toronto faculty members, Raisa 
Deber, Gail Thompson and Peggy Leatt, described the experience of technology acquisition within the 
national and provincial health systems and identified the shortcomings which cause rational decision- 
making to fail. The authors focused on Ministry of Health policies related to the acquisition of CT 
scanners in Ontario hospitals. The pattern appears to be: hospitals acquire "illegal scanners" in 
violation of Ministry of Health policy; the Ministry of Health commissions an external study by an 
expert task force; the task force recommends a revision of the policy to encourage more scanners and 
to legitimize the CT scanner in question. The authors conclude that "CT diffusion suggests that 
governments: (a) often lack the political will to penalize offending hospitals, and hence retroactively 
rewards faits accomplis; (b) are hampered by their dependence upon experts who are potential users of 
the technology being evaluated; and make relatively little use of formal technology assessment in 
acquisition decision" (Deber et al. 1988). 
The scenario described above should not be over generalized because of Saskatchewan's contrary 
policy method of controlling CT diffusion, but it does point out the strong temptation for decision- 
makers to introduce technology on an ad hoc basis. 
The rationalization of the diffusion of technology is being welcomed. Health service executives should 
ensure that the best possible information is available to guide decisions on the diffusion of technology. 
What must be recognized, however, is that we live in a pluralistic society where democratic action 
may at times run contrary to rational decision-making. Health service executives must be sensitive to 
political circumstances. Since all of our endeavours are of a public nature, we must be prepared for 
political factors to mitigate. This is not to condone a "wrong" political decision, but rather to suggest 
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that the political cost of condemning it is great. Health service executives make allocation decisions on 
technology based on some question of values. "Value-based decisions that affect the public have to be 
made with considerable support by that public. That support is more likely when the public views 
itself as having a role in the process" (Blank 1988, p. 176). This does not invalidate contributions 
made by technology assessors, but rather presents a context for information to be shared with the 
community and to gain their support. 
Perverse Economic Incentives 
University of British Columbia economist Robert Evans (1984) identifies several factors which detract 
from a rational assessment and diffusion of technology in health care. Evans claims that the public 
perception of what a technology can do is as important, if not more so, than what it is actually capable 
of doing. This would go some &stance in explaining why today's methods of ensuring smoking 
cessation and weight reduction which purport significant results without any compelling evidence are 
so successful. Other perverse incentives Evans identifies are 
The temptation to define health care "needs7' in terms of technology which is available; 
The existence of a natural bias towards costs - and utilization-expanding technologies and away 
from cost reduction - particularly if the incomes of the physicians are subsequently increased; 
Excessive and inappropriate utilization, as is the case with prescription drugs and diagnostic 
procedures; and 
Testing new technology soley for safety and not efficacy. 
Physicians and hospitals share an economic interest with technology manufacturers in exploring 
' opportunities for new technology without consideration for efficacy. Evans summarizes his views by 
stating, "Just as a new piece of equipment will be more marketable if it is economically rewarding for 
providers to buy and use, and will thus have allies against challenges to its efficacy, so a breakthrough 
which reduces billing opportunities for professionals or needs for hospital care is likely to meet much 
heavier resistance" @vans 1984, p. 228). 
In a recent article, professor Pran Manga, from the University of Ottawa, reminded us that "among the 
most cost-effective medical technologies is the technology that promotes health, prevents disease, 
pennits self care to be effectively given by primary care professionals or delivery systems. Many 
technologies that save money are not medical. For example, occupational health, sdety and 
environmental health" (Manga 1989). Future emphasis should, Manga argues, be toward health 
promotion initiatives. 
Myths of Technology Assessment 
There are many fallacies and myths about health care technology which are either prevalent in the 
health system or perceived by the public. One of the most pervasive fallacies is that adopting more 
technology will mean an improved health status in the community. This thought is based on the 
assumption that all the community's maladies can be addressed by health care technology. Studies 
undertaken in the past 15 years have shown this to be false. However, a recent American survey 
revealed that, given the choice of a surgical operation or a change in lifestyle to arrest ill health, the 
majority chose surgical intervention. 
A second myth is that more technology means better care. An example of this would be the use of 
limited dollars on a nuclear magnetic resonance imaging unit. Although this technology is able to 
more precisely measure and illustrate pathology, such an expenditure foregoes opportunities to 
improve other equipment or services which may benefit a larger group. The delivery of home care for 
the elderly, for example, would also benefit from such funding. 
Another misconception is that wiser decisions are made when new technology is acquired. The 
diffusion of technology is based on many complex factors, only one of which is whether the 
technology actually improves the health status of the community. 
A fourth fallacy is the theory that science will provide us with answers on how to deal with disease 
and, thus, we do not need to worry about scientists having a vested interest in misdirecting public 
policy. This fallacy is easily debunked by simple asking, "Who represents science?" Is it the 
physician, the research scientist employed by a large corporation manufacturing diagnostic imaging 
equipment or members of the community who are attempting to understand scientific contributions to 
health care technology? Often political factors have more to do with disease prevention policy than 
any other influences. 
There is also a belief that because man created technology, he is the master of it. It has been 
demonstrated in the literature that the introduction of technology changes man's relationship to what 
that technology does. (When we look at the introduction of CT scanner in Canada, we see an example 
of technology diffusion out of control.) In addition, technology has become so powerful and has 
developed so quickly, that it is literally beyond human capacity to control it. 
A sixth misconception is that the Canadian health care system is technically advanced. However, 
much of the technology used in Canada's health care facilities is from the United States, Japan, Britain 
and Europe. Canada is a resource-based economy that exports raw material and buys back technology. 
The final fallacy is that if a technology is safe, it should be used. In other words, whether a 
technology is shown to be effective or not, it should be used because it does not have perceptible 
negative effect on patients. This has been shown to be very costly and, in the long run, often harmful. 
Pitfalls to Avoid in Utilizing Technology Assessment 
There are several problems and issues to avoid when introducing a technology assessment process in 
your organization: 
The process may be initially interpreted as being a "tactic" or "stonewall" in the diffusion of new 
technology. Involve those who are likely to be the distracters and ensure that the process is 
rational, analytical and objective. 
The senior members of the organization must be committed to the importance of the process. 
Avoid overloading the committee with too much work at the outset. 
Some will accuse the technology assessment process as being "antiscience" or "antitechnology." 
Involving respected members of the medical staff who have a broad vision of health care delivery 
in the 1990s will help to ameliorate this criticism. 
Take the time to assess existing technology already in use in the facility as well as the new 
technology arising. 
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Recognize that strong departments with good organizational skills will be able to accommodate to 
the technology assessment process easily, and ensure that good ideas that do not have a champion 
do not get lost. 
Finally, it is useful to recognize that introducing a technology assessment process does not avoid 
the necessity for tough decision to be made. In fact, the process really forces the organization to 
look very carefully at what trade-offs can be made to achieve the objective of introducing a 
beneficial technology. 
Conclusion 
I have attempted to provide a broad description of the context in which the technology assessment 
process was introduced at GVHS. The model developed at GVHS may not be appropriate for other 
facilities, and organizations should assess carefully which characteristics would be useful in their 
settings. What has become clear since the introduction of the process is that it must become well 
integrated into the culture and functioning of the organization to be successful. The case study of the 
Laparoscopic cholecystectomy example provides evidence that a rational approach to assessing 
technology can facilitate a rational introduction and continuing evaluation of technology. 
Good luck with meeting the challenges of technology in the future! 
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This group lo?ked at the implementation of a new technology, laparoscopic cholecystectomy, in a 
community hospital not a#liated with a university, the Greater Victoria Hospital Society (GVHS), in 
Victoria, British Columbia. 
How do we define a needs-based technology assessment approach? 
The first question which came up was: whose needs are we talking about? Needs were identified from 
three drfferent perspectives: those of the consumer or client, the needs of the provider and the needs 
of the policy-maker. 
With respect to the consumer or client, there was information from the popular literature, that the 
consumers or community could easily access, in such magazines as MacLean 's, the Red Book, etc. In 
terms of the advent of this "new and wonde&l technology," there were issues of interest to the 
consumer or client such as: shorter hospital stays, much less suflering in terms of pain, getting back 
to work much faster than with an open cholecystectomy and this of course for clients, including 
ourselves, would be very enticing. It was dzfficult to assess what their information was in terms of 
efficacy or safety of this particular procedure; from the poplar literature, it almost seemed like a 
"magic bullet." 
Turning now to the health care providers (the surgical stafland people who work with the surgical 
stafn, there was an awareness of this procedure; this technology was developed in Germany in the 
early 1980s and was brought into North America in the late 1980s. By then, there were some hospitals 
that had invested in training their surgical stafl to per$orm this procedure. At the GVHS, there was an 
interest among the surgeons who would perform this intervention at this particular hospital. There was 
also a commitment by the surgical staflto contribute to cost savings: the surgeons were committed to 
actually closing the be& saved by the shortened length of stay. 
In terms of the policy makers, there was a strong interest generated because policy makers are 
continuously looking for safe and eflcacious interventions that are much more cost-eflective. 
Has This Study Taken a Needs-Based Approach? 
In terms of this second question, the rates for cholecystectomy were well known in the general 
population and the volume of procedures and their resource utilisation were well documented at this 
particular hospital. Nee& of the three constituencies mentioned above were taken into account. 
What Were the Needs-Based Methodologies Used in mis Case Study? 
The methodologies used for the implementation of this new technology included literature reviews and 
site visits to hospitals that had alreody implemented the technology;@rthennore, in this particular 
hospital, there was already a Technology Assessment (TA) model in place, used to evaluate existing 
interventions both in medicine and in surgery. 
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What Are the Emerging Overall Methodologies or Approaches to Needs-Based 
Technology Assessment? 
Many models already exist. The Technology Assessment process at the G W S  was described. 
Did the Technology Transfer Actually Take Place? 
Yes, there was a technology transfer. There was a commitment to training and to certtfication. This 
hospital invested in the training of their stafJfrom other institutions in Canada. They came back and 
taught their own sta8 Cerh3cation of physicians was a hospital-based procedure and not a college- 
based procedure. There is ongoing monitoring of outcomes (rate of complications, conversion rate 
from closed to open procedure, infections, patient satisfaction, cost-saving measures). 
Were the Case Study Results Linked to Policy Making? If So, How? 
The policy of this institution is to provide the best possible care at the least cost possible. Improved 
patient outcomes and clear cost reductions were shown in the interim analysis. 
The money savedfrom closing hospital be& was plowed back into the institution. Were these true cost 
savings? There were a lot of questions about whether or not this was appropriate. Who are the 
persons who decide what to do with the money that is being saved? 
One interesting outcome was the formal adoption of clinical guidelines. This specific activity 
generated a broad interest in practice guidelines. It also demonstrated the success of this TA process 
which, in this case, was hospital-based and which was not limited to this particular procedure but was 
used for other technologies being considered by the hospital. 
This case is particularly interesting because of the fact that this is a hospital-based TA model as 
opposed to any model linked to a regulatory agency or an academic institution. This is one of the first 
such models and this has clear implications for policy. The GWS is a large community hospital with 
no formal ties to teaching institutions which would be in a position to supply epidemiological and 
biostatistical support for TA. In spite of this limitation, it was suggested that this case study 
demonstrated the success of the TA process developed and implemented within an institutional setting. 
Finally, the issue of the broadening of indications was raised, as the annual number of 
cholecystectomies had gone from 575 in the previm year to 620 in the current year. It was 
mentioned that it appeared that there may be some asymptomatic gall bladder disease which is being 
responded to. This will require some further analysis and was one of the reasons for continuing the 
monitoring and pursuing the analysis. It was also mentioned that one had to be careful in examining 
the numbers as these could reflect patients coming from other areas to this hospital in order to get the 
newer procedure or patients having waited to have surgery until the new procedure was available. 

PART Ill - 
OPPORTUN~TIES AND CHALLENGES FOR COLLABORATION 

- 
THE CONCEPT AND KEY IDEAS EMERGING FROM THE 
Elizabeth McGregor and Yves Bergevin' 
Rationale Behind the Concept 
The challenge confronting conference participants was to translate the debates and discussions of the 
conference into action-oriented recommendations for health development. The concept, around which a 
rich range of ideas crystallized, was the idea to create a "tool kit" - a mobile, interactive, electronic 
"tool box" containing a selection of "best-practices" and tested tools to assist health care policy- 
makers in the planning and provision of health care to communities and countries. 
Enthusiasm to assemble a "Needs-Based Technology Assessment Tool Kit" containing best practices, 
tested methodologies and case studies from around the globe was expressed by participants who 
wished to promote globally consistent and standardized approaches to community-based health 
development. 
The tool-kit concept was also supported by participants involved in development who sought support 
from their colleagues to facilitate "knowledge-brokering" to communities and countries without 
immediate access to the already researched range of options in order to avoid wasting scarce resources 
on reinventing the wheel while at the same time promoting a sound policy process and needs-based 
decision making. 
' Elizabeth McGregor is currently Policy Analyst: Office of the Science Advisor to the President, 
International Development Research Centre (IDRC), Ottawa, and Director of Studies: Gender Working Group, 
UN Commission on Science and Technology for Development. Previously, she was Director, Science and 
Technology Task Force, Prosperity Secretariat of the Minister of Industry, Canada; Team Member, Food Safety 
Task Force and Member, Policy Review Secretariat, Agriculture Canada. She worked with the Food and 
Agriculture Organization (FAO) on a South East Asia Field Assignment and at Headquarters. She was the 
Founding President of the World Women's Veterinary Association (WWVA), a global nongovernmental 
organization. Dr McGregor was on the Board of Advisors of Women in Livestock Development, Heifer Project 
Intemational, and received an Award of Distinction from the American Association of Women Veterinarians. 
Yves Bergevin, MD, MSc (Epidemiology), CCFP (Family Medicine), FRCPC (Community Medicine), is 
Senior Specialist, Health and Population, Canadian International Development Agency, on an interchange from 
McGill University where he is an Associate Professor, Departments of Epidemiology and Biostatistics and of 
Family Medicine. Prior to this interchange, he was Associate Dean, Inter-Hospital and Govemmental Affairs and 
Director, Faculty Programme in International Health, Faculty of Medicine. He has worked in northern Quebec 
with Cree and Inuit communities; with the Quebec Ministry of Health to reorganize health services in outlying 
regions; in Ethiopia as Project Director of the McGill-Ethiopia Community Health Project; and as a consultant 
to WHO, CIDA, IDRC, the World Bank, the Province of Quebec, and the Canadian Medical Association. He 
specializes in health policies and health systems both in industrialized and developing countries. 
An addttional advantage to seeking support for the development of such a generic, internationally 
accepted "tool kit" was the apparent need for donor agencies to have available to them a generic guide 
for their discussions with countries concerned with community health development and the allocation 
of precious and scarce resources. 
Such a standardized source of information and accepted approaches has predecessors in the health 
field. In a process similar to the "tool kit" concept for needs-based technology assessment, others have 
already operationalized the concept of "essential drugs" and "essential equipment" in health delivery. 
Policy and planning methodologies are advanced enough to promote and disseminate a standardized 
set of "essential methods" in decision making. 
The creation of a user-friendly tool kit containing such a set of "essential methods" for community- 
based health development would promote an orderly approach to sound policy decision-making. The 
use of such a kit would lead to more community-based health development, "needs-based" health 
policies, services and technologies incorporating the concepts of equity, consensus building, 
accountability, cost-effectiveness, priority setting, community involvement and community-based 
governance. 
Characteristics of Desirable Tool Kits 
First and foremost, the tool kit is intended to be interactive and ever-evolving. With sufficient tools at 
hand now, a "starter kit" could be designed to promote international cooperation. In different 
disciplines, there exists already a rich range of decision-making tools. Some, which could be placed 
into the tool kit are robust, well researched and ready to be applied. Other tools, in earlier stages of 
development, could be placed into the tool kit to be fine tuned and substantiated by added case studies 
and inviting partnerships in furthering research and application. 
Such a tool kit should be adapted for the three strata of the health system; the institution or health 
centrehospital; the district entities; and federal or Ministry agencies. Tools should also be selected to 
serve decision-making across the whole spectrum of health professionals involved in the policy 
process from practitioners to public servants. 
Tools placed into the kit should be generic and suf?i?iciently adaptable as to be tailored to suit local 
environments in different communities globally. Designed to set out "essential methods" in needs- 
based technology assessment for communities, the kit should promote simple, rapid assessment 
techniques. Methods should lead to choices of "appropriate technologies" in the community context. 
Additionally, the tools should be used together to the degree possible since technology assessment is a 
synthetic or systemic process. Each tool interacts dynamically with the others in the system. 
A "living" and evolving tool box requires designing the network to provide users the freedom and 
capability to provide feed-back and contribute to the fine-tuning of the tools. Furthennore, participants 
envisaged a network where users could seek advice and expert opinion by activating various nodes on 
the network. Several suggestions were tabled. Internet and the global information highway could play 
an important role in achieving this dynamic vision. Access to MEDLINE should be included and in 
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this regard, participants suggested that information available under the "Devices" heading would be 
useful.The HEALTH Planning and Administration database, a companion of MEDLINE provides 
references to biomedical literature addressing nonclinical aspects of health care delivery. 
Ultimately, the tool kit must remain flexible, "portable" and user-friendly. The challenge to the design 
team will be to make available a broad range of rapid decision-making techniques without weighting 
down the system with cumbersome details. The reward to reap, well beyond resource savings, is the 
expectation that a health system which currently suffers from a lack of predictability or accountability 
can become grounded in a set of guidelines leading to an equitable and "needs-based" policy process 
in health. 
Contents of the Tool Kit 
What might a tool kit contain? Discussions among participants suggested that such a "Needs-Based 
Technology Assessment Tool Kit" should contain at least the following "tool sets"; 
Assessment of "Burden of Disease7' and "Needs7'; 
Technology Assessment Priorisation (for services, education, and research); 
Measuring Cost-Effectiveness; 
Tools for "Equity" and "Distribution"; 
Management Training Tools; 
Policy Formulation Tools; and 
Practice Guidelines Incorporating "Evidence-Based Technology Assessment." 
Physically - the form of the tools within the kit could take the form of software packages, such as 
PHC MAP (described in Case Study 5); networks of resource persons; catalogue or inventory of 
existing resources; videos; leading articles and books; case studies from around the world; and 
electronic networking and information systems such as the "Cochrane Coll aboration." 
Elaboration on Each Tool Set 
Assessing "Burden of Disease" and "Need" 
Conference participants recognized that different constituencies could arrive at quite different 
assessments of "needs" and lists of "priorities." Communities and users, health care providers, public 
health specialists and politicians - each have their own objectives and approaches to "needs" 
identification. Good health program decisions require judicious partnership between these different. 
stakeholders. 
Conference participants recognized the invaluable contribution of the World Development Report 1993 
"Investing in Health" (World Bank, Oxford Press, 1993) - particularly in its approach to the 
assessment of "burden of disease" through the use of disability adjusted life years @ALYs). Readers 
are referred also to one of the key background documents entitled Diseuse Control Priorities in 
Developing Countries (Jamison, D.; Mosley, T.; Measham, A.R.; Bobadilla, J.L., ed. 1993. Oxford 
University Press, New York, NY, USA.). This approach builds upon that of others using "Potential 
Years of Life Lost" (PYLL) or "Quality Adjusted Life Years" (QALY's). 
11 6 - HEALTH TECHNOLOGY ASSESSMENT 
Caution was expressed, however, in employing these methods indiscriminantly in the context of 
developing countries. These methods are re1 atively cumbersome. They require quantitative information 
and usually focus on "disease entities" rather than on "health determinants." The absence of good 
data, or the biases in existing data (e.g., referral bias from health facility-based providers) for 
important conditions such as violence against women, trauma from road accidents or physical 
violence); and the near impossibility to quantify the effects of health determinants such as education, 
sanitation and water, housing, nutrition, status of women and fertility could potentially lead to 
important miscalculations of the "ranking" of burden of disease or contributing factors. 
Furthermore, it was noted that the focus on disease entities could lead to a skewing of policy towards 
health service interventions where alternative health development strategies might have been more 
cost-effective. Tools addressing alternative "health development" strategies could be far more cost- 
effective and should be placed into the kit in a balanced and complimentary fashion. 
Likewise, the "wants" of consumers - and the "needs" identified by health care providers, if 
combined with politicians' wishes to please all constituencies, could lead health systems to bankruptcy 
while not having an optimal impact on the health status of the population. "Wants" and "needs" must 
be kept in check through a rigorous quantitative population approach. In this context, the integration 
of a "public health" perspective starting in the early stages of the curricula of future health providers 
appeared essential to symposium participants. 
Assessment tools tailored to the specific conditions of different socioeconomic subgroups within 
communities, such as street children or displaced persons, should be supported. 
"Rapid assessment methods," drawing upon a mixture of qualitative and quantitative methodologies 
(such as key informant interviews, and focus groups) and including sufficient community 
representation and representation of providers - linked with rapid epidemiological methods such as 
community surveys or sentinel site surveillance could provide a useful set of tools. 
As an initial step in priority setting, tools to ensure "feed-back" of information obtained from all 
sources - and from consensus building methods - can be included into the kit to help policy 
makers. 
The conference also elevated the issue of "power relationships" between various groups in the decision 
process like politicians, health care providers and various groups in the community. Where power is 
disproportionately distributed, decisions taken can end up serving selected power groups rather than 
the "basic needs" of the community as a whole. While the power of consumer activism can be 
persuasive, it is based upon an informed choice between alternative policy options and therefore, 
requires concerted effort and resources dedicated to public information. 
In summary, it appeared essential to include in the kit tools to facilitate participatory decision making, 
consensus building and public information. Such tools are an essential part of the kit and the objective 
to achieve a health system responsive to the needs of the population which it serves. Such a strategy 
requires tools for communication and a commitment to a networking strategy among consumers, 
providers and policy-makers. 
Interesting resource materials mentioned during the group discussions included Guide to Health Needs 
Assessment: A Critique of Available Sources of Health cmd Health Care Information (revised ed. Larry 
W. Chambers, Christel A. Woodward, Caroline M. Dok. Canadian Public Health Association, Ottawa, 
ON, Canada 1983). 
Technology Assessment Priorization: Services, Education, and Research 
Building a "tool box" to assist policy makers with priority setting in "needs-based" community health 
decision making should take into account at least the following factors: burden of illness (current 
situation and future trends); community concern; health development strategies; and the availability of 
cost-effective interventions. A range of sensitivities including political circumstances, the social 
environment and the economic context are must be considered in the decision process. 
Tools should be adaptable to priority setting at the local, district and national level. The use of 
consensus-building methods such as those promulgated by the Institute of Medicine and the Office for 
Technology Assessment (USA) are important tools to ensure sustained commitment to adopted 
strateges. Examples of important priority setting exercises mentioned at the conference included the 
US "Health Objectives of the Nation" and the priority setting work camed out by Oregon State. 
Education of health providers should include sufficient public health training from an early stage to 
ensure appropriate "needs-based" priority setting by these future health providers. The training should 
also be task-oriented, taking into account the priority health problems and appropriate technologies 
chosen to address them. 
Priority setting in research can also be facilitated by developed tools. Examples are available to policy 
makers to build upon such as the work of the Commission on Health Research for Development 
(Health Research: Essential Link to Equity in Development. Oxford University Press, 1990). The Task 
Force on Health Research in Development Report (A Strategy for Action in Health and Human 
Development, Geneva, Switzerland. 1991) is a further example of methods to employ in setting 
priorities in research. The concept of "essential national health research implies priority setting for a 
nation. The Commission also emphasizd the determining role of "research capacity building" in 
developing countries to ensure that each country can address its own "essential national health 
research" agenda 
Measuring Cost-Effectiveness 
Conference participants reviewed the difference between the concepts of "efficacy" (theoretical and 
under well controlled conditions), "effectiveness (as applied in communities); and the similarity 
between "efficiency" and "cost-effectiveness." Strengths and weaknesses of different research designs 
were reviewed including case-control studies, cohort studies and randomized controlled trials (RCTs). 
Often, the cost-analysis component can be added to a community-based RCT without significant 
additional cost or effort. This enables the policy maker to secure cost-effectiveness information 
without carrying out further studies. While the RCT remains the gold standard and should be strived 
towards wherever possible, field conditions and ethical considerations often preclude its use. Other 
designs, if carefully planned, executed and analyzed with appropriate caution, can often lead to 
important results at lower costs. Useful resources include the book entitled Economic Evaluation in the 
Development of Medicines Wchael Drummond, Office of Health Economics, London, UK. 1988) and 
also selected World Health Organization (WHO) publications. 
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Equity and Distribution 
The concept of equity-centred health development permeated the deliberations of the conference. In 
order for cost-effective technologies and health services to have the maximal impact on the health of 
populations, they must be readily accessible to all. Access to quality health programs should be 
equitable in terms of geography (adequate distribution of appropriate health facilities), in terms of 
financing (at a cost which communities can afford and subsidized for the poor); and responsive to 
sociocultural considerations such as language, ethnicity, religion, and education. 
Equity was accepted as fundamental to community based health development. To concerns that true 
equity was uneconomic, the clarion response was that anything which fell short of this standard was 
not only unethical but also unsustainable in the long run. Furthermore, participants noted that the 
concepts of "cost-effectiveness" on the one hand, and "equity" on the other can be complimentary and 
linked to advantage. As one conference participant said: 
If we are efficient, then it is much easier to be equitable in our distribution of services. 
The concept of allocative efficiency is defined in the "World Development Report 1993," as the 
"extent of optimality in distribution of resources among a number of competing uses." It includes not 
only the concepts of equity and distribution, but also the optimal mix and packaging of health 
technologies and programs which will have the maximal health status impact per unit of resource 
invested. 
Useful resources mentioned include Guyatt's "Technology Assessment" book and, in particular, the 
chapter written by Roberta Labelle and David Bantas on technology assessment in developing 
countries. (Reference: Feeny, D. ; Guy att, G.; Tugwell, P., eds. Health Care Technology: Eflectiveness, 
Eficiency and Public Policy. Institute for Research on Public Policy, Montreal, PQ, Canada. 1986.) 
Management Tools 
Conference participants pointed out the need to include in the kit, management training tools. Often, 
management does not receive the attention it deserves in developing countries. Frequently, it is the 
weak link in the chain between "needs-based" technology assessment and the delivery of effective and 
efficient services. The hierarchical structure and authoritarian style of administration in many countries 
does not foster managerial leadership or commitment to reform. The lack of gender-balance in 
management or lack of presence of other minorities also limits the likelihood that management 
appreciates the full range of issues and options. 
Yet, managers are the key link between policy decisions taken at the "top" of structures, and the 
actual operations of health services at the "bottom" - the community. Also, the district level was 
recognized to be essential in ensuring linkages between policy makers and those who implemented 
policy in developing countries and developed countries alike. The tool kit design, therefore, should 
address the needs of district managers. 
Tools should facilitate effective delivery and feed-back mechanisms. The "communication" skill set of 
managers was viewed as critical to successful strategies in the implementation of community health 
development. Flows must be facilitated between the decision makers, the managers, and the 
community of care. "Feed-down" and "feed-back" are both important in effectively influencing 
decisions and implementing policy. 
A superb example of a "tool set" for inclusion in the "tool box" is the Primary Health Care 
Management Advancement Programme (PHC MAP) of the Aga Khan Foundation. The software 
version of modules includes reference documents and allows for easy adaptation of material to local 
needs. 
Some participants felt that effective management tools could be borrowed from successful examples in 
the private sector. The obvious caution expressed by others to this strategy was to keep in mind the 
difference in end objectives between "public" and "private" pursuits. Public policy is directed towards 
achieving the greatest good for the greatest number. Private sector policy is driven by the profit 
motive. 
Policy Formulation: Roundtables, Consensus Conferences 
Tools are also available to facilitate effective "policy formulation." Like management, policy 
formulation has not received the attention it deserves, especially in developing countries. In many 
cases, this has lead to decision-making based more on political expediency rather than community- 
based needs. 
Policy is often influenced by pressure from international agencies without taking sufficiently into 
account the needs of the population. For example, without questioning the need for structural 
adjustment, most would agree now that structural adjustment programs have been implemented to date 
with insufficient attention to the needs of the most vulnerable groups or key development sectors such 
as education and health. 
If policy formulation is truly to reflect needs, it must take into account community concerns. This 
"democratization" of the policy formulation process is fundamental to building commitment and 
achieving a sustainable result. This consensus-building from the grassroots up requires significant 
community involvement; and the use of consensus-building tools including documents, focus groups 
and policy roundtable exercises. Community participation has to be developed in a systematic way, 
particularly when it comes to the priorization process. 
Research must be relevant to policy formulation. The Essential National Health Research (ENHR) 
effort has not yet lead to significant policy formulation. Some Conference participants suggested that 
this global effort be renamed 'Essential National Health Research and Policy (ENHR-P)." Universities 
could build on their traditional strength in research by focusing on essential research and its attendant 
policy formulation aspect, thus contributing further to the advancement of the society. 
Unlike other aspects of technology assessment, the "science" and "methods" of policy advocacy are in 
their infancy. Policy advocacy tools are essential components for the tool kit. The development and 
testing of such tools was identified as a priority. Readers are referred to the work of Jonathan Lomas, 
the presentation of Dr Davidson R. Gwatkin, later in this publication, on the "International Health 
Policy Program," and the material produced by this Program. 
Practice Guidelines Incorporating "Eviden ce-Based Technology Assessment" 
Practice guidelines, previously focused on physician bbproviders," should be developed for all 
categories of health professionals - and expanded to apply to a variety of settings within the health 
system. Useful resources in this field include the work of John Ferguson and that of the "International 
Technology Assessment Society." 
Conclusion 
Conference participants welcomed the action-oriented recommendation to seek support for the design 
and dissemination of a "Needs Based Technology Assessment Tool Kit." Lively discussions led to the 
design of some elements of such a "starter kit." Agencies like the International Development Research 
Centre (IDRC) in Canada are particularly active at this interface as agents of "knowledge-brokering." 
The conference urged support for the "Tool Box" as a critical next step. The need is urgent as 
national health care resources evaporate and critical choices between technologies loom large. The 
time is ripe. Tools are already on the shelf. Others are in the making. 
The conference concluded that the design and implementation of a health in development "Tool Box" 
was an essential next step - toward achieving equitable and sustainable "needs-based" community 
health policies and programs globally. 
Davidson R. Gwaikinl 
Please allow me to make a few comments on the topic of health policy as it relates to needs-based 
technology assessment. I am associated with the International Health Policy Program. This Program 
provides grants in Africa and Asia to groups of policy-makers and researchers. Our explicit objective 
is to try to bring about policy change; which is not to say that we always succeed. 
Our experience and the experiences of others leads me to make a set of suggestions: four of them 
have to do with how to work in an environment where there is a reasonable chance of attracting the 
policy-makers' interests: in other words, how to build bridges and; three other suggestions on how to 
work in hostile environments, where only politics count. Let me say that none of these suggestions is 
magic and they all have their down sides. 
Working in a Receptive Environment 
How do you build bridges with policy-makers when the environment is receptive? First of all 
involving them from the beginning; this has been mentioned previously and is fairly straight forward. 
This means not just going to them with topics that you think are important and seeing if you can get 
them on board, but rather going to them and asking what is on their mind and then using that as the 
basis for selecting a topic. In other words, their interests rather than yours should be the determining 
factor in what sets the policy research agenda 
The second point, which has also been mentioned, is reliance on policy round tables and other 
dissemination techniques for research results. The third point is: be flexible in formats; do not think 
just or even primarily in terms of scientific publications, the standard approach taken. But think of 
mechanisms such as memos and conferences. I, for example, have argued that the International Health 
Policy P r o m  should be prepared to support the preparation of confidential memos between the 
researcher and the Ministry that we would never see. 
Fourth, focus more on personal relationships than on policy products. I would argue that individual 
studies very rarely bring about any significant policy change. Policies are made through endless 
rounds of committee meetings and private discussions over dinner. The point here is to get somebody 
at the table where the decisions are made so that helshe can participate on a regular, on-going basis. 
Working in a Hostile Environment 
In this second part, we will deal with ways of working in hostile environment where only politics rule. 
Here again, there are three suggestions and I would stress they are even less perfect. They convey no 
guarantee of success, rather they just change the odds slightly. 
Davidson Ryan Gwatkin has been Director of the International Health Policy Program, the World Bank, 
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Affairs ftom Princeton University and the author of numerous publications in the field of health policy and 
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The first suggestion is to take the long term view: remember that times change, settle in, and bet on 
the chance that there will be change. As Dr. Battista said earlier in the Conference, the policy climate 
does seem to be changing. Concern yourself with getting the capacity developed, the work done, and 
your recommendations ready to go for the day when conditions change and you can put them into 
effect. A dramatic case example of that came in Chile with the overthrow of the Pinochet regime. 
Jorge Jimenez, who had been working on policy reforms during the previous five years, became 
Minister of Health and was able to move quickly on a set of reforms. 
Second, be an opportunist: look for opportunities and find a niche in a hostile world. Now not every 
Government is inevitably hostile to e v e w n g .  A dramatic instance of this was in El Salvador where 
UNICEF got a day of truce in the warring factions. You would have thought that a country in the 
middle of war is not a time where you can bring about interventions. But UNICEF managed to 
persuade both sides that it would be to their political advantage to hold a day of truce and run an 
immunization program. 
A third suggestion would be don't think of just cooperating with Government. Instead, you can go 
into opposition and use empirical information to reveal scandals and embarrass governments into 
change. Here is an example again citing UNICEF. In The Progress of Nations, issued just recently, 
UNICEF ranks countries by their performance on each of selected health, education and development 
indicators, in an explicit effort to embarrass the governments at the lower end of the accomplishment 
pattern to do something. They have had hostile reactions, but they are getting change. 
I hope that these few suggestions for policy influence might prove useful. 
SYNTHESIS AND RECOMMENDATIONS FOR ACTIONS - 
Chitr Sinhi-Amorn 
What should we take away from here, where we should go? 
During the Conference, we discussed "whose needs?" - those of the consumer and the point of view 
of the society, those of the provider or of the policy-maker. I would like to suggest that the society 
view point must be the most important one because, in the end, consumers might want services that 
benefit them. The perception of the society should be incorporated into the needs assessment. 
I would like to suggest however, that, although these views may be important, they might reflect only 
the felt needs and not the unfelt needs; they might reflect supply-induced demand and therefore 
represent a misconception of true need. 
We should consider three kinds of needs: need for action, need for research and need for education. In 
terms of need for action, not only do we have to focus on treatment modalities but also on the 
preventive approach. Furthermore, we must focus on equity-centred health development. Who does the 
assessment? is it the influential card holder or the social activists? How do we prioritize the needs 
identified by different stakeholders? 
We should try to apply the existing methodologies and tools together, bearing in mind that a balanced 
perspective is the most important, without reflecting the viewpoints of any specific interest group 
while, at the same time, not ignoring the cultural context. 
What do we want to achieve out of policy development? we are striving for equity, efficiency and 
quality services. The policy debate must progress from the political expediency to a more technical 
approach. This would be possible through the early involvement of the politicians in the policy 
formulation process with the support of the policy and planning division of the ministry of health. 
Start with the interests of the politicians, build consensus, be flexible on format, be prepared for the 
long term approach or to go into opposition. Better policy advocacy tools need to be developed and 
tested. 
At the program level, we should address allocative efficiency including optimal facility planning and 
manpower planning, that is trylng to match the distribution of the available technology with the needs 
of the population. 
Certain technologies are already available and we should make better use of them. One of the 
instruments mentioned during this Conference is the National Account Expenditure versus Health 
Status. This tool, I believe, has been underutilized; it can provide considerable information. As an 
example, one can examine the production function: output versus expenditure, for different categories 
of health facilities . 
Let us turn now to management efficiency. The Primary Health Care Management Advancement 
Programme (PHC MAP) is an excellent tool, especially for certain levels of the health system. Given 
the importance of sound management of the health system, more management tools are needed. 
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Concerning technical efficiency, we discussed cost-effectiveness, efficacy and safety. I would suggest 
that we also need to look at the quality aspect using total quality management methodology. This 
should allow a critical appraisal of the quality of services provided within the health institution; the 
appropriate feedback to management and; the setting of targets for continuous quality improvement. 
The tools hscussed during this Conference should be in the hands of competent craftsmen; solid 
training of health professionals is one of the most important health service investment a country can 
make. The linkages between the tools are just as important as the tools themselves. Communication is 
therefore very important. 
Finally, we need both North-South and South-South collaboration. For example, Thailand has certain 
capacities to help countries like Laos and Vietnam, yet at the same time Thailand also needs to 
collaborate with countries such as those in North America. These transfers bring technology to bear on 
local problems in the South. This, I believe, is one of the most important themes as it will contribute 
to better health in developing countries. 
SYNTHESIS AND RECOMMENDATIONS FOR ACTIONS - 
ONE PERSPECTIVE 
Judith Mawelf  
Being a newcomer to health research, I want first to express my admiration for what you have done 
here in the last 2 days. I also want to say that I am immensely proud of the prominent role of women 
in these proceedings. In the kind of economics that I do on a regular basis, there are far too few 
women in leadership positions. 
If I had to summarize the meeting in three words, they would be "knowledge is power." Power here 
being the capacity to allocate resources rationally. Knowledge also shifts the locus of decision-making: 
who makes the decisions and whose concerns are accounted for when those decisions are made. 
Laporoscopy - /- R h e u m y  D. 
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Elg 1. The Technology Assessment Iterative Loop or 'TAIL" Source: Tugwell. 
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Health Technology Assessment is, as we defined it in our last discussion group, an orderly way of 
thinking, a way of organizing information for policy but also for practice. Here, there is much shared 
temtory between South and North. 
Going back to the opening of the Conference, I would like to remind you of this slide which Peter 
Tugwell used earlier (Fig. 1). The case studies we have discussed have taken us through the whole 
loop of Technology Assessment. 
We have looked at studies where we were trying to identify the burden of illness and some of its 
causation (Rheumatic Diseases). 
We looked at studies where we focused on community effectiveness (ART in the Philippines and 
the Cameroon case). 
The Caribbean case looked at the efficient use of resources. 
And the last two cases examined management issues (PHC MAP and Laparoscopy). 
This shows excellent planning on the part of the organizers and has permitted us to work on a wide 
range of Technology Assessment issues around the whole Technology Assessment Iterative Loop. 
Borrowing another slide from Peter Tugwell's presentation (Fig. 2), it strikes me that we really 
concentrated our debates on the issues of systems compliance and the patient-subject compliance. 
These are all community issues. 
We learned about the importance of the village health worker in the South as being the key agent 
transmitting knowledge into the community. Shehe is also the agent with the capacity to collect the 
primary data necessary to move the information back up the loop to policy-makers. 
The study of the extent to which the manoeuvre, 
procedure or service does more good than harm 
to those patients (citizens) in need 
COMMUNITY 
EFFECTIVENESS 













(CAN IT WORK 
IN IDEAL 
CIRCLIMSTANCES?) 
Fig. Z Community Effectiveness. Source: Tugwell. 

stanlng what the community beliefs are, why things are not happening, how we can better transmit 
information into the community, and how we can make policy more sensitive to community needs. 
Other common issues between South and North include 
First of all, that there is an important role for the social scientist in technology assessment. Not 
just economists like me, but also anthropologists and sociologists, who can help us deal with 
cultural beliefs. 
Second, there are common gaps in knowledge about the burden of disease; about client concerns; 
about community-effectiveness and system performance. 
Third, the tensions in the system are remarkably similar. We are debating whether to focus on 
health or on illness. We are concerned about whether we have over allocated resources to the 
tertiary sector versus the primary sector. And many of us wonder whether sustainability is more 
important than achieving a biomedical breakthrough. 
Finally, on the policy-making side, there is a common concern as to whether information will 
govern decisions or whether it will be strictly a political process. 
In essence, we are all aiming to improve health status and to reduce costs. So, I am going take time 
for a short commercial and show you the framework that we are using in the project on the cost- 
effectiveness of the Canadian health care system, directed by Doug Angus (Fig. 3). 
In Fig. 3, we are looking here at the health care system; we have, if you want, stove pipes. One 
describes the Human and Material Resource inputs that go into health care; the hospitals, physicians, 
the medications, and the continuing care. Then, we have the Cost per Treatment, which is a huge gap 
in information in Canada, so we have invested a lot of research time in linking costs to the inputs. 
Then, we want to link that to the outcomes from the system, using the Oregon system of Quality 
Adjusted Life Years (QALYs) and adapting them for Canada. 
The objective is to assess the cost-effectiveness of the current system, and then to explore changes in 
the allocation of health care resources that would lead to improved health status or to dollar savings. 
Now, we recognize that there are many other determinants of health status that will not be quantified 
in this project. It is, nonetheless, a broader picture of the health care system than anyone else has 
produced to date. 
We call it a "patchwork quilt" because we have to take proxy information from so many different 
places. But, like the World Development Report, what we are really trying to do here is to be the 
pioneers. We want to make policy-makers and researchers realize where the information gaps are. This 
should help to drive the research and data collection process in new directions. 
Again, I want to thank you for inviting me to participate, and to thank the organizers for 2 fascinating 
days. 
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